ާක≮▤ℂቇ⻠ᐳި㧔1㧕ක≮ᖱႎቇಽ㊁1㧚⎇ⓥߩ᭎ⷐ
ᖱႎㅢାᛛⴚ㧔ICT㧕ߩ⊒ዷߦࠃࠅ࡜ࠗࡈࠨࠗࠛࡦࠬߦ㑐ߔࠆᄢ㊂ߩ࠺࡯࠲߇⊒↢࡮࠺࡯࠲ࡌ࡯ࠬൻߐ
ࠇߟߟ޽ࠆ‫ߚ߹ޕ‬㧘EBM㧔evidence based medicine㧧⑼ቇ⊛ᩮ᜚ߦၮߠ޿ߚක≮ߩታ〣㧕߇ต߫ࠇࠆਛ㧘ࠦࡦࡇࡘ࡯࠲ᛛⴚ࡮ᖱႎಣℂಽ㊁߆ࠄߩᛛⴚ⒖ォߛߌߢߥߊ㧘⫾Ⓧߐࠇߚᄢⷙᮨ࠺࡯࠲ߩቯ㊂⊛ߥ⸃ᨆ࡮
ಽᨆᚻᴺߩ㐿⊒߿⸃㉼㧘୘೎ൻක≮߿ഃ⮎ߦᓎ┙ߟᣂߒ޿⍮⷗ߩ⊒⷗߇ᦸ߹ࠇߡ߅ࠅ㧘࡜ࠗࡈࠨࠗࠛࡦࠬ
ಽ㊁ߦ߅ߌࠆᣂߒ޿࠺࡯࠲ࠨࠗࠛࡦࠬߩ⏕┙߇ᕆ߇ࠇߡ޿ࠆ‫ޕ‬ක≮ᖱႎቇಽ㊁ߢߪ㧘ߎߩࠃ߁ߥ␠ળ⊛ⷐᦸߦᔕ߃ࠆߎߣ㧘․ߦ࡜ࠗࡈࠨࠗࠛࡦࠬಽ㊁ߢߩ࠺࡯࠲ࠨࠗ
ࠛࡦࠬࠍ᭴▽ߔࠆߎߣࠍ⋡ᜰߒ㧘ᣣᏱ⸻≮ߢ⊒↢ߔࠆฦ⒳ᖚ⠪ᖱႎ߿ஜ⸻ߢ⊒↢ߔࠆஜᐽᖱႎ╬ࠍ⛔ว⊛࡮૕♽⊛ߦ▤ℂ࡮ㆇ↪ߔࠆ⛔วࡃࠗࠝࡃࡦࠢࠪࠬ࠹ࡓߩ᭴▽ߣㆇ↪㧘୘೎ൻක≮߳ߩዷ㐿ࠍ⋡⊛ߣߒߚ⸻≮ࡊࡠ࠮ࠬߩ▤ℂ࡮ಽᨆᚻᴺߩ㐿⊒㧘ක⮎ຠߩㆡᱜ૶↪߿᦭ኂ੐⽎ಽᨆߩߚ߼ߩ⍮⼂⊒⷗ᚻᴺߩ㐿⊒㧘ක≮⚻ᷣ࡮ක≮⚻༡ੱ᧚⢒ᚑࡊࡠࠣ࡜ࡓߩ㐿⊒ߥߤࠍ⎇ⓥߒߡ޿ࠆ‫ߚ߹ޕ‬㧘ࠥࡁࡓ࡮ࡐࠬ࠻ࠥࡁࡓᤨઍߩ
ࠝࡒ࠶ࠢࠬක≮ߦᔅⷐߥࡃࠗࠝ࡮ࠗࡦࡈࠜࡑ࠹ࠖࠢࠬߩഃㅧߣ૕♽ൻ࡮᭴▽㧘molecular imaging ᚻᴺߩ㐿⊒㧘⸻≮ߩᚑᨐಽᨆᚻᴺߩ㐿⊒㧘╬ࠍ⎇ⓥߒߡ޿ࠆ‫ޕ‬
2㧚ฬ★
ᢎ᝼㧦
♿ࡁቯ଻⤿
ಎᢎ᝼㧦 ౝጊ⦟৻

Yasutomi Kinosada
Yoshikazu Uchiyama

3㧚⎇ⓥᚑᨐߩ⊒⴫⪺ᦠ㧔๺ᢥ㧕
1㧕 ♿ࡁቯ଻⤿㧚Φකᬺ⚻༡▤ℂ૕೙᭴▽࡮ታᣉߦ㑐ߔࠆ⍮⼂ 9 කᬺ⚻༡▤ℂ⺰(3)㧦කᬺ⚻༡ࠦࡦࠨ࡞࠲ࡦ
࠻⹺ቯ⻠ᐳ࡮⹺ቯ⹜㛎࠹ࠠࠬ࠻㧘᧲੩㧦␠࿅ᴺੱᣣᧄකᬺ⚻༡ࠦࡦࠨ࡞࠲ࡦ࠻දળ㧧2007 ᐕ㧦317㧙359㧚
2㧕 ♿ࡁቯ଻⤿㧚⹺ቯ⊓㍳කᬺ⚻༡ࠦࡦࠨ࡞࠲ࡦ࠻਄⚖ࡆࠫࡀࠬࠦ࡯ࠬ⎇ୃᚲ ✬㓸㧚⚻༡▤ℂ૕೙ߩ᭴▽Ϋ(ᖱႎ▤ℂ૕೙ߩᢛ஻)㧦⹺ቯ⊓㍳කᬺ⚻༡ࠦࡦࠨ࡞࠲ࡦ࠻(਄⚖ࡆࠫࡀࠬࠦ࡯ࠬ)࠹ࠠࠬ࠻㧘᧲੩㧦␠࿅ᴺੱ
ᣣᧄකᬺ⚻༡ࠦࡦࠨ࡞࠲ࡦ࠻දળ㧧2007 ᐕ㧦17-4-1㧙17-4-9㧘17-5-1㧙17-5-8㧘17-9-1㧙17-9-8㧘17-10-1
㧙17-10-9㧚
3㧕 ♿ࡁቯ଻⤿㧚ࡌࡦ࠳࡯ㆬቯᚻ㗅ឭ᩺㧦ᖱႎൻ⹺ቯࠦࡦࠨ࡞࠲ࡦ࠻ᜰቯ⻠ᐳ࡮৻ᰴ⹜㛎࠹ࠠࠬ࠻㧘᧲੩㧦␠
࿅ᴺੱᣣᧄකᬺ⚻༡ࠦࡦࠨ࡞࠲ࡦ࠻දળ㧧2008 ᐕ㧦125㧙133㧚
4㧕 ♿ࡁቯ଻⤿㧚࠹ࠬ࠻࡮࡝ࡂ࡯ࠨ࡞ᡰេ㧦ᖱႎൻ⹺ቯࠦࡦࠨ࡞࠲ࡦ࠻ᜰቯ⻠ᐳ࡮৻ᰴ⹜㛎࠹ࠠࠬ࠻㧘᧲੩㧦
␠࿅ᴺੱᣣᧄකᬺ⚻༡ࠦࡦࠨ࡞࠲ࡦ࠻දળ㧧2008 ᐕ㧦177㧙180㧚
5㧕 ♿ࡁቯ଻⤿㧚ዉ౉ࠪࠬ࠹ࡓߩຠ⾰⹏ଔ㧦ᖱႎൻ⹺ቯࠦࡦࠨ࡞࠲ࡦ࠻ᜰቯ⻠ᐳ࡮৻ᰴ⹜㛎࠹ࠠࠬ࠻㧘᧲੩㧦
␠࿅ᴺੱᣣᧄකᬺ⚻༡ࠦࡦࠨ࡞࠲ࡦ࠻දળ㧧2008 ᐕ㧦181㧙188㧚
6㧕 ♿ࡁቯ଻⤿㧚ᗧᕁ᳿ቯᵴ↪ᡰេ㧦ᖱႎൻ⹺ቯࠦࡦࠨ࡞࠲ࡦ࠻ᜰቯ⻠ᐳ࡮৻ᰴ⹜㛎࠹ࠠࠬ࠻㧘᧲੩㧦␠࿅ᴺੱᣣᧄකᬺ⚻༡ࠦࡦࠨ࡞࠲ࡦ࠻දળ㧧2008 ᐕ㧦205㧙215㧚
7㧕 ♿ࡁቯ଻⤿㧚㔚ሶࠞ࡞࠹㧦ᄢ㑐ᱞᒾ㧘ㄭ⮮⋥ታ✚✬㓸㧚ዊఽ⑼ቇ╙ 3 㧘᧲੩㧦කቇᦠ㒮㧧2008 ᐕ㧦286
㧙289㧚
8㧕 ♿ࡁቯ଻⤿㧚ක≮⚻༡ᢎ⢒ද⼏ળ‫ޟ‬ක≮ࡑࡀࠫࡔࡦ࠻‫ޠ‬ડ↹✬㓸ᆔຬળ✬㧚⚵❱ߩᵴᕈൻ㧙ࠝࡍ࡟࡯࡚ࠪ
ࡦࡑࡀࠫࡔࡦ࠻㧙㧦ක≮ࡑࡀࠫࡔࡦ࠻㧙ක≮ߩ⾰ะ਄ߩߚ߼ߩක≮⚻༡ቇ㧙㧘᧲੩㧦(ᩣ)ᣣ⚻ࡔ࠺ࠖࠞ࡞
㐿⊒㧧2008 ᐕ㧦206㧙229㧚
9㧕 ♿ࡁቯ଻⤿㧚ක≮ᯏ㑐ߩ ICT ᚢ⇛㧦ක≮⚻༡ᢎ⢒ද⼏ળ‫ޟ‬ක≮ࡑࡀࠫࡔࡦ࠻‫ޠ‬ડ↹✬㓸ᆔຬળ✬㧚ක≮ࡑࡀࠫࡔࡦ࠻㧙ක≮ߩ⾰ะ਄ߩߚ߼ߩක≮⚻༡ቇ㧙㧘᧲੩㧦 (ᩣ)ᣣ⚻ࡔ࠺ࠖࠞ࡞㐿⊒㧧2008 ᐕ㧦230㧙255㧚
10㧕 ᷓᵤඳ㧘቟⮮⵨㧘♿ࡁቯ଻⤿㧘ᅏ⌀਽㧘Ꮉᷨቁ৻㧘㤥ፒ㚌㧚Medical IT ߩ⃻࿷ߘߒߡᧂ᧪㧙‫ᤨޟ‬ઍߩᄌൻ‫ޠ‬ߦኻಣߔࠆߚ߼ߩಣᣇ▐㧙㧦Medical IT 2008-2009 MOOK㧘᧲੩㧦↥ᬺ㐿⊒ᯏ᭴ᩣᑼળ␠㧧2008 ᐕ㧦20
㧙37㧚
⪺ᦠ㧔᰷ᢥ㧕
ߥߒ✚⺑㧔๺ᢥ㧕
1㧕 ♿ࡁቯ଻⤿㧚IT ࠍᵴ↪ߒߚᣂᤨઍߩ∛㒮⚻༡Ԛ㧙ࠪࠬ࠹ࡓ⸳⸘ߩ⠨߃ᣇߣ᭴▽૕೙㧙㧘IT VISION 2006
ᐕ㧧10 Ꮞ㧦46㧙50㧚
2㧕 ർፉᐽ㓶㧘♿ࡁቯ଻⤿㧘⊕㠽⟵ቬ㧘ၳ⇌೑ᴦ㧚ጘ㒂ᄢቇකቇㇱ㒝ዻ∛㒮‫ޟ‬㔚ሶࠞ࡞࠹ࠪࠬ࠹ࡓዉ౉ߦߟ޿
ߡ‫(ޠ‬1)㧘࿖┙ᄢቇࡑࡀࠫࡔࡦ࠻ 2006 ᐕ㧧1 Ꮞ㧦2㧙12㧚
3㧕 ♿ࡁቯ଻⤿㧚ጘ㒂ᄢቇකቇㇱ㒝ዻ∛㒮ߩࠗࡦ࠹࡝ࠫࠚࡦ࠻ൻ㧙̌⷗߃ߑࠆ⽷↥ (intangible assets)̍ߩജ

㧙㧙ߣߘߩนⷞൻ߇ࠪࠬ࠹ࡓㆇ↪ߩࡐࠗࡦ࠻㧙㧘Kodak view 2006 ᐕ㧧7 Ꮞ㧦20㧙25㧚
4㧕 ർፉᐽ㓶㧘♿ࡁቯ଻⤿㧘⊕㠽⟵ቬ㧘ၳ⇌೑ᴦ㧚ጘ㒂ᄢቇකቇㇱ㒝ዻ∛㒮‫ޟ‬㔚ሶࠞ࡞࠹ࠪࠬ࠹ࡓዉ౉ߦߟ޿
ߡ‫(ޠ‬2)㧘࿖┙ᄢቇࡑࡀࠫࡔࡦ࠻ 2006 ᐕ㧧2 Ꮞ㧦12㧙24㧚
5㧕 ♿ࡁቯ଻⤿㧚㔚ሶࠞ࡞࠹ࠪࠬ࠹ࡓㆇ↪ߦࠃࠆ DPC ߳ߩኻᔕߣ࠺࡯࠲ᵴ↪㧘ᣂක≮ 2006 ᐕ㧧33 Ꮞ㧦118
㧙121㧚
6㧕 ♿ࡁቯ଻⤿㧚IT ࠍᵴ↪ߒߚᣂᤨઍߩ∛㒮⚻༡ԛ㧙ࠪࠬ࠹ࡓ߇ਈ߃ࠆࠗࡦࡄࠢ࠻㧙㧘IT VISION 2006 ᐕ㧧
11 Ꮞ㧦54㧙58㧚
7㧕 ♿ࡁቯ଻⤿㧚ㄦㅦ⸻ᢿߦࠃࠆല₸ൻߩⷞὐ߆ࠄߺߚ PACS ߩ૏⟎ߠߌࠍ໧߁㧘ᣂක≮ 2006 ᐕ㧧33 Ꮞ㧦
48㧙50㧚
8㧕 ♿ࡁቯ଻⤿㧚IT ࠍᵴ↪ߒߚක≮⚻༡ᡰេ㧙̌⷗߃ࠆൻ̍ߣ̌ᢙ୯ൻ̍㧘ߘߩᗧ๧㧙㧘ᣂක≮ 2006 ᐕ㧧33
Ꮞ㧦48㧙51㧚9㧕 ♿ࡁቯ଻⤿㧚ᓴⅣེක≮ߦ߅ߌࠆ IT ߩᓎഀߣน⢻ᕈࠍ⠨߃ࠆ㧘ᣣᧄᓴⅣེቇળኾ㐷ක⹹ ᓴⅣེኾ㐷ක
2006 ᐕ㧧14 Ꮞ㧦263㧙269㧚
10㧕 ♿ࡁቯ଻⤿㧚IT ࠍᵴ↪ߒߚᣂᤨઍߩ∛㒮⚻༡Ԝ㧙ක≮ߩ IT ൻ߇↢ߺ಴ߔᣂߚߥዷ㐿㧙㧘IT VISION 2006
ᐕ㧧12 Ꮞ㧦52㧙56㧚
11㧕 ♿ࡁቯ଻⤿㧚ᄢቇ∛㒮ߢߩ㔚ሶࠞ࡞࠹ߦࠃࠆ⸻≮ߩ⃻⁁㧘ᣣᧄකᏧળ㔀⹹ 2006 ᐕ㧧╙ 135 Ꮞ㧦1967㧙1971㧚
12㧕 ♿ࡁቯ଻⤿㧚☨࿖వㅴක≮ IT ੐ᖱߣᣣᧄߩㅴ߻ߴ߈ᣇะᕈߦߟ޿ߡߩ⠨ኤ㧘ᣂක≮ 2006 ᐕ㧧33 Ꮞ㧦150
㧙153㧚
13㧕 ♿ࡁቯ଻⤿㧚ᄢቇ∛㒮ߢߩ㔚ሶࠞ࡞࠹ߦࠃࠆ⸻≮ߩ⃻⁁㧘ᣣᧄකᏧળ㔀⹹ 2006 ᐕ㧧135 Ꮞ㧦1967㧙1971㧚
14㧕 ♿ࡁቯ଻⤿㧚ጘ㒂ᄢቇකቇㇱ㒝ዻ∛㒮 ℂᗐߩࠗࡦ࠹࡝ࠫࠚࡦ࠻࡮ࡎࠬࡇ࠲࡞ࠍ⋡ᜰߒߡ(࠮ࠠࡘ࡝࠹ࠖࠍਛᔃߦ)The Way to the Intelligent Hospital (⇟ᄖ✬)㧘Kodak view 8 2007 ᐕ㧧22㧙26㧚
15㧕 ♿ࡁቯ଻⤿㧚ක≮ߣ IT㧘bios 2007 ᐕ㧧12 Ꮞ㧦3㧙6㧚
16㧕 ᧻ፉ⑲㧘♿ࡁቯ଻⤿㧚ಽሶࠗࡔ࡯ࠫࡦࠣߩᦨᣂേะ㧙MRI ࠍਛᔃߦ㧙㧘INNERVISION 2007 ᐕ㧧22 Ꮞ㧦
30㧙31㧚
17㧕 ♿ࡁቯ଻⤿㧚∛㒮ߦ߅ߌࠆ IT ᵴ↪ߩ⃻⁁ߣ⺖㗴㧘ጘ㒂⋵∛㒮ᤨႎ 2007 ᐕ㧧╙ 41 ภ㧦3㧚
18㧕 ♿ࡁቯ଻⤿㧚⸻≮ᖱႎ▤ℂᯏ⢻ࠍ᦭ߔࠆ቟ోᕈ⏕଻ဳหᤨᦠㄟߺࠪࠬ࠹ࡓ CDBS (Clinical Data Backup
System)ߩ㐿⊒㧘G-NICE News Letter 2007 ᐕ㧧24 Ꮞ㧦2㧙3㧚
19㧕 ጊᧄ⋿↱⟤㧘ᱞ↰⚐㧘♿ࡁቯ଻⤿㧚SMBG ࠺࡯࠲ߩ㔚ሶࠞ࡞࠹਄ߢߩㆇ↪ߪ㧫㧘⢈ḩߣ♧ዩ∛ 2007 ᐕ㧧
6 Ꮞ㧦475㧙477㧚
20㧕 Ⓑጟೣሶ㧘♿ࡁቯ଻⤿㧘ቝㇺ↱⟤ሶ㧘⍹ේ⻞㧘ફ⷗ᷡ⑲㧚࠺࡯࠲࠙ࠚࠕࡂ࠙ࠬߣ࠺࡯࠲೑ᵴ↪㧘ක≮ᖱႎ
ቇ 2007 ᐕ㧧27 Ꮞ㧦261㧙268㧚
21㧕 ♿ࡁቯ଻⤿㧚ߎࠇ߆ࠄߩ∛㒮ᖱႎࠪࠬ࠹ࡓߩᣇะᕈߦߟ޿ߡ㧘╙ 92 ࿁ㄭ⇰∛ᱧ▤ℂ࠮ࡒ࠽࡯⸥㍳㓸 2007ᐕ㧧1㧙5㧚
22㧕 ♿ࡁቯ଻⤿㧘㈬੗㗅຦㧘ᐔᎹ⑲♿㧘␹㊁ᱜඳ㧚㔚ሶࠞ࡞࠹ࠍߎߎ߹ߢᵴ↪ߒߡ޿ࠆ㧘∛㒮 2007 ᐕ㧧66
Ꮞ㧦1013㧙1020㧚
23㧕 ♿ࡁቯ଻⤿㧚ක≮ߩ⾰ะ਄߳ߤߩࠃ߁ߦ⽸₂ߔࠆ߆㧘ᣣᧄ᡼኿✢ᛛᏧળ㔀⹹ 2008 ᐕ㧧55 Ꮞ㧦31㧙32㧚
24㧕 ♿ࡁቯ଻⤿㧚ࡈࠖ࡞ࡓ࡟ࠬߩലᨐࠍ‫ࠆ߃⷗ޟ‬ൻ‫ߒޠ‬ක≮ᯏ㑐⚻༡ߦ⽸₂ߔࠆ PACS ߩዉ౉߇᳞߼ࠄࠇߡ޿
ࠆ㧘IT Vision 2008 ᐕ㧧15 Ꮞ㧦26㧙27㧚
25㧕 ጊᧄ⋿↱⟤㧘♿ࡁቯ଻⤿㧘㜞Ⴆ⋥⢻㧚IT ߇ታ⃻ߔࠆක≮⃻႐ߢߩല₸ൻ‫ޟ‬ක≮ኾ㐷⡯ߩࡑࡀࠫࡔࡦ࠻ᢎ⢒ߦ߅ߌࠆ IT ᵴ↪ߩน⢻ᕈ‫ޠ‬㧘ᣂක≮ 2008 ᐕ㧧35 Ꮞ㧦54㧙57㧚
26㧕 ᧻ፉ⑲㧘♿ࡁቯ଻⤿㧚ಽሶࠗࡔ࡯ࠫࡦࠣߩᦨᣂേะ㧙MR ࠍਛᔃߦ㧙㧘INNERVISION 2008 ᐕ㧧23 Ꮞ㧦38㧙39㧚
27㧕 ᧻ፉ⑲㧘♿ࡁቯ଻⤿㧚੤Ꮕ✭๺₸ࠗࡔ࡯ࠫࡦࠣߦࠃࠆ߇ࠎ⸻ᢿ㧘ᤋ௝ᖱႎ MEDICAL 2008 ᐕ㧧40 Ꮞ㧦
480㧙484㧚
28㧕 ♿ࡁቯ଻⤿㧘ක≮ᯏ㑐ߦ߅ߌࠆ IT ᚢ⇛ߣ࠺࡯࠲ߩᵴ↪㧘᦬ೀࠫࡖ࡯ࡑ࠶ࠢ 2008 ᐕ㧧19 Ꮞ㧦23㧙26㧚
✚⺑㧔᰷ᢥ㧕
ߥߒේ⪺㧔๺ᢥ㧕
1㧕 ጊᧄ⋿↱⟤㧘ᱞ↰⚐㧘♿ࡁቯ଻⤿㧚ోᯏ⒳ߩ⥄Ꮖⴊ♧᷹ቯེߩ࠺࡯࠲ࠍጘ㒂ᄢቇ∛㒮ߩ㔚ሶࠞ࡞࠹਄ߢㆇ
↪ߐߖࠆ⹜ߺ㧘⢈ḩߣ♧ዩ∛ 2006 ᐕ㧧5 Ꮞ೎ౠ 5㧦47㧙51㧚
2㧕 ♿ࡁቯ଻⤿㧘᪢ᧄᢘᄦ㧘ⁿญ᣿ඳ㧘ᱞ↰ᶈ৻㧘Ⓑጟೣሶ㧚ࡑࠗ࠾ࡦࠣᛛⴚࠍᵴ↪ߒߚቯ㊂⊛ߥ⸻≮ࡊࡠ࠮ࠬಽᨆ߳ߩ᜸ᚢ㧘ක≮ᖱႎቇ 2006 ᐕ㧧26 Ꮞ㧦191㧙199㧚
3㧕 ᄥ↰ᶈᢅ㧘ฎ↰િⴕ㧘᦯ㇱ㜞ᐘ㧘ਣᧄ㓷ᄦ㧘೨↰ᖗม㧘♿ࡁቯ଻⤿㧘┻᧛ᱜ↵㧘દ⮮ᒄᐽ㧘ᢧ⮮㇌᣿㧘ᷡፉḩ㧚ቢో㔚ሶൻ∛㒮ߦ߅ߌࠆᬌᩏઃടଔ୯ᖱႎឭଏߩ⹏ଔߦߟ޿ߡ㧙ࠕࡦࠤ࡯࠻⺞ᩏ⚿ᨐ߆ࠄ㧙㧘ᣣᧄ⥃ᐥᬌᩏ⥄േൻቇળળ⹹ 2008 ᐕ㧧33 Ꮞ㧦295㧙300㧚
4㧕 ጟ቟િੑ㧘ਅ↰ᶈᰵ㧘♿ࡁቯ଻⤿㧘ᱞ↰⚐㧘ጊᧄ⋿↱⟤㧚ࠗࡦࠬ࡝ࡦߩ቟ో▤ℂߦ㑐ߔࠆ㔚ሶࠞ࡞࠹ᯏ⢻ߩ᦭↪ᕈߣ໧㗴ὐ㧘⢈ḩߣ♧ዩ∛(ᣣᧄ♧ዩ∛ᖱႎቇળ⺰ᢥ⹹) 2008 ᐕ㧧7 Ꮞ㧦28㧙35㧚
5㧕 ጊᧄ⋿↱⟤㧘Ꮉ಴㕏ᒾ㧘ᚭ⼱ℂ⧷ሶ㧘ᱞ↰⚐㧘᪢ᧄᢘᄦ㧘♿ࡁቯ଻⤿㧚ጘ㒂⋵කᏧળ∛⸻ㅪ៤ࠪࠬ࠹ࡓߦ
߅ߌࠆ♧ዩ∛∛⸻ㅪ៤ࠨࡐ࡯࠻ࠪࠬ࠹ࡓߩ⹜૞㧘⢈ḩߣ♧ዩ∛(ᣣᧄ♧ዩ∛ᖱႎቇળ⺰ᢥ⹹) 2008 ᐕ㧧7Ꮞ㧦56㧙61㧚㧙㧙6㧕 ਅ↰ᶈᰵ㧘ጟ቟િੑ㧘♿ࡁቯ଻⤿㧘ᱞ↰⚐㧘ጊᧄ⋿↱⟤㧚㔚ሶࠞ࡞࠹ᖱႎ߆ࠄಽᨆߔࠆᄢቇ∛㒮ߩ♧ዩ∛∛᫟ᖚ⠪ߩ․ᓽಽᨆߩ⹜ⴕ㧙ᬺോࠍนⷞൻߔࠆ᦭↪ᕈߦߟ޿ߡ㧙㧘⢈ḩߣ♧ዩ∛(ᣣᧄ♧ዩ∛ᖱႎቇળ⺰ᢥ⹹) 2008 ᐕ㧧7 Ꮞ㧦89㧙93㧚
7㧕 ࿡ᨑ℉਽㧘ౝጊ⦟৻㧘ේᱞผ㧘⮮↰ᐢᔒ㧘ട⮮ඳၮ㧘ᵻ㊁㓉ᒾ㧘ᤊඳᤘ㧘ጊᎹᒄ଻㧘቟⮮ᒄ㆏㧘ጤ㑆੧㧚ࠢ࡜ࠬ࠲࡝ࡦࠣࠍ↪޿ߚ⣖࠼࠶ࠢ MR ↹௝ߦ߅ߌࠆή∝୥ᕈᄢ⣖⊕⾰∛ᄌߩᬌ಴ᴺ㧘Medical Imaging
Technology 2008 ᐕ㧧26 Ꮞ㧦39㧙47㧚
8㧕 ጊౝ዁ผ㧘ౝጊ⦟৻㧘ዊ᫾Ả㧘ᮮጊ㦖ੑ㇢㧘ේᱞผ㧘቟⮮ᒄ㆏㧘ጊᎹᒄ଻㧘ጤ㑆੧㧘ᤊඳᤘ㧘⮮↰ᐢᔒ㧚⣖ MRA ↹௝ߦ߅ߌࠆ㐽Ⴇߩᬌ಴㧘Medical Imaging Technology 2008 ᐕ㧧26 Ꮞ㧦251㧙260㧚ේ⪺㧔᰷ᢥ㧕
1㧕 Inaba T, Nakano T, Tsutsumi M, Kawasaki S, Kinosada Y, Tokuda M . Quantitative Evaluation of Left
Ventricular Wall Motion in Patient with Coronary Artery Bypass Grafting Using Magnetic ResonanceTagging Technique, JSME International Journal. 2006;49:597-603.
IF 0.298
2㧕 Matsushima S, Nishiofuku H, Iwata H, Era S, Inaba Y, Kinosada Y. Equivalent cross-relaxation rate
imaging of axillary lymph nodes in breast cancer, J Mag Reson Imag. 2008;27:1278-1283.
IF 2.2093㧕 Uchiyama Y, Kunieda T, Asano T, Kato H, Hara T, Kanematsu M, Iwama T, Hoshi H, Kinosada Y,
Fujita H. Computer-aided diagnosis scheme for classification of lacunar infarcts and enlarged
Virchow-Robin spaces in brain MR images. Proc of IEEE Engineering in Medicine and Biology Society.
2008:3908-3911.
IF 1.0664㧚⎇ⓥ⾌₪ᓧ⁁ᴫ
1㧕┹੎⊛⾗㊄1㧕 ⎇ⓥઍ⴫⠪㧦♿ࡁቯ଻⤿㧘⎇ⓥಽᜂ⠪㧦⊕㠽⟵ቬ㧘┻ౝ⊓⟤ሶ㧧ᢥㇱ⑼ቇ⋭⑼ቇ⎇ⓥ⵬ഥ㊄ၮ⋚⎇ⓥ(B)㧦
‫ޟ‬ᰴ਎ઍ㔚ሶࠞ࡞࠹ࠪࠬ࠹ࡓߦࠃࠆ⸻≮Ꮏ⒟࡮∛㒮ㆇ༡Ꮏ⒟ߩ⛔วಽᨆⅣႺߩ᭴▽ߣ⸃ᨆ‫ޠ‬㧧
ᐔᚑ 17㧙18 ᐕᐲ㧧12,100 ජ౞(7,400㧦4,700 ජ౞)
2㧕 ⎇ⓥઍ⴫⠪㧦᧻ፉ⑲㧧߇ࠎߘߩઁߩᖡᕈᣂ↢‛⎇ⓥഥᚑ㊄(⽷࿅ᴺੱᗲ⍮⋵߇ࠎ⎇ⓥᝄ⥝ળ)㧧
Equivalent cross relaxation image ߦࠃࠆ molecular lymph node imaging㧧ᐔᚑ 18 ᐕᐲ㧧500 ජ౞3㧕 ⎇ⓥઍ⴫⠪㧦⊕㠽⟵ቬ㧘⎇ⓥಽᜂ⠪㧦᫪⣁ਭ㓉㧘♿ࡁቯ଻⤿㧘ඨ↰ብ㧘྾┬ሶᅢᐢ㧧ၮ⋚⎇ⓥ(C)㧦
‫⚦≸ޟ‬⢩ߦ߅ߌࠆᩭౝฃኈ૕ߥࠄ߮ߦ⤑ฃኈ૕ߩ⇣Ᏹߣߘߩ೙ᓮߦ㑐ߔࠆ⎇ⓥ‫ޠ‬㧧ᐔᚑ 16㧙18 ᐕᐲ㧧3,400 ජ౞(1,700㧦1,100㧦600 ජ౞)‫ޟ‬MRI ࠍ↪޿ߚ⣲≌⚦4㧕 ⎇ⓥઍ⴫⠪㧦᧻ፉ⑲㧘⎇ⓥಽᜂ⠪㧦♿ࡁቯ଻⤿㧘ᗆ⦟⡛৻㧧ၮ⋚⎇ⓥ(C)(2)㧦
⢩ኒᐲࠍนⷞൻߔࠆಽሶ↹௝ߩ㐿⊒ߣ≸ᴦ≮߳ߩᔕ↪‫ޠ‬㧧ᐔᚑ 19㧙20 ᐕᐲ㧧3,300 ජ౞(2,200㧦1,100ජ౞)
5㧕 ⎇ⓥઍ⴫⠪㧦᧻ፉ⑲㧧߇ࠎߘߩઁߩᖡᕈᣂ↢‛⎇ⓥഥᚑ㊄(⽷࿅ᴺੱᗲ⍮⋵߇ࠎ⎇ⓥᝄ⥝ળ)㧦⢄⚦⢩≸ᖚ⠪ߦ߅ߌࠆ୘೎ൻක≮ࠍ⋡ᜰߒߚ MR-Cellular imaging㧧ᐔᚑ 19 ᐕᐲ㧧500 ජ౞6㧕 ⎇ⓥઍ⴫⠪㧦ᕺ⦟⡛৻㧘⎇ⓥಽᜂ⠪㧦᧻ፉ⑲㧘♿ࡁቯ଻⤿㧧ၮ⋚⎇ⓥ(C)(2)㧦‫⏛ޟ‬᳇౒㡆ᴺߦࠃࠆ↢૕⚵❱∛ᄌᬌ಴ߩߚ߼ߩಽሶࠗࡔ࡯ࠫࡦࠣߩ㐿⊒ߣ⥃ᐥᔕ↪‫ޠ‬㧧ᐔᚑ 19㧙20 ᐕᐲ㧧3,570 ජ౞(2,470㧦1,100 ජ౞)
7㧕 ⎇ⓥઍ⴫⠪㧦ਅ᧛⋿⟤(ᄢ㒋ᄢቇ㜞╬มᴺ⎇ⓥᚲ)㧘⎇ⓥಽᜂ⠪㧦⮮ᧄ೑৻(ᄢ㒋ᄢቇ)㧘♿ࡁቯ଻⤿㧧ၮ⋚⎇ⓥ(C)(2㧕㧦‫ޟ‬ක≮⸷⸩ߦ߅ߌࠆක≮ᖱႎࠪࠬ࠹ࡓߩ޽ࠅᣇߦ㑐ߔࠆ⎇ⓥ‫ޠ‬㧧ᐔᚑ 20㧙22 ᐕᐲ㧧
3,500 ජ౞(1,200㧦1,100㧦1,200 ජ౞)
8㧕 ⎇ⓥઍ⴫⠪㧦ౝጊ⦟৻㧧ᢥㇱ⑼ቇ⋭⑼ቇ⎇ⓥ⾌⵬ഥ㊄ၮ⋚⎇ⓥ(B)(⧯ᚻ)㧦࡜ࠢ࠽᪪Ⴇ㐓೎ߩߚ߼ߩ
ࠦࡦࡇࡘ࡯࠲ᡰេ⸻ᢿ㧧ᐔᚑ 20㧙21 ᐕᐲ㧧1,700 ජ౞(900㧦800 ජ౞)
2㧕ฃ⸤⎇ⓥߥߒ
3㧕౒ห⎇ⓥߥߒ
5㧚⊒᣿࡮․⸵಴㗿⁁ᴫ
1㧕 ♿ࡁቯ଻⤿㧘᧻ፉ⑲㧘ᗆ⦟⡛৻㧘㐳↰⌀ੑ㧦MR ⵝ⟎ߦࠃࠆ⏛ൻ⒖േലᨐᴺߣലᨐᲧṶ▚ࠍ૬↪ߒߚ∛ᄌ⇣Ᏹߩᣧᦼᬌ಴ᴺ㧧ᐔᚑ 19 ᐕ(․⸵಴㗿ਛ)
2㧕 ⮮↰ᐢᔒ㧘ౝጊ⦟৻㧘ጤ㑆੧㧘቟⮮ᒄ㆏㧘ੑ᧛ੳ㧦ක↪↹௝ಣℂⵝ⟎(․⸵)㧧ᐔᚑ 20 ᐕ(․⸵ 4139869
ภ)

㧙㧙

3㧕 ⮮↰ᐢᔒ㧘ౝጊ⦟৻㧦ක↪↹௝ಣℂⵝ⟎෸߮⇣Ᏹ㒶ᓇᬌ಴ᣇᴺ(⊒᣿)㧧ᐔᚑ 20 ᐕ(․㗿 2008㧙75961)
6㧚ቇળᵴേ
1㧕ቇળᓎຬ
♿ࡁቯ଻⤿㧦
1㧕 ᣣᧄ⏛᳇౒㡆කቇળℂ੐(㨪⃻࿷)2㧕 ᣣᧄ↢૕කᎿቇળઍ⼏ຬ(㨪⃻࿷)3㧕 ᣣᧄක≮ᖱႎቇળ⹏⼏ຬ(㨪⃻࿷)4㧕 ᣣᧄකቇ᡼኿✢ቇળ㔚ሶᖱႎᆔຬળᆔຬ(㨪⃻࿷)2㧕ቇળ㐿௅
♿ࡁቯ଻⤿㧦
1㧕 ╙ 29 ࿁ MR ၮ␆⻠ᐳ(ᐔᚑ 19 ᐕ 8 ᦬㧘᧲੩)
2㧕 ᐔᚑ 19 ᐕᐲᣣᧄ↢૕කᎿቇળ᧲ᶏᡰㇱቇⴚ㓸ળ(ᐔᚑ 19 ᐕ 10 ᦬㧘᧲੩)
3㧕ቇⴚ㔀⹹ౝጊ⦟৻㧦
1㧕 ࠦࡦࡇࡘ࡯࠲ᡰេ↹௝⸻ᢿቇળ⹹㧧✬㓸ᆔຬ(㨪ᐔᚑ 20 ᐕ 10 ᦬)
2㧕 ක↪↹௝ᖱႎቇળ⹹㧧✬㓸ᆔຬ(ᐔᚑ 20 ᐕ 7 ᦬㨪⃻࿷)7㧚ቇળ᜗ᓙ⻠Ṷ㧘᜗ᓙࠪࡦࡐࠫࠬ࠻㧘ᐳ㐳♿ࡁቯ଻⤿㧦
1㧕 ᐔᚑ 17 ᐕᐲᄢቇ∛㒮ᖱႎࡑࡀࠫࡔࡦ࠻ㇱ㐷ㅪ⛊ળ⼏(ᐔᚑ 18 ᐕ 1 ᦬㧘㕒ጟ㧘ಽ⑼ળ 2‫ޟ‬㔚ሶࠞ࡞࠹࠺࡯࠲ࡌ࡯ࠬߩ⥃ᐥ⎇ⓥ࠺࡯࠲ࡌ࡯ࠬߣߒߡߩ೑ᵴ↪ 㧙ጘ㒂ᄢቇ∛㒮ߩ႐ว㧙‫ޠ‬Ṷ⠪)
2㧕 ╙ 15 ࿁ᣣᧄ⣖␹⚻ᄖ⑼ࠦࡦࡇࡘ࡯࠲⎇ⓥળ(ᐔᚑ 18 ᐕ 1 ᦬㧘ጊญ㧘․೎⻠Ṷ‫∛ޟ‬㒮ߩ IT ൻߣᄖ⑼ቇ߳ߩ⽸₂ࠍ⋡ᜰߒߡ‫ޠ‬Ṷ⠪)
3㧕 ╙ 12 ࿁ጘ㒂ක≮ᖱႎ⎇ⓥળ(ᐔᚑ 18 ᐕ 1 ᦬㧘ጘ㒂㧘ࡊ࡟࠽࡝࡯࠮࠶࡚ࠪࡦ‫ޟ‬IT ߣࡠࡏ࠶࠻ࠍߟߥ
ߋᣂߒ޿ᛛⴚ߇ᓴⅣེක≮ߩᧂ᧪ࠍߤߩࠃ߁ߦᜏ߆‫ޠ‬Ṷ⠪)
4㧕 ᐔᚑ 17 ᐕᐲጘ㒂⋵කᏧળ✚วක≮ᖱႎࡀ࠶࠻ࡢ࡯ࠢ࡮ጘ㒂࿾඙✚วක≮ᖱႎࡀ࠶࠻ࡢ࡯ࠢวห✚ળ(ᐔᚑ 18 ᐕ 2 ᦬㧘ጘ㒂㧘․೎⻠Ṷ‫ޟ‬ጘ㒂⋵ߦ߅ߌࠆ IT ࠍᵴ↪ߒߚ∛⸻ㅪ៤ࠪࠬ࠹ࡓߩ੹ᓟ‫ޠ‬Ṷ⠪)
5㧕 ╙ 228 ࿁ක≮ߣ࠾ࡘ࡯ࡔ࠺ࠖࠕࠍ⠨߃ࠆળ(ᐔᚑ 18 ᐕ 2 ᦬㧘᧲੩㧘⻠Ṷ‫ޟ‬ጘ㒂ᄢቇ∛㒮ߦ߅ߌࠆ㔚ሶࠞ࡞࠹ࠪࠬ࠹ࡓዉ౉ߩᚑᨐ‫ޠ‬Ṷ⠪)
6㧕 ᐔᚑ 17 ᐕᐲ㑐᧲ IBM ࡙࡯ࠩ࡯⎇ⓥળ ╙ੑ࿁‫ޟ‬IT ࠰࡝ࡘ࡯࡚ࠪࡦ࡮࠮ࡒ࠽࡯‫(ޠ‬ᐔᚑ 18 ᐕ 3 ᦬㧘᧲੩㧘⻠Ṷ‫⚻ࠆߌ߅ߦ࡞࠲ࡇࠬࡎ࠻ࡦࠚࠫ࡝࠹ࡦࠗޟ‬༡▤ℂᚻᴺ‫ޠ‬Ṷ⠪)7㧕 ਛㇱࡎࠬࡇ࠲࡞࡚ࠪ࠙ 2006(ᐔᚑ 18 ᐕ 3 ᦬㧘ᗲ⍮㧘⻠Ṷ‫ޟ‬ᰴ਎ઍ㔚ሶࠞ࡞࠹ࠪࠬ࠹ࡓߢㅴൻߔࠆ∛㒮ࡑࡀࠫࡔࡦ࠻‫ޠ‬Ṷ⠪)8㧕 ╙ 70 ࿁⸥ᔨᣣᧄᓴⅣེቇળࡊ࡟࠽࡝࡯࠮࠶࡚ࠪࡦ(ᐔᚑ 18 ᐕ 3 ᦬㧘ᗲ⍮㧘⻠Ṷ‫ޟ‬IT Impact on the
Cardio-Vascular Robotic Surgery‫ޠ‬Ṷ⠪)9㧕 ක≮ᯏ㑐࠰࡝ࡘ࡯࡚ࠪࡦ࠮ࡒ࠽࡯(ᐔᚑ 18 ᐕ 5 ᦬㧘㕒ጟ㧘⻠Ṷ‫∛ޟ‬㒮⚻༡ߦ߅ߌࠆ IT ߩᵴ↪‫ޠ‬Ṷ⠪)10㧕 ᄢ၂Ꮢ᳃∛㒮 ቇⴚ⎇ୃળ(ᐔᚑ 18 ᐕ 6 ᦬㧘ጘ㒂㧘⻠Ṷ‫ޟ‬DPC ೙ᐲߩዉ౉ߣ∛㒮ㆇ༡ߩᄌൻߦߟ޿
ߡ‫ޠ‬Ṷ⠪)
11㧕 ጘᄢ࡮ච౐↥ቇㅪ៤ක≮ IT ࠮ࡒ࠽࡯(ᐔᚑ 18 ᐕ 6 ᦬㧘ጘ㒂㧘⻠Ṷ‫ޟ‬ක≮ಽ㊁ߦ߅ߌࠆ IT ᵴ↪ߩᣇะᕈ‫ޠ‬Ṷ⠪)12㧕 ᐔᚑ 18 ᐕᐲߺ߃ࡔ࠺ࠖࠞ࡞⎇ⓥળ✚ળ(ᐔᚑ 18 ᐕ 6 ᦬㧘ਃ㊀㧘⻠Ṷ‫ޟ‬ᣣᧄ EHR 㧙ᣂߚߥ↢ᶦဳஜᐽ࡮ක≮ᖱႎࠪࠬ࠹ࡓߩ᭴▽ߦะߌߡ㧙‫ޠ‬Ṷ⠪)
13㧕 㣐⷗∛㒮㧦቟ో▤ℂ⎇ୃળ(ᐔᚑ 18 ᐕ 9 ᦬㧘ጘ㒂㧘⻠Ṷ‫ޟ‬㔚ሶࠞ࡞࠹ࠪࠬ࠹ࡓ㧦ߘߩ᭴▽ߣㆇ↪㧘ᵴ↪ߦߟ޿ߡ ‫ޠ‬Ṷ⠪)
14㧕 ጘᄢ࡮ච౐↥ቇㅪ៤ක≮ IT ࠮ࡒ࠽࡯(ᐔᚑ 18 ᐕ 9 ᦬㧘ጘ㒂㧘⻠Ṷ‫ޟ‬ක≮⚻༡ࠍᡰ߃ࠆᖱႎಽᨆᛛⴚ
-Information-based management-‫ޠ‬Ṷ⠪)
15㧕 ╙৻࿁᧲ᶏක≮ᖱႎࠪࠬ࠹ࡓᙣ⺣ળ(ᐔᚑ 18 ᐕ 9 ᦬㧘ᗲ⍮㧘ᢎ⢒⻠Ṷ‫ޟ‬㔚ሶࠞ࡞࠹࠺࡯࠲ࠍ᦭ലߦ
೑ᵴ↪ߔࠆߚ߼ߩᚻᴺߣࠪࠬ࠹ࡓ᭴▽ߦߟ޿ߡ‫ޠ‬Ṷ⠪)16㧕 InterSystems in Healthcare ࠮ࡒ࠽࡯(ᐔᚑ 18 ᐕ 10 ᦬㧘᧲੩㧘⻠Ṷ‫ޟ‬ක≮ IT㧦ᣣ☨ᦨᣂ੐ᖱߩᲧセߣ੹ᓟߩขࠅ⚵ߺ‫ޠ‬Ṷ⠪)㧙㧙

17㧕 ╙ 44 ࿁ᣣᧄ∛㒮▤ℂቇળቇⴚ✚ળ(ᐔᚑ 18 ᐕ 10 ᦬㧘ᗲ⍮㧘ࠪࡦࡐࠫࡘ࡯ࡓ‫ޟ‬ක≮ࡑࡀࠫࡔࡦ࠻ߦ
⽸₂ߔࠆ㔚ሶࠞ࡞࠹ࠪࠬ࠹ࡓ‫ޠ‬Ṷ⠪)18㧕 ක≮ᯏ㑐࠰࡝ࡘ࡯࡚ࠪࡦ࠮ࡒ࠽࡯(ᐔᚑ 18 ᐕ 10 ᦬㧘㕒ጟ㧘⻠Ṷ‫∛ޟ‬㒮⚻༡ߦ߅ߌࠆ IT ߩᵴ↪‫ޠ‬Ṷ
⠪)19㧕 㔚ሶᖱႎᛛⴚ↥ᬺදળ‫ࠣࡦࠪࡦ࠮ࠢ࡯ࡢ࠻࠶ࡀޟ‬ᛛⴚኾ㐷ᆔຬળ‫(ޠ‬ᐔᚑ 18 ᐕ 10 ᦬㧘᧲੩㧘⻠Ṷ‫ࡀޟ‬࠶࠻ࡢ࡯ࠢ࠮ࡦࠪࡦࠣᛛⴚࠍᔕ↪ߒߚ∛㒮ㆇ༡ᚻᴺߦߟ޿ߡ‫ޠ‬Ṷ⠪)20㧕 ឳ᢫ෘ↢∛㒮࠮ࡒ࠽࡯(ᐔᚑ 18 ᐕ 10 ᦬㧘ጘ㒂㧘⻠Ṷ‫ޟ‬DPC ೙ᐲߩዉ౉ߣ∛㒮ㆇ༡ߩᄌൻߦߟ޿ߡ‫ޠ‬Ṷ⠪)21㧕 ╙ 4 ࿁ᣣᧄ࡮ࡉ࡜ࠫ࡞㧛࿾ၞ࡮࿾ၞⅣႺ࿖㓙ࡢ࡯࡚ࠢࠪ࠶ࡊ(ᐔᚑ 18 ᐕ 10 ᦬㧘ጘ㒂㧘⻠Ṷ‫ᦨޟ‬వ┵ක≮ߣጘ㒂ᄢቇ∛㒮‫ޠ‬Ṷ⠪)22㧕 ISACA ฬฎደᡰㇱ᦬଀ળ(ᐔᚑ 18 ᐕ 10 ᦬㧘ᗲ⍮㧘⻠Ṷ‫ޟ‬ጘ㒂ᄢቇ∛㒮ߦ⷗ࠆᖱႎࠪࠬ࠹ࡓߩ⸽᜚
଻ో⢻ߦߟ޿ߡ‫ޠ‬Ṷ⠪)23㧕 ᐔᚑ 18 ᐕᐲ⚻ᷣ↥ᬺ⋭‫ޟ‬ක≮⚻༡ੱ᧚⢒ᚑ੐ᬺ‫ޠ‬ක≮ኾ㐷⡯ߩߚ߼ߩක≮ࡑࡀࠫࡔࡦ࠻࠮ࡒ࠽࡯(ᐔᚑ 18 ᐕ 10 ᦬㧘ጘ㒂㧘⻠Ṷ‫ޟ‬ක≮ᖱႎ▤ℂߣ∛㒮⚻༡㧔ࠝࡍ࡟࡯࡚ࠪࡦ▤ℂ㧕‫ޠ‬Ṷ⠪)24㧕 ╙ 26 ࿁ක≮ᖱႎቇㅪวᄢળ(ᐔᚑ 18 ᐕ 11 ᦬㧘ർᶏ㆏㧘ࠪࡦࡐࠫࡘ࡯ࡓ‫࠻࠶ࡇࠢࠦ࡮࡞ࠞ࠾࡝ࠢޟ‬㧦ߘߩࠦࡦ࠮ࡊ࠻ߣㆇ↪‫ޠ‬Ṷ⠪)25㧕 ╙ 26 ࿁ක≮ᖱႎቇㅪวᄢળ(ᐔᚑ 18 ᐕ 11 ᦬㧘ർᶏ㆏㧘࡜ࡦ࠴࡚ࡦ࠮ࡒ࠽࡯
‫ޟ‬㔚ሶࠞ࡞࠹ᤨઍߩ PACSᵴ↪੐଀‫ޠ‬ᐳ㐳)26㧕 ጘ㒂⋵කᏧળ㧦↥ᬺක⎇ୃળ(ᐔᚑ 18 ᐕ 11 ᦬㧘ጘ㒂㧘⻠Ṷ‫ޟ‬⡯ၞߦ߅ߌࠆஜ⸻࠺࡯࠲ߩ㊀ⷐᕈ-↢ᵴ⠌ᘠ∛੍㒐ߩⷰὐ߆ࠄ-‫ޠ‬Ṷ⠪)27㧕 ᐔᚑ 18 ᐕᐲ‫(ޠ࡞ࡌ࡟࠼ࡦࠞ࠮ޟ‬ᐔᚑ 18 ᐕ 11 ᦬㧘౓ᐶ㧘⻠Ṷ‫▤⼔⋴ޟ‬ℂࠍᡰេߔࠆᖱႎᛛⴚ‫ޠ‬Ṷ⠪)28㧕 ጘᄢ࡮ච౐↥ቇㅪ៤ක≮ IT ࠮ࡒ࠽࡯(ᐔᚑ 18 ᐕ 12 ᦬㧘ጘ㒂㧘⻠Ṷ‫ࠢ࡯ࡢ࠻࠶ࡀ࡯ࠨࡦ࠮ޟ‬ᛛⴚ‫ޠ‬Ṷ⠪)29㧕 ࿖଻੐ᬺផㅴ࠻࠶ࡊ࠮ࡒ࠽࡯(ᐔᚑ 19 ᐕ 1 ᦬㧘ጘ㒂㧘․೎⻠Ṷ‫ޟ‬ஜ⸻ߩ⟵ോൻߦ㑐ࠊࠆஜ⸻࠺࡯࠲
╬ߩㆇ↪࡮▤ℂߦߟ޿ߡ‫ޠ‬Ṷ⠪)30㧕 ጘ㒂ᄢቇ∛㒮⋴⼔ㇱ⻠Ṷળ(ᐔᚑ 19 ᐕ 1 ᦬㧘ጘ㒂㧘⻠Ṷ‫∛ޟ‬㒮ࠍขࠅᏎߊක≮ᖱ൓‫ޠ‬Ṷ⠪)31㧕 ᐔᚑ 18 ᐕᐲ⚻ᷣ↥ᬺ⋭‫ޟ‬ක≮⚻༡ੱ᧚⢒ᚑ੐ᬺ‫ޠ‬ක≮ኾ㐷⡯ߩߚ߼ߩක≮ࡑࡀࠫࡔࡦ࠻࠮ࡒ࠽࡯(ᐔᚑ 19 ᐕ 2 ᦬㧘ጘ㒂㧘⻠Ṷ‫∛ޟ‬㒮 IT ൻߣක≮ߩᄌൻ(ࠝࡍ࡟࡯࡚ࠪࡦ▤ℂ)‫ޠ‬Ṷ⠪㧕32㧕 ක੐㑐ଥ⸷⸩ߩㆇ༡ࠍ߼ߋࠆᙣ⺣ળ(ᐔᚑ 19 ᐕ 2 ᦬㧘ᄢ㒋㧘⻠Ṷ‫ޟ‬ጘ㒂ᄢቇ∛㒮ߩ㔚ሶࠞ࡞࠹ࠪࠬ
࠹ࡓߣᖱႎ࠮ࠠࡘ࡝࠹ࠖ㧘⸽᜚଻ోߦߟ޿ߡ‫ޠ‬Ṷ⠪)33㧕 ᐔᚑ 18 ᐕᐲጘ㒂⋵කᏧળ✚วක≮ᖱႎࡀ࠶࠻ࡢ࡯ࠢ࡮ጘ㒂࿾඙✚วක≮ᖱႎࡀ࠶࠻ࡢ࡯ࠢวห✚ળ(ᐔᚑ 19 ᐕ 2 ᦬㧘ጘ㒂㧘‫ޟ‬ක≮଻㒾೙ᐲߣක≮ࠨ࡯ࡆࠬ㧘IT ᵴ↪ߩᦨᣂ੐଀ߦߟ޿ߡ-․ߦᣣ☨⧷ࠍᲧセߔࠆ‫ޠ‬Ṷ⠪)34㧕 (␠)ᣣᧄකᬺ⚻༡ࠦࡦࠨ࡞࠲ࡦ࠻දળᐔᚑ 18 ᐕᐲ⛮⛯⎇ୃ(2 ᦬㧛㓸ਛ)(ᐔᚑ 19 ᐕ 2 ᦬㧘ᗲ⍮㧘⻠Ṷ‫ޟ‬ක≮ᯏ㑐ߦ߅ߌࠆ ICT ൻߩ⃻⁁ߣ੹ᓟߩᓎഀ㧙ක≮ࡑࡀࠫࡔࡦ࠻ࠍᡰ߃ࠆ ICT㧙‫ޠ‬Ṷ⠪)35㧕 ᴺੱ⡯ຬኻ⽎⻠Ṷળ(ᐔᚑ 19 ᐕ 2 ᦬㧘ᗲ⍮㧘⻠Ṷ‫ޟ‬㔚ሶࠞ࡞࠹ߩዉ౉ߣߘߩലᨐ‫ޠ‬Ṷ⠪)36㧕 ᐔᚑ 18 ᐕᐲ⚻ᷣ↥ᬺ⋭‫ޟ‬ක≮⚻༡ੱ᧚⢒ᚑ੐ᬺ‫ޠ‬ක≮ࡑࡀࠫࡔࡦ࠻ᦨᣂ੐ᖱ⻠Ṷળ(ᐔᚑ 19 ᐕ 3 ᦬㧘ጘ㒂㧘⻠Ṷ‫ޟ‬ක≮⚻༡ߣ IT㧔ක≮ᖱႎቇ⠪ߩ┙႐߆ࠄ㧕‫ޠ‬Ṷ⠪)
37㧕 ක≮⚻༡ᦨᣂ੐ᖱ⻠Ṷળ(ᐔᚑ 19 ᐕ 3 ᦬㧘ᄢ㒋㧘⻠Ṷ‫ޟ‬ක≮⚻༡ߣ IT‫ޠ‬Ṷ⠪㧕38㧕 ጊ↰⿒චሼ∛㒮․೎⻠Ṷળ(ᐔᚑ 19 ᐕ 6 ᦬㧘ਃ㊀㧘․೎⻠Ṷ‫ޟ‬㔚ሶࠞ࡞࠹㧘↹௝ᬌᩏߩࡈࠖ࡞ࡓ࡟
ࠬㆇ↪ߩታ㓙㧙ዉ౉ߩ⸘↹߆ࠄㆇ↪߹ߢߩࡊࡠ࠮ࠬࠍਛᔃߦ㧙‫ޠ‬Ṷ⠪)39㧕 ╙ 23 ࿁ో࿖᡼኿✢ᛛᏧ✚วቇⴚᄢળ․೎ࡊࡠࠣ࡜ࡓ‫ޟ‬ක≮⚻༡ߦ߅ߌࠆ᡼኿✢ᛛᏧߩᓎഀ‫(ޠ‬ᐔᚑ19 ᐕ 6 ᦬㧘⍹Ꮉ㧘⻠Ṷ‫ޟ‬ක≮ߩ⾰ะ਄߳ߤߩࠃ߁ߦ⽸₂ߔࠆ߆‫ޠ‬Ṷ⠪)40㧕 ╙ 11 ࿁ᣣᧄක≮ᖱႎቇળᤐቄቇⴚᄢળ(ࠪࡦࡐࠫ࠙ࡓ 2007)‫࠲࡯࠺ߣࠬ࠙ࡂࠕࠚ࠙࠲࡯࠺ޟ‬೑ᵴ↪‫ޠ‬(ᐔᚑ 19 ᐕ 6 ᦬㧘ᄢ㒋㧘ࠪࡦࡐࠫࡘ࡯ࡓ‫ ߣࠬ࠙ࡂࠕࠚ࠙࠲࡯࠺ޟ‬Information-based Management‫ޠ‬ᐳ㐳࡮Ṷ⠪)
41㧕 ጘᄢ࡮ච౐↥ቇㅪ៤ක≮⚻༡ࠪࡦࡐࠫ࠙ࡓ(ᐔᚑ 19 ᐕ 6 ᦬㧘ጘ㒂㧘ࠪࡦࡐࠫࡘ࡯ࡓ‫ޟ‬ା㗬ߐࠇࠆ∛㒮ߣߪ‫ޠ‬ᐳ㐳)42㧕 ╙ 29 ࿁ MR ၮ␆⻠ᐳ(ᐔᚑ 19 ᐕ 8 ᦬㧘᧲੩㧘⻠Ṷ‫ޟ‬⢄ߩ MRI㧙ᦨㄭߩ⹤㗴ࠍ฽߼ߡ㧙‫ޠ‬ᐳ㐳)43㧕 ╙ 17 ࿁කᬺ⚻༡ࠦࡦࠨ࡞࠲ࡦ࠻⹺ቯ⻠ᐳ(ᐔᚑ 19 ᐕ 8 ᦬㧘᧲੩㧘‫ޟ‬ᖱႎ▤ℂ‫ޠ‬Ṷ⠪)44㧕 ⹺ቯ⋴⼔▤ℂ⠪೙ᐲᐔᚑ 19 ᐕᐲ‫࡞ࡌ࡟࠼ࡦࠞ࠮ޟ‬ᢎ⢒⺖⒟‫(ޠ‬ᐔᚑ 19 ᐕ 9 ᦬㧘౓ᐶ㧘‫▤⼔⋴ޟ‬ℂࠍᡰេߔࠆᖱႎᛛⴚ‫ޠ‬Ṷ⠪)㧙㧙

45㧕 ╙ 35 ࿁ᣣᧄ⏛᳇౒㡆කቇળᄢળ(ᐔᚑ 19 ᐕ 9 ᦬㧘౓ᐶ㧘ᢎ⢒⻠Ṷ‫ޟ‬ၮ␆Τ‫ޠ‬ᐳ㐳)46㧕 ጊ↰⿒චሼ∛㒮․೎⻠Ṷળ(ᐔᚑ 19 ᐕ 10 ᦬㧘ਃ㊀㧘․೎⻠Ṷ‫ޟ‬㔚ሶࠞ࡞࠹㧘↹௝ᬌᩏߩࡈࠖ࡞ࡓ࡟
ࠬㆇ↪ߩታ㓙㧙ዉ౉ߩ⸘↹߆ࠄㆇ↪߹ߢߩࡊࡠ࠮ࠬࠍਛᔃߦ㧙‫ޠ‬Ṷ⠪)47㧕 ᐔᚑ 19 ᐕᐲᣣᧄ↢૕කᎿቇળ᧲ᶏᡰㇱቇⴚ㓸ળ(ᐔᚑ 19 ᐕ 10 ᦬㧘ᗲ⍮㧘․೎⻠Ṷ‫ޟ‬ᝄേಽశᴺߢ
㕖ଚⷅ⊛ߦੱ૕ߩઍ⻢ࠍⷰࠆ‫ޠ‬ᐳ㐳)48㧕 ╙ 92 ࿁ㄭ⇰∛ᱧ▤ℂ࠮ࡒ࠽࡯(ᐔᚑ 19 ᐕ 10 ᦬㧘ᄢ㒋㧘⻠Ṷ‫∛ߩࠄ߆ࠇߎޟ‬㒮ᖱႎࠪࠬ࠹ࡓߦ᳞߼
ࠄࠇࠆ߽ߩ‫ޠ‬Ṷ⠪)49㧕 ╙ 20 ࿁㔚ሶᖱႎ⎇ⓥળ(ᣣᧄකቇ᡼኿✢ቇળ)(ᐔᚑ 19 ᐕ 10 ᦬㧘ᗲ⍮㧘ࠪࡦࡐࠫࡘ࡯ࡓ‫ޟ‬᡼኿✢ㇱ㐷ߩ IT ൻ࡮ࠪࠬ࠹ࡓൻ‫ޠ‬ᐳ㐳)50㧕 ⹺ቯ⊓㍳කᬺ⚻༡ࠦࡦࠨ࡞࠲ࡦ࠻਄⚖ࡆࠫࡀࠬࠦ࡯ࠬ(ᐔᚑ 20 ᐕ 3 ᦬㧘᧲੩㧘⻠Ṷ‫ޟ‬ක≮ᖱႎ▤ℂߩၮᧄ㧛ᖱႎ࠮ࠠࡘ࡝࠹ࠖ‫ޠ‬Ṷ⠪)51㧕 ක≮⚻༡ੱ᧚⢒ᚑၮ␆⎇ୃࠦ࡯ࠬ(ᐔᚑ 20 ᐕ 3 ᦬㧘ᄢ㒋㧘⻠Ṷ‫ޟ‬ක≮ᯏ㑐ߩ IT ᚢ⇛‫ޠ‬Ṷ⠪)52㧕 ⹺ቯ⊓㍳කᬺ⚻༡ࠦࡦࠨ࡞࠲ࡦ࠻਄⚖ࡆࠫࡀࠬࠦ࡯ࠬ(ᐔᚑ 20 ᐕ 3 ᦬㧘᧲੩㧘⻠Ṷ‫ޟ‬ᖱႎࠦࡦࠨ࡞
࠹ࠖࡦࠣ㧛㒮ౝᖱႎൻߩㅴ߼ᣇ‫ޠ‬Ṷ⠪)53㧕 Cyberrad2008(ᣣᧄ࡜ࠫࠝࡠࠫ࡯දળ)(ᐔᚑ 20 ᐕ 4 ᦬㧘␹ᄹᎹ㧘⻠Ṷ‫ޟ‬᡼኿✢ㇱ㐷ࠍขࠅᏎߊ∛㒮ౝߩᖚ⠪േ✢‫ޠ‬Ṷ⠪)54㧕 ╙ 9 ࿁∛㒮ߩ⚻༡ࠍ⠨߃ࠆળ(ᐔᚑ 20 ᐕ 6 ᦬㧘ᄢ㒋㧘⻠Ṷ‫ޟ‬ක≮ᯏ㑐ߦ߅ߌࠆ ICT ᚢ⇛ߣࡑࡀࠫࡔ
ࡦ࠻ߩ⺞๺ࠍ᳞߼ߡ‫ޠ‬Ṷ⠪)55㧕 ╙ 7 ࿁࿖㓙ࡃࠗࠝࡈࠜ࡯࡜ࡓ(࿖㓙ࡃࠗࠝ 2008)(ᐔᚑ 20 ᐕ 7 ᦬㧘᧲੩㧘⻠Ṷ‫↢ޟ‬ᶦߦਗ਼ࠆஜᐽᖱႎ
ߩ▤ℂߣ቟ోߥฃ⸻≮ࠍᡰេߔࠆࠪࠬ࠹ࡓ‫ޠ‬Ṷ⠪)56㧕 ⹺ቯ⊓㍳කᬺ⚻༡ࠦࡦࠨ࡞࠲ࡦ࠻දળ ᐔᚑ 20 ᐕᐲ㓸ਛ⎇ୃ(ᐔᚑ 20 ᐕ 7 ᦬㧘᧲੩㧘⻠Ṷ‫ޟ‬ක≮ᯏ㑐ߦ߅ߌࠆ IT ᚢ⇛ߣ࠺࡯࠲ߩ᦭ലᵴ↪‫ޠ‬Ṷ⠪)57㧕 IBM ⵾⮎ᬺᄤၔ࠮ࡒ࠽࡯(ᐔᚑ 20 ᐕ 7 ᦬㧘㕒ጟ㧘⻠Ṷ‫ޟ‬ක≮ IT ࠍขࠅᏎߊⅣႺߣ੹ᓟߩࠪࠬ࠹ࡓ
ߩ࿷ࠅᣇ‫ޠ‬Ṷ⠪)58㧕 ᐔᚑ 20 ᐕᐲో࿖ᄢቇ଻ஜ▤ℂදળ᧲ᶏ࡮ർ㒽࿾ᣇㇱળ⎇ⓥ㓸ળ(ᐔᚑ 20 ᐕ 7 ᦬㧘ጘ㒂㧘ၮ⺞⻠Ṷ‫ޟ‬ቇ↢ᡰេߦ߅ߌࠆ IT ൻߩ዁᧪ߦߟ޿ߡ‫ޠ‬Ṷ⠪)59㧕 ᐔᚑ 20 ᐕᐲ╙ 18 ࿁කᬺ⚻༡ࠦࡦࠨ࡞࠲ࡦ࠻ᜰቯ⻠ᐳ(ᐔᚑ 20 ᐕ 8 ᦬㧘᧲੩㧘⻠Ṷ‫ޟ‬කᬺ⚻༡▤ℂ⺰㧦ᖱႎ▤ℂ‫ޠ‬Ṷ⠪)60㧕 ᐔᚑ 20 ᐕᐲ╙ 19 ࿁කᬺ⚻༡ࠦࡦࠨ࡞࠲ࡦ࠻ᜰቯ⻠ᐳ(ᐔᚑ 20 ᐕ 8 ᦬㧘ᄢ㒋㧘⻠Ṷ‫ޟ‬කᬺ⚻༡▤ℂ⺰㧦ᖱႎ▤ℂ‫ޠ‬Ṷ⠪)61㧕 ᐔᚑ 20 ᐕᐲ⹺ቯ⋴⼔▤ℂ⠪೙ᐲ‫࡞ࡌ࡟࠼ࡦࠞ࠮ޟ‬ᢎ⢒⺖⒟‫(ޠ‬ᐔᚑ 20 ᐕ 8 ᦬㧘౓ᐶ㧘‫▤⼔⋴ޟ‬ℂࠍᡰេߔࠆᖱႎᛛⴚ‫ޠ‬Ṷ⠪)62㧕 ᖱႎൻ⹺ቯࠦࡦࠨ࡞࠲ࡦ࠻ᜰቯ⻠ᐳ(ᐔᚑ 20 ᐕ 9 ᦬㧘᧲੩㧘⻠Ṷ‫ޟ‬ᖱႎൻ⾗Ḯ⺞㆐ᡰេ ࡌࡦ࠳ㆬቯᚻ㗅ឭ᩺‫ޠ‬Ṷ⠪)63㧕 ᖱႎൻ⹺ቯࠦࡦࠨ࡞࠲ࡦ࠻ᜰቯ⻠ᐳ(ᐔᚑ 20 ᐕ 9 ᦬㧘᧲੩㧘⻠Ṷ‫ޟ‬ᖱႎൻㆇ↪ᡰេ ᗧᕁ᳿ቯᵴ↪
ᡰេ‫ޠ‬Ṷ⠪)64㧕 ╙ 36 ࿁ᣣᧄ⏛᳇౒㡆කቇળᄢળ(ᐔᚑ 20 ᐕ 9 ᦬㧘ᣩᎹ㧘ᢎ⢒⻠ṶΣၮ␆Ԙ‫ޠࠣࡦࠫ࡯ࡔࠗޟ‬ᐳ㐳)65㧕 ╙ 36 ࿁ᣣᧄ⏛᳇౒㡆කቇળᄢળ(ᐔᚑ 20 ᐕ 9 ᦬㧘ᣩᎹ㧘ᢎ⢒⻠ṶΦၮ␆ԙ‫ޠ࡯ࡇࠦࠬࡠ࠻ࠢࡍࠬޟ‬ᐳ㐳)66㧕 ᖱႎൻ⹺ቯࠦࡦࠨ࡞࠲ࡦ࠻ᜰቯ⻠ᐳ(ᐔᚑ 20 ᐕ 10 ᦬㧘᧲੩㧘⻠Ṷ‫ޟ‬ᖱႎൻ⾗Ḯ⺞㆐ᡰេ ࡌࡦ࠳ㆬቯᚻ㗅ឭ᩺‫ޠ‬Ṷ⠪)67㧕 ᖱႎൻ⹺ቯࠦࡦࠨ࡞࠲ࡦ࠻ᜰቯ⻠ᐳ(ᐔᚑ 20 ᐕ 10 ᦬㧘᧲੩㧘⻠Ṷ‫ޟ‬ᖱႎൻዉ౉ᡰេ ዉ౉Ḱ஻૞ᬺ㧘࠹ࠬ࠻࡮࡝ࡂ࡯ࠨ࡞ᡰេ㧘ዉ౉ࠪࠬ࠹ࡓߩຠ⾰⹏ଔ‫ޠ‬Ṷ⠪)68㧕 ᣣᧄ㆙㓒ක≮ቇળቇⴚᄢળ(ᐔᚑ 20 ᐕ 10 ᦬㧘ጘ㒂㧘․೎⻠Ṷ‫ࠊ߇߆ޟ‬㆙㓒ක≮ࡀ࠶࠻ࡢ࡯ࠢ߆ࠄᣣ
ᧄ
EHR ߳ߩ⊒ዷ㧙ක≮ᓥ੐⠪ਛᔃߩ㔚ሶࠞ࡞࠹ࡀ࠶࠻ࡢ࡯ࠢ߆ࠄ૑᳃ਛᔃߩ↢ᶦஜᐽࠞ࡞࠹߳
㧙‫ޠ‬ᐳ㐳)69㧕 ᣣᧄ㆙㓒ක≮ቇળቇⴚᄢળ(ᐔᚑ 20 ᐕ 10 ᦬㧘ጘ㒂㧘ડ↹ࠪࡦࡐࠫࡘ࡯ࡓ‫↹ޟ‬௝㆙㓒ක≮‫ޠ‬ᐳ㐳)70㧕 ᣣᧄ㆙㓒ක≮ቇળቇⴚᄢળ(ᐔᚑ 20 ᐕ 10 ᦬㧘ጘ㒂㧘‫↹ޟ‬௝㆙㓒ක≮߳ߩᦼᓙ‫ޠ‬Ṷ⠪)71㧕 ᖱႎൻ⹺ቯࠦࡦࠨ࡞࠲ࡦ࠻ᜰቯ⻠ᐳ(ᐔᚑ 20 ᐕ 10 ᦬㧘ጘ㒂㧘⻠Ṷ‫ޟ‬ᖱႎൻㆇ↪ᡰេ ᗧᕁ᳿ቯᵴ↪
ᡰេ‫ޠ‬Ṷ⠪)72㧕 ᢙℂࠪࠬ࠹ࡓ࡙࡯ࠩ࡯ࠦࡦࡈࠔ࡟ࡦࠬ 2008(ᐔᚑ 20 ᐕ 11 ᦬㧘᧲੩㧘⻠Ṷ‫ޟ‬ක≮ಽ㊁ߢߩᗧᕁ᳿ቯ
ࠍᡰ߃ࠆ࠺࡯࠲ࠨࠗࠛࡦࠬ㧙VMS ߩᵴ↪ࠍਛᔃߦ㧙‫ޠ‬Ṷ⠪)73㧕 ක≮⚻༡ੱ᧚⢒ᚑၮ␆⎇ୃࠦ࡯ࠬ(ᐔᚑ 20 ᐕ 11 ᦬㧘ᄢ㒋㧘⻠Ṷ‫ޟ‬ක≮ᯏ㑐ߩ IT ᚢ⇛‫ޠ‬Ṷ⠪)㧙㧙74㧕 ╙ 28 ࿁ක≮ᖱႎቇㅪวᄢળ(ᐔᚑ 20 ᐕ 11 ᦬㧘␹ᄹᎹ㧘‫ޟ‬ක≮࠺࡯࠲ࡌ࡯ࠬ࡮࠺࡯࠲ࡑࠗ࠾ࡦࠣ‫ޠ‬ᐳ㐳)75㧕 The 2008 Annual Conference of the Japanese Society for Bioinformatics(ᐔᚑ 20 ᐕ 12 ᦬㧘ᄢ㒋㧘᜗ᓙ⻠Ṷ‫ޟ‬ICT Revolution and Paradigm Shift In Hospital‫ޠ‬Ṷ⠪)
᧻ፉ⑲㧦
1㧕 ╙ 54 ࿁ർᶏ㆏ MRI ↹௝⎇ⓥળ(ᐔᚑ 18 ᐕ 11 ᦬㧘ർᶏ㆏㧘⻠Ṷ‫ޟ‬ಽሶ᭴ㅧᄌൻߣ MRI ~ Tissue
imaging ߆ࠄ Cellular imaging ߳ ~‫ޠ‬Ṷ⠪)
2㧕 ᐔᚑ 19 ᐕᐲߺ߃ࡔ࠺ࠖࠞ࡞⎇ⓥળ‫ޟ‬ක↪Ꮏቇ⎇ⓥળ‫ ╙ޠ‬3 ࿁⎇ⓥ࡮⻠Ṷળ(ᐔᚑ 19 ᐕ 11 ᦬㧘ਃ㊀㧘‫ᦨޟ‬ᣂߩක≮↹௝⸻ᢿⵝ⟎ߩၮ␆ߣᔕ↪‫ޠ‬Ṷ⠪)
3㧕 ╙ 15 ࿁࡜ࡏ࡮ࡈࠜ࡯࡜ࡓ(ᗲ⍮⋵⡯ຬ⥃ᐥᬌᩏᛛᏧળ)(ᐔᚑ 20 ᐕ 1 ᦬㧘ᗲ⍮㧘‫ޟ‬MRI ߩၮ␆ߦߟ޿
ߡ‫ޠ‬Ṷ⠪)ౝጊ⦟৻㧦1㧕 ක↪↹௝ᖱႎቇળ╙ 151 ࿁ᄢળ(ᐔᚑ 20 ᐕ 5 ᦬㧘ጘ㒂㧘ฃ⾨⻠Ṷ‫࡞࠻ࠢࡌޟ‬㓸ਛᐲࡈࠖ࡞࠲ࠍ↪޿ߚ MRA ↹௝ߦ߅ߌࠆ⣖േ⣂≜ߩᬌ಴ᴺ‫ޠ‬Ṷ⠪)8㧚ቇⴚ⾨╬ߩฃ⾨⁁ᴫ1㧕 ᧻ፉ⑲㧦╙ 66 ࿁ᣣᧄකቇ᡼኿✢ቇળ Gold Medal ⾨(ᐔᚑ 19 ᐕᐲ)
2㧕 㜞ᨋஜ⊓㧘ⁿญ᣿ඳ㧘㣐የ㓉㧘♿ࡁቯ଻⤿㧦ᖱႎಣℂቇળ DBS ⎇ⓥળ‫ ߣࠬ࡯ࡌ࠲࡯࠺ޟ‬Web ᖱႎࠪࠬ࠹ࡓߦ㑐ߔࠆࠪࡦࡐࠫ࠙ࡓ(DBWeb2007)‫ޠ‬㧘ቇ↢ᅑബ⾨(ᐔᚑ 19 ᐕᐲ)
3㧕 ౝጊ⦟৻㧦╙ 64 ࿁ᣣᧄ᡼኿✢ᛛⴚቇળ CyPos ㌃⾨(ᐔᚑ 20 ᐕᐲ)
4㧕 ౝጊ⦟৻㧦ක↪↹௝ᖱႎቇળ㊄᫪ᅑബ⾨(ᐔᚑ 20 ᐕᐲ)
5㧕 ᷡ᳓⑲ᐕ㧘ች᧛ᑝ᮸㧘᧻ፉ⑲㧘᧛਄᡽㓉㧘ᗆ⦟⡛৻㧘ౝጊ⦟৻㧘♿ࡁቯ଻⤿㧦↢૕කᎿቇࠪࡦࡐࠫ
࠙ࡓ 2008 ࡌࠬ࠻࡝ࠨ࡯࠴ࠕࡢ࡯࠼⾨(ᐔᚑ 20 ᐕᐲ)
9㧚␠ળᵴേ
♿ࡁቯ଻⤿㧦
1㧕 ጘ㒂⋵කᏧળൕോකㇱળ IT ᆔຬળᆔຬ㐳(㨪⃻࿷)2㧕 ጘ㒂⋵කᏧળᖱႎࠪࠬ࠹ࡓᆔຬળᆔຬ(㨪⃻࿷)3㧕 ో࿖ஜᐽ଻㒾දળጘ㒂ᡰㇱ⹏⼏ળᆔຬ(㨪⃻࿷)10㧚ႎ๔ᦠ
1㧕 ጊᧄ⋿↱⟤㧘♿ࡁቯ଻⤿㧘㋈ᧁᐽਯ㧘㜞Ⴆ⋥⢻㧦⚻ᷣ↥ᬺ⋭ᐔᚑ 17 ᐕᐲ‫ޟ‬ක≮⚻༡ੱ᧚⢒ᚑ੐ᬺㆇ༡ߦ㑐ࠊࠆᢎ⢒ࡊࡠࠣ࡜ࡓ‫ ޠ‬ታ❣ႎ๔ᦠ ‫ޟ‬ක≮⚻༡ੱ᧚⢒ᚑᢎ⢒ࡊࡠࠣ࡜ࡓ㐿⊒ࡊࡠࠫࠚࠢ࠻
㜞ᐲක≮ᢎ⢒ࠦࡦ࠰࡯ࠪࠕࡓ (ઍ⴫࡮ᄢ㒋ᄢቇ)‫⵬ ޠ‬ഥᢎ᧚(ࠤ࡯ࠬ)㧦ක≮ᖱႎ▤ℂࠪࠬ࠹ࡓߣ⸻
≮ࡕ࠺࡞㧙♧ዩ∛㧙㧦141㧙176(2006 ᐕ 3 ᦬)
2㧕 ♿ࡁቯ଻⤿㧦ஜ⸻ߩ⟵ോൻߦ㑐ࠊࠆஜ⸻࠺࡯࠲╬ߩㆇ↪࡮▤ℂߦߟ޿ߡ㧘࿖଻੐ᬺផㅴ࠻࠶ࡊ࠮ࡒ
࠽࡯⻠Ṷ⸥㍳㧦32㧙40(2007 ᐕ 1 ᦬)
3㧕 ♿ࡁቯ଻⤿㧦ࡀ࠶࠻ࡢ࡯ࠢ࠮ࡦࠪࡦࠣᛛⴚࠍᔕ↪ߒߚ∛㒮ㆇ༡ᚻᴺߦߟ޿ߡ㧘ᐔᚑ 18 ᐕᐲ‫࠻࠶ࡀޟ‬ࡢ࡯ࠢ࠮ࡦࠪࡦࠣࠪࠬ࠹ࡓᛛⴚ⺞ᩏ⎇ⓥႎ๔ᦠ‫ޠ‬
㧦74㧙77(2007 ᐕ 3 ᦬)
4㧕 㜞Ⴆ⋥⢻㧘Ꮉญ㗅ᢘ㧘㜞ᯅቁᄦ㧘♿ࡁቯ଻⤿㧘ጊᧄ⋿↱⟤㧦ᕆᕈᦼ∛㒮⚻༡ߦ߅ߌࠆ∛ᐥࡑࡀࠫࡔࡦ࠻ 㧙․ቯᯏ⢻∛㒮ᶖൻེᄖ⑼ߩࠤ࡯ࠬ㧙㧘ᐔᚑ 18 ᐕᐲ⚻ᷣ↥ᬺ⋭‫ޟ‬ක≮⚻༡ੱ᧚⢒ᚑ੐ᬺ‫ޠ‬ႎ๔ᦠ 㜞ᐲක≮ᢎ⢒ࠦࡦ࠰࡯ࠪࠕࡓ(ઍ⴫࿅૕࡮ᄢ㒋ᄢቇ)(2007 ᐕ 3 ᦬)
5㧕 㐳ἑᷡ㧘㜞Ⴆ⋥⢻㧘♿ࡁቯ଻⤿㧘ጊᧄ⋿↱⟤㧦ᕆᕈᦼ∛㒮⚻༡ߦ߅ߌࠆᚻⴚㇱࡑࡀࠫࡔࡦ࠻ 㧙․ቯᯏ⢻∛㒮ᚻⴚቶߩࠤ࡯ࠬ㧙㧘⚻ᷣ↥ᬺ⋭ᐔᚑ 19 ᐕᐲࠨ࡯ࡆࠬ↥ᬺੱ᧚⢒ᚑ੐ᬺ(∛㒮ᬺോࡑࡀࠫ
ࡔࡦ࠻ߦ㑐ߔࠆࠤ࡯ࠬࠬ࠲࠺ࠖᢎ⢒㐿⊒ࡊࡠࠫࠚࠢ࠻)ႎ๔ᦠ(2008 ᐕ 3 ᦬)
11㧚ႎ㆏1㧕 ♿ࡁቯ଻⤿㧦IT ᵴ↪ߦࠃࠆක≮ᡷ㕟ߩᦨ೨✢ࠍㅊ߁㧦CIO(2006 ᐕ 10 ᦬ภ)
2㧕 ♿ࡁቯ଻⤿㧦ࠛࠠࠬࡄ࡯࠻ࠗࡦ࠲ࡆࡘ࡯‫ోޟ‬૕ᦨㆡࠍᔀᐩߐߖߚ৻ర▤ℂߣ౒᦭ߢ̌࠺࡯࠲̍߆ࠄ
ଔ୯ࠍ↢ߺ಴ߔㆇ↪ࠍ⋡ᜰߔ‫ޠ‬
㧦MELTOPIA(2006 ᐕ 11 ᦬ภ)
3㧕 ♿ࡁቯ଻⤿㧦ᚢ⇛⊛ߥࡑࡀࠫࡔࡦ࠻ߣ IT ൻߩផㅴ߇ਇนᰳ㧦ᣣ⚻ࠦࡦࡇࡘ࡯࠲(2006 ᐕ 11 ᦬ 27 ᣣ

㧙㧙

ภ)
4㧕 ♿ࡁቯ଻⤿㧦࠮ࡦࠨ࡯ࡀ࠶࠻ࡢ࡯ࠢᛛⴚ㧦ጘ㒂ᣂ⡞(2006 ᐕ 12 ᦬ 8 ᣣ)
5㧕 ♿ࡁቯ଻⤿㧦⢄⤳߇ࠎ ⢄⎬ᄌ ⦡ᄌൻߢ੍ళ⊒⷗㧘ጘ㒂ᄢ⎇ⓥࠣ࡞࡯ࡊ MRI ᣂࠪࠬ࠹ࡓ㐿⊒㧦⺒ᄁᣂ⡞(2007 ᐕ 5 ᦬ 1 ᣣ)
6㧕 ♿ࡁቯ଻⤿㧦‫ޟ‬ㆬ߫ࠇࠆ∛㒮ߣߪ‫ޠ‬㧘ච౐㌁ⴕ࡮ጘ㒂ᄢቇਥ௅‫ޟ‬ක≮⚻༡ࠪࡦࡐࠫ࠙ࡓ‫ޠ‬㧦ጘ㒂ᣂ⡞(2007ᐕ 7 ᦬ 1 ᣣ)
7㧕 ♿ࡁቯ଻⤿㧦ක≮ߩ IT ൻࠍ೨ㅴߐߖࠆᣂ⾗ᩰ೙ᐲ߇੹ㅳᆎേ㧦᦬ೀࠫࡖ࡯ࡑ࠶ࠢ Vol.9 No.9 11
㧙14(2008 ᐕ 9 ᦬ 1 ᣣ)
8㧕 ♿ࡁቯ଻⤿㧦∛㒮 IT ൻߢක≮ߩ⾰ߣ෼⋉ࠕ࠶ࡊࠍ᳞߼ࠆ㧦ITOKI Healthcare Facilities㧘8㧙9(2008
ᐕ 12 ᦬ 10 ᣣ)
12㧚⥄Ꮖ⹏ଔ
⹏ଔ
ᐔᚑ 19 ᐕᐲ߆ࠄߩᄢቇ㒮ㅪวഃ⮎ක≮ᖱႎ⎇ⓥ⑼ߩ┙ߜ਄ߍ߿ᄢቇ㒮↢ߩ⏕଻߽޽ࠅ㧘ో૕⊛ߦߪḩ⿷ߢ߈ࠆᚑᨐࠍ਄ߍࠆߎߣ߇ߢ߈ߚߣ⠨߃ߡ޿ࠆ‫ߚ߹ޕ‬㧘⎇ⓥߩਛᔃࠍᓥ೨ߩක≮ᖱႎࠪࠬ࠹ࡓߩ㐿⊒߆ࠄ⛔วࡃࠗࠝࡃࡦࠢࠪࠬ࠹ࡓߩ㐿⊒ߣᄢⷙᮨ࠺࡯࠲ߩಽᨆߦࠪࡈ࠻ߒ㧘ߎߩࠃ߁ߥᚑᨐߢᐞߟ߆ߩฃ
⾨ࠍᓧࠆߎߣ߇ߢ߈ߚ‫ޕ‬
ߎߩ 3 ᐕ㑆ߪ੹ᓟߩਥᵹߦߥࠆߣᕁࠊࠇࠆ࡜ࠗࡈࠨࠗࠛࡦࠬಽ㊁ߢߩࡃࠗࠝ࡮ࠗࡦࡈࠜࡑ࠹ࠖࠢࠬߦ
⎇ⓥߩゲ⿷ࠍࠪࡈ࠻ߔࠆߎߣࠍ⋡ᮡߣߒߡ⎇ⓥⅣႺߩᢛ஻ࠍⴕߥߞߡ߈ߚ‫⋡ߩߘޕ‬ᮡߪలಽߦ㆐ᚑߢ߈㧘੹ᓟߩᵴ⊒ߥ⎇ⓥߦᔅⷐߥⅣႺߪᢛߞߚߣ⠨߃ߡ޿ࠆ‫ޕ‬⃻⁁ߩ໧㗴ὐ෸߮ߘߩኻᔕ╷᰷ᢥߩේ⪺⺰ᢥ߇ዋߥ޿ߎߣ߇⃻⁁ߩ໧㗴ὐߢ޽ࠆ‫ߩߘޕ‬ኻ╷ߣߒߡ㧘੹ᓟߪ⛔วࡃࠗࠝࡃࡦࠢࠪࠬ
࠹ࡓߦ⫾Ⓧߐࠇߚ࠺࡯࠲ߩಽᨆᚑᨐࠍⓍᭂ⊛ߦේ⪺⺰ᢥൻߔࠆߎߣࠍ⋡ᮡߦ⎇ⓥᵴേࠍߐࠄߦᵴ⊒ൻߒߚ޿‫ߚ߹ޕ‬㧘⎇ⓥಽ㊁ࠍࡃࠗࠝ࡮ࠗࡦࡈࠜࡑ࠹ࠖࠢࠬߦ⇐߹ࠄߕ㧘ߘߩᔕ↪ಽ㊁ߢ޽ࠆഃ⮎࡮ක⮎ຠߩㆡᱜ૶↪߿᦭ኂ੐⽎ಽᨆ㧘ઍ⻢ࡄࠬߩಽᨆߥߤߦ߽᜛ᄢߒ㧘⺰ᢥൻߢ߈ࠆᚑᨐࠍჇ߿ߒߚ޿ߣ⸘↹ߒߡ
޿ࠆ‫ޕ‬
੹ᓟߩዷᦸ
ක≮ᖱႎቇಽ㊁ߦ߅ߌࠆ੹ᓟߩ⎇ⓥኻ⽎ߪᄢⷙᮨ࠺࡯࠲ߩಽᨆ߇ਛᔃߦߥࠆ‫߿࠲࡯࠺≮⸻ޕ‬ஜᐽ࠺࡯࠲㧘ࠥࡁࡓ࠺࡯࠲㧘ක⮎ຠᖱႎ߿↢૕ౝߩઍ⻢ᖱႎ㧘ߘߩઁߩ㑐ㅪߔࠆ࡜ࠗࡈࠨࠗࠛࡦࠬ࠺࡯࠲╬ࠍ⛔
วൻߒ㧘⛔วࡃࠗࠝࡃࡦࠢߣߒߡౣ᭴▽ߔࠆ‫ߡߒߦ߁ࠃߩߎޕ‬ᓧࠄࠇߚᄢⷙᮨ࠺࡯࠲ࠍ⋧੕ߦ㑐ㅪߔࠆ࠺࡯࠲ߣߒߡᝒ߃㧘ߘߩ㑐ㅪ᭴ㅧߣ࠳ࠗ࠽ࡒࠢࠬࠍ⸃ᨆߔࠆߎߣ߇㊀ⷐߢ޽ࠆ‫ޕ‬ߒߚ߇ߞߡ㧘Ԙ᷹ⷰߐࠇߚᬌᩏ୯㑆ߢߩ㑐ଥࡀ࠶࠻ࡢ࡯ࠢ࿑ߩ૞ᚑ㧘ԙ㑐ଥࡀ࠶࠻ࡢ࡯ࠢ਄ߢߩࡊࡠ
࠮ࠬಽᨆ㧘Ԛ㑐ଥࡀ࠶࠻ࡢ࡯ࠢ਄ߩ࠳ࠗ࠽ࡒࠢࠬಽᨆ㧘ԛ㑐ଥࡀ࠶࠻ࡢ࡯ࠢ਄ߩ᭴ㅧ᛽಴㧘Ԝ㑐ଥࡀ࠶࠻ࡢ࡯ࠢ࠺࡯࠲ߦၮߠ޿ߚ∔∛╬ߩᣧᦼ⊒⷗ᛛⴚ߳ߩᔕ↪㧘╬ࠍਥ⌒ߦߒߡᵴ⊒ߥ⎇ⓥᵴേࠍዷ㐿ߒߚ޿ߣ⠨߃ߡ޿ࠆ‫ߚ߹ޕ‬㧘ߎߩࠃ߁ߥᚑᨐࠍᢎ⢒ߦᵴ߆ߔߎߣࠍ⋡ᜰߔ‫ޕ‬㧙㧙㧔2㧕✚ว∛ᘒౝ⑼ቇಽ㊁1㧚⎇ⓥߩ᭎ⷐ
ߎࠇ߹ߢߣห᭽㧘એਅߩ࠹࡯ࡑࠍਛᔃߦ⎇ⓥࠍⴕߞߡ޿ࠆ‫ޕ‬1㧕ࠗࡦࠬ࡝ࡦ૞↪ᯏ᭴ߦ㑐ߔࠆ⎇ⓥ
2 ဳ♧ዩ∛㧘㜞ⴊ࿶∝㧘⢽⾰⇣Ᏹ∝㧘⢈ḩ㧘NASH ࠍ㗫❥ߦว૬ߔࠆࡔ࠲ࡏ࡝࠶ࠢࠪࡦ࠼ࡠ࡯ࡓߪ↢ᵴ⠌ᘠ∛ߩᄢㇱಽࠍභ߼㧘ࡊ࡜ࠗࡑ࡝࡮ࠤࠕߢߩ common disease ߢ޽ࠆ‫∛ߩࠄࠇߎޕ‬ᘒߦߪࠗࡦࠬ࡝ࡦᛶ
᛫ᕈ߇ᒝߊ㑐ਈߒߡ޿ࠆߚ߼㧘ࠗࡦࠬ࡝ࡦᛶ᛫ᕈࠍ⥃ᐥ⊛㧘ၮ␆⊛ߦ⸃᣿ߔࠆߚ߼ߩ⎇ⓥߪᭂ߼ߡ㊀ⷐߢ޽ࠆ‫ࠍ࠻ࡅޕ‬ኻ⽎ߣߒߚ⥃ᐥ⎇ⓥߛߌߢߥߊ㧘࡜࠶࠻߿࡜࠶࠻⢽⢌⚦⢩ࠍ૶↪ߒߚၮ␆⊛⎇ⓥ߽ⴕߞߡ޿
ࠆ‫ࡦ࡝ࠬࡦࠗޕ‬૞↪ᯏ᭴߿㧘dehydroepiandrosterone㧔DHEA㧕ߦࠃࠆࠗࡦࠬ࡝ࡦᗵฃᕈᡷༀᯏ᭴ࠍ㧘ࡑࠗࠢࡠࠕ࡟ࠗ࡮఺∉⚵❱ൻቇ࡮࡝ࠕ࡞࠲ࠗࡓ PCR ߥߤࠍ૶ߞߡߘߩ㑐ਈ࿃ሶࠍតࠆߎߣࠍታ〣ߒߡ޿ࠆ‫ߚ߹ޕ‬㧘ઁߩࠗࡦࠬ࡝ࡦᗵฃᕈᡷༀ࿃ሶߢ޽ࠆࠕ࠺ࠖࡐࡀࠢ࠴ࡦ㧘࡟ࡊ࠴ࡦ㧘DHEA ߿ AMP-kinaseߥߤߣߩ㑐ㅪ߽ᬌ⸛ߒߡ޿ࠆ‫ޕ‬
2㧕↢ᵴ⠌ᘠ∛ߦ߅ߌࠆⴊዊ᧼ಝ㓸ߣⴊẏ࡟ࡊ࠴ࡦỚᐲߣߩ㑐ㅪ⢈ḩࠍਥᓽߣߔࠆᖚ⠪ߪⴊẏ࡟ࡊ࠴ࡦỚᐲ߇㜞޿߇㧘࡟ࡊ࠴ࡦᛶ᛫ᕈ߇޽ࠆߣ⠨߃ࠄࠇߡ޿ࠆ‫৻ޕ‬ᣇ㧘ⴊዊ᧼ߦ࡟ࡊ࠴ࡦฃኈ૕߇⊒⃻ߒߡ߅ࠅ㧘⢈ḩࠍ๒ߔࠆᖚ⠪ߩⴊ▤ว૬∝ߣߩ㑐ㅪߩ⸃᣿߇ᔅⷐߢ޽ࠆ‫ޕ‬
3㧕㐳ኼߦ㑐ߔࠆ⥃ᐥ∉ቇ⊛⎇ⓥ↢ᵴ⠌ᘠ㧔㘩੐㧘ㆇേ㧘༛ᾍ㧘⌧⌁ߥߤ㧕߿േ⣂⎬ൻߦ㑐ㅪߔࠆߣ⠨߃ࠄࠇࠆⴊᷡࡑ࡯ࠞ࡯ࠍ㧘㐳ኼ࿾඙ߣ㕖㐳ኼ࿾඙ߩ૑᳃ߢ⺞ᩏߒᲧセߔࠆ∉ቇ⎇ⓥࠍ㧘ࠗ࠮࠶࠻ᩣᑼળ␠㧘᫪᳗੃ᬺᩣᑼળ␠㧘ࠕࡇᩣᑼળ
␠ߣߩ౒หߢ 2000 ᐕ߆ࠄ㜞ጊᏒߢᲤᐕⴕߞߡ޿ࠆ‫⎇ߩߎޕ‬ⓥ߆ࠄ㧘㐳ኼߦ⚿߮ߟߊ↢ᵴ⠌ᘠ߇૗ߢ޽ࠆ
߆ࠍ᣿ࠄ߆ߦߔࠆߎߣ߇ᦼᓙߐࠇࠆ‫ߦࠄߐޕ‬㧘ߘࠇࠄߩ࿃ሶࠍᡷༀߐߖࠆ੺౉⎇ⓥࠍⴕߞߡ߅ࠅ㧘ஜᐽኼ๮ߩᑧ㐳ࠍ⋡ᜰߒߡ޿ࠆ‫ޕ‬
4㧕േ⣂⎬ൻ࡮ࡔ࠲ࡏ࡝࠶ࠢࠪࡦ࠼ࡠ࡯ࡓߦ㑐ߔࠆ᷹ቯᯏེ㐿⊒⎇ⓥ
Ꮏቇㇱࠪࠬ࠹ࡓᎿቇ⑼ߩ㊁ᣇᢥ㓶ᢎ᝼ߣߩ⍮⊛ࠢ࡜ࠬ࠲࡯ഃ↢੐ᬺߢߩ౒ห⎇ⓥߢ㧘2004 ᐕ߆ࠄขࠅ
⚵ࠎߢ޿ࠆ‫ߦߢ߹ࠇߎޕ‬㧘㗪േ⣂ࠛࠦ࡯߆ࠄേ⣂ߩࠦࡦࡊ࡜ࠗࠕࡦࠬࠍ⍴ᤨ㑆ߦ᷹ቯߔࠆᯏེࠍ㐿⊒ߒߚ‫ޕ‬⃻࿷㧘ⴊ▤ౝ⊹ᯏ⢻᷹ቯⵝ⟎ߣ⣻ㇱౝⵝ⢽⢌᷹ቯⵝ⟎ߩ㐿⊒ࠍᩣᑼળ␠ࡄ࡜ࡑ࡮࠹࠶ࠢߣ౒ห㐿⊒ਛߢ޽ࠆ‫ޕ‬5㧕ฦ⒳↢ᵴ⠌ᘠ∛ᴦ≮⮎ߩࡒ࠻ࠦࡦ࠼࡝ࠕᲥᕈߦ㑐ߔࠆ⎇ⓥᣢߦ☨࿖♧ዩ∛ቇળߢ߽᣿ࠄ߆ߦߒߚ᭽ߦ⢄ࡒ࠻ࠦࡦ࠼࡝ࠕ㓚ኂࠍ troglitazone ߇ᒁ߈⿠ߎߒߚࡒ࠻
ࠦࡦ࠼࡝ࠕᲥᕈߦ㑐ߔࠆᯏ᭴ࠍ᣿ࠄ߆ߦߒߚ‫ߦᦝޕ‬ฦ⒳᛫㜞⢽ⴊẏ⮎೷߿᛫♧ዩ∛⮎೷ߩࡒ࠻ࠦࡦ࠼࡝ࠕ
Ქᕈࠬࠢ࡝࡯࠾ࡦࠣᬌᩏߩ㐿⊒ࠍᬌ⸛ߒߡ޿ࠆ‫ޕ‬
2㧚ฬ★
ᢎ᝼㧦
ಎᢎ᝼㧦
⻠Ꮷ㧦
කຬ㧦
කຬ㧦
කຬ㧦
කຬ㧦
කຬ㧦
කຬ㧦

⍹Ⴆ㆐ᄦ
᫪↰ᶈਯ
᫃↰๺↵
ችౝ࡞ࡒሶ
ᳰ↰⾆⧷
᫪ ৻㇢
⮮ጟ ࿻
ጟ↰⧷ਯ
⮮ដ⾆ᢅ

Tatsuo Ishizuka
Hiroyuki Morita
Kazuo Kajita
Rumiko Miyauchi
Takahide Ikeda
Ichiro Mori
Kei Fujioka
Hideyuki Okada
Takatoshi Fujikake

3㧚⎇ⓥᚑᨐߩ⊒⴫⪺ᦠ㧔๺ᢥ㧕
1㧕 ⍹Ⴆ㆐ᄦ㧚ᶖൻེ㧦ኾ㐷කㇱળ✬㧚↢ᶦᢎ⢒ߩߚ߼ߩ࠮࡞ࡈ࠻࡟࡯࠾ࡦࠣ໧㗴ߣ⸃⺑㧘᧲੩㧦␠࿅ᴺੱᣣ
ᧄౝ⑼ቇળ㧧2008 ᐕ㧦4㧙12㧚⪺ᦠ㧔᰷ᢥ㧕
ߥߒ✚⺑㧔๺ᢥ㧕
1㧕 ⍹Ⴆ㆐ᄦ㧚Doctor's view Vol. 5 ↢ᵴ⠌ᘠ∛੍㒐ߦ㑐ߒߡ㧘ጘ㒂ߩ࿖଻ 2006 ᐕ㧧281 Ꮞ㧦9㧚
2㧕 ⍹Ⴆ㆐ᄦ㧚Doctor's view Vol. 6 ↢ᵴ⠌ᘠ∛੍㒐ߦ㑐ߒߡ㧙21 ਎♿ߩ♧ዩ∛੍㒐㧙㧘ጘ㒂ߩ࿖଻ 2006ᐕ㧧282 Ꮞ㧦11㧚㧙㧙

3㧕 ⍹Ⴆ㆐ᄦ㧚Doctor's view Vol. 7 ↢ᵴ⠌ᘠ∛੍㒐ߦ㑐ߒߡ㧙↢ᵴ⠌ᘠ∛ߣࡊ࡜ࠗࡑ࡝ࠤࠕ㧙㧘ጘ㒂ߩ࿖଻
2006 ᐕ㧧283 Ꮞ㧦1㧚
4㧕 ᫃↰๺↵㧘⍹Ⴆ㆐ᄦ㧚♧ዩ∛࡮ౝಽᴲ∔ᖚߦࠃࠆ⓭ὼᱫ㧘ᴺක∛ℂ 2006 ᐕ㧧12 Ꮞ㧦17㧙21㧚
5㧕 ⍹Ⴆ㆐ᄦ㧚Doctor's view Vol. 8 ↢ᵴ⠌ᘠ∛੍㒐ߦ㑐ߒߡ㧙♧ዩ∛㧘㜞ⴊ࿶㧘㜞⢽ⴊ∝⸻≮ࠟࠗ࠼࡜ࠗࡦ
㧙㧘ጘ㒂ߩ࿖଻ 2007 ᐕ㧧284 Ꮞ㧦14㧙15㧚
6㧕 ⍹Ⴆ㆐ᄦ㧚Doctor's view Vol. 9 ↢ᵴ⠌ᘠ∛੍㒐ߦ㑐ߒߡ㧙ࡔ࠲ࡏ࡝࠶ࠢࠪࡦ࠼ࡠ࡯ࡓߣ⢽⢌⢄㧙㧘ጘ㒂ߩ࿖଻ 2007 ᐕ㧧285 Ꮞ㧦16㧙17㧚
7㧕 ⍹Ⴆ㆐ᄦ㧚Doctor's view Vol. 10 ↢ᵴ⠌ᘠ∛੍㒐ߦ㑐ߒߡ㧙਎⇇♧ዩ∛࠺࡯㧙㧘ጘ㒂ߩ࿖଻ 2007 ᐕ㧧
286 Ꮞ㧦16㧙17㧚
8㧕 ⍹Ⴆ㆐ᄦ㧚Doctor's view Vol. 11 ↢ᵴ⠌ᘠ∛੍㒐ߦ㑐ߒߡ㧙㜞ⴊ࿶ᴦ≮ࠟࠗ࠼࡜ࠗࡦ㧙㧘ጘ㒂ߩ࿖଻2007 ᐕ㧧287 Ꮞ㧦10㧙11㧚
9㧕 ⍹Ⴆ㆐ᄦ㧚↢ᵴ⠌ᘠ∛ߣߪ૗߆ ․㓸․ቯஜ⸻ᤨઍߩ↢ᵴ⠌ᘠ∛ኻ╷㧘JIM 2008 ᐕ㧧18 Ꮞ㧦14㧙19㧚
10㧕 ⍹Ⴆ㆐ᄦ㧚Doctor's view Vol. 12 ↢ᵴ⠌ᘠ∛੍㒐ߦ㑐ߒߡ㧙㑐▵࡝࠙ࡑ࠴ߣ↢ᵴ⠌ᘠ∛㧙㧘ጘ㒂ߩ࿖଻
2008 ᐕ㧧288 Ꮞ㧦16㧙17㧚
11㧕 ⍹Ⴆ㆐ᄦ㧚ࠗࡦࠬ࡝ࡦฃኈ૕᛫૕ ᣂᤨઍߩ♧ዩ∛ቇ(2)㧙∛࿃࡮⸻ᢿ࡮ᴦ≮⎇ⓥߩㅴᱠ㧙㧘ᣣᧄ⥃ᐥ 2008
ᐕ㧧66 Ꮞ(Ⴧೀ 4)㧦310㧙313㧚
12㧕 ⍹Ⴆ㆐ᄦ㧚ᣣ♧ද࡮࿖㓙ᆔຬળߛࠃࠅ(2) ╙ 43 ࿁ EASD(᰷Ꮊ♧ዩ∛ળ⼏)ߦෳടߒߡ㧘ߐ߆߃ 4 ᦬ภ㧧2008 ᐕ㧦64㧚
13㧕 ᫪↰ᶈਯ㧚කቇ↢ߦࠃࠆ⸰໧⋴⼔૕㛎ታ⠌㧘කቇߩ޽ࠁߺ 2008 ᐕ㧧224 Ꮞ㧦163㧙165㧚
14㧕 ⍹Ⴆ㆐ᄦ㧚⮎‛ᜰዉߦ߅ߌࠆ⻉໧㗴 ♧ዩ∛ߩ≮㙃ᜰዉ㧦♧ዩ∛ቇߩㅴᱠ 42 ࿁ 2008 ᐕ㧦86㧙91㧚
15㧕 ⍹Ⴆ㆐ᄦ㧚✚วౝ⑼ኾ㐷කߣࠨࡉࠬࡍࠪࡖ࡝࠹ࠖ㧘ᣣᧄౝ⑼ቇળ㔀⹹ 2008 ᐕ㧧97 Ꮞ㧦222㧙226㧚
16㧕 ⍹Ⴆ㆐ᄦ㧚♧ዩ∛߳ᬌᩏߣᜰᮡ߆ࠄࠕࡊࡠ㧙࠴ ࠗࡦࠬ࡝ࡦᛶ᛫ᕈߩ◲ᤃ⸻ᢿᴺߣ㒢⇇㧘♧ዩ∛ UP࡮DATE
⾫ፉ࠮ࡒ࠽࡯24 2008 ᐕ㧦44㧙53㧚
17㧕 ⍹Ⴆ㆐ᄦ㧚ᴦ≮ਛߩ 2 ဳ♧ዩ∛ᖚ⠪ߪ߁ߟ∝⁁ࠍ⊒⃻ߒ߿ߔ޿㧙߁ߟ∝⁁ߣ♧ዩ∛ߩ෺ᣇะ㑐ㅪߦߟ޿ߡ
ߩᬌ⸛㧙㧘MMJ 2008 ᐕ㧧4 Ꮞ㧦840㧙841㧚
18㧕 ⍹Ⴆ㆐ᄦ㧚ࡊ࡜ࠗࡑ࡝ࠤࠕߣ↢ᵴ⠌ᘠ∛߆ࠄ࿾ၞක≮࡮㆙㓒ක≮߳ߩዷᦸ㧘ᣣᧄ㆙㓒ක≮ቇળ㔀⹹ 2008
ᐕ㧧4 Ꮞ㧦172㧙174㧚✚⺑㧔᰷ᢥ㧕
1㧕 Ishizuka T. Adrenal insufficiency complicated with antiphospholipid syndrome. Intern Med.
2006;45:1077-1078.
ේ⪺㧔๺ᢥ㧕
1㧕 ⑔ᴛཅቁ, ᩊ↰ᢕሶ, 㢬Ỉᱜੳ, ฦോિ৻, የ㑐ᢎ↢, ᫪↰ᶈਯ, ౝᧁ㓉ᢥ, ⊕ဈ๺ା, ዊᎹ㓁ሶ, ᦯ㇱᵏテ,቟↰৻ᦶ, ⍹Ⴆ㆐ᄦ, ේἑ৻㇢, ᫃↰๺↵, ᱞ↰ೣਯ㧚ోりୱᕃᗵࠍਥ⸷ߦ⪺᣿ߥ⢄ᯏ⢻㓚ኂࠍ๒ߒߚ 12ᱦ↵ఽ଀㧘ౝ⑼ኾ㐷කળ⹹ 2006 ᐕ㧧18 Ꮞ㧦255㧙268㧚
2㧕 ਣጊᢥᄦ㧘⍹Ⴆ㆐ᄦ㧘ᩙᧄ⑲ᒾ㧘ਃፉାᒾ㧘᦯ㇱ๺᮸㧘ਃỈஜᄥ㇢㧘ችፒੳ㧚⹺ቯౝ⑼ኾ㐷කߦࠃࠆᢎ⢒࠮ࡒ࠽࡯߹ߣ߼㧙޿߹ߎߘࡊࡠࡉ࡟ࡓ࡝ࠬ࠻ࠍ⷗⋥ߘ߁㧙㧘ౝ⑼ኾ㐷කળ⹹ 2006 ᐕ㧧18 Ꮞ㧦269㧙296㧚
3㧕 ᵻ㊁ᤘ㆏, ᫪↰ᶈਯ, ർ⼱⌀ሶ, ౎ᧁ㇌౏, ㋈ᧁ⮍, ጊ⑺⋥ੱ, ᱞ↰⟵ാ, ዊᴰ㗅ੑ, ᧻੗Ꮧઍሶ, Ⓑ၂⟤ᥓሶ㧚㜞ⴊ♧ߩߚ߼➅ࠅ㄰ߒᢎ⢒౉㒮ࠍⷐߒߚ 2 ဳ♧ዩ∛㧘♧ዩ∛ߩ≮㙃ᜰዉ㧦♧ዩ∛ቇߩㅴᱠ 40 ࿁ 2006
ᐕ㧦213㧙219㧚
4㧕 ᨋ⟤૫㧘ጤᧁඳ⟤㧘᫪↰ᶈਯ㧘ḡ਄⧷⤿㧘ቝ㊁ཅᒄ㧘᫃↰๺↵㧘᧻ᧄ㓷⟤㧘ᳰ↰⾆⧷㧘᫪৻㇢㧘᧻ේஜᴦ㧘๺↰␭Ὼ㧘⍹Ⴆ㆐ᄦ㧚࿷ቛஜᐽ▤ℂࠪࠬ࠹ࡓߦࠃࠆ㒠࿶ലᨐ㧙ஜᐽ⸻ᢿߢߩ㕖೑↪⠪ߣߩᲧセ⎇ⓥ㧙㧘ᣣᧄ㆙㓒ක≮ቇળ㔀⹹ 2006 ᐕ㧧2 Ꮞ㧦222㧙223㧚
5㧕 ጤᧁඳ⟤㧘ᨋ⟤૫㧘᫪↰ᶈਯ㧘ḡ਄⧷⤿㧘ቝ㊁ཅᒄ㧘᫃↰๺↵㧘᧻ᧄ㓷⟤㧘ᳰ↰⾆⧷㧘᫪৻㇢㧘᧻ේஜᴦ㧘๺↰␭Ὼ㧘⍹Ⴆ㆐ᄦ㧚࿷ቛஜᐽ▤ℂࠪࠬ࠹ࡓߩ᦭↪ᕈ㧙ᔃ㔚࿑ߦࠃࠆਇᢛ⣂ߩ᦬೎࡮ᐕઍ೎ᄌേ㧙㧘ᣣᧄ㆙㓒ක≮ቇળ㔀⹹ 2006 ᐕ㧧2 Ꮞ㧦224㧙225㧚
6㧕 ᫪↰ᶈਯ㧘ቝ㊁ཅᒄ㧘⍹Ⴆ㆐ᄦ㧘଻૑ഞ㧘›Ⴆ⾆㧚කቇ↢ߦࠃࠆ⸰໧⋴⼔૕㛎ታ⠌ߩ⹏ଔ㧘කቇᢎ⢒ 2006ᐕ㧧37 Ꮞ㧦311㧙315㧚
7㧕 ᫪↰ᶈਯ㧘᳓㊁ᥓሶ㧘᫃↰๺↵㧘ቝ㊁ཅᒄ㧘ᳰ↰⾆⧷㧘᫪৻㇢㧘᧻ේஜᴦ㧘᧻ᧄ㓷⟤㧘㐳੗ቁᄥ㇢㧘⍹Ⴆ㆐ᄦ㧚ਔ஥ߦ೽⣢⊹⾰⣼⣲߇⷗ࠄࠇߚේ⊒ᕈࠕ࡞࠼ࠬ࠹ࡠࡦ∝ߩ 1 ଀㧙ฝࠕ࡞࠼ࠬ࠹ࡠࡦ↥↢⣼⣲ߣᏀ㕖ᯏ⢻ᕈ⣼⣲㧙㧘ᣣᧄౝಽᴲቇળ㔀⹹ ╙ 16 ࿁⥃ᐥౝಽᴲઍ⻢ Update Proceeding 2006 ᐕ㧧82 Ꮞ㧦61
㧙63㧚
8㧕 ㊁ᣇᢥ㓶㧘ቝ㊁ཅᒄ㧘᫪↰ᶈਯ㧘⍹Ⴆ㆐ᄦ㧘ᴡ᧛ᵗሶ㧘ᮮ↰ᐽᚑ㧘ਅਛᥓ㧘↰ਛ㕏ື㧚ஜᐽ㜞㦂⠪ᬌᩏࠪࠬ࠹ࡓߩ㐿⊒㧘ᣣᧄࠦࡦࡇࡘ㧙࠲ᄖ⑼ቇળ㔀⹹ 2006 ᐕ㧧8 Ꮞ㧦134㧙135㧚
9㧕 ᧻ේஜᴦ, ᫪৻㇢, ᳰ↰⾆⧷, ᧻ᧄ㓷⟤, ᧖ጊජ਎, ᫃↰๺↵, ቝ㊁ཅᒄ, ᫪↰ᶈਯ, ⍹Ⴆ㆐ᄦ㧚㐳ኼߦᓇ㗀ࠍਈ߃ࠆ࿃ሶߩᬌ⸛ ࿖ᐭ࡮⟤ጊ࿾඙Ყセ⎇ⓥ㧘ጘ㒂⋵ౝ⑼කળ㔀⹹ 2007 ᐕ㧧21 Ꮞ㧦19㧙21㧚
10㧕 ⍹Ⴆ㆐ᄦ㧘Ḋญା਽㧘⑔ᴛཅቁ㧘ൎᧁ㗼㧘ቝ㊁ཅᒄ㧚ࡔ࠲ࡏ࡝࠶ࠢࠪࡦ࠼ࡠ࡯ࡓ㧙ኾ㐷㗔ၞ߆ࠄߩࡔ࠶࠮
㧙ࠫߣ⸛⺰㧙ᣣᧄౝ⑼ቇળኾ㐷කㇱળᡰㇱ࠮ࡒ࠽࡯߆ࠄ㧘ᣣᧄౝ⑼ቇળ㔀⹹ 2007 ᐕ㧧96 Ꮞ㧦174㧙180㧚
11㧕 ᫪↰ᶈਯ㧘ᨋ⟤૫㧘ቝ㊁ཅᒄ㧘᫃↰๺↵㧘⮮ጟ࿻㧘᫪৻㇢㧘ᳰ↰⾆⧷㧘᧻ේஜᴦ㧘๺↰␭Ὼ㧘ጤᧁඳ⟤㧘ḡ਄⧷⤿㧘⍹Ⴆ㆐ᄦ㧚࿷ቛஜᐽ▤ℂࠪࠬ࠹ࡓ೑↪ߦࠃࠆ↢ᵴ⠌ᘠ∛㑐ㅪᜰᮡ߳ߩലᨐ㧙ஜᐽ⸻ᢿߢߩ㕖೑↪⠪ߣߩᲧセ⎇ⓥ㧙㧘ᣣᧄ㆙㓒ක≮ቇળ㔀⹹ 2007 ᐕ㧧3 Ꮞ㧦229㧙230㧚
12㧕 㜞ᧁஜ⵨㧘᫪↰ᶈਯ㧘የㆺ೑⧷㧘᧛ጊᱜᙗ㧘ᯅᧄ⋥⚐㧘⍹Ⴆ㆐ᄦ㧚2 ᐕ㑆ߩ⚻ㆊߢᄌൻࠍ␜ߒߚ⢖⚿▵㒶㧙㧙ᓇߩ 1 ଀㧙ᣣᧄౝ⑼ቇળኾ㐷කㇱળᡰㇱ࠮ࡒ࠽࡯߆ࠄ㧙㧘ᣣᧄౝ⑼ቇળ㔀⹹ 2008 ᐕ㧧97 Ꮞ㧦849㧙856㧚
13㧕 ⍹Ⴆ㆐ᄦ㧘⑔ᴛཅቁ㧘ศን ⚐㧘᧖ᶆ ാ㧘ဈ㊁┨๋㧘᫪↰ᶈਯ㧚⊒ᾲ∔ᖚ߳ߩฦಽ㊁߆ࠄߩࠕࡊࡠ࡯࠴
㧙╙ 3 ࿁᧲ᶏᡰㇱౝ⑼ኾ㐷කㇱળᢎ⢒࠮ࡒ࠽࡯߆ࠄ㧙㧘ᣣᧄౝ⑼ቇળ㔀⹹ 2008 ᐕ㧧97 Ꮞ㧦1363㧙1370㧚
14㧕 ᳰ↰⾆⧷㧘᫪↰ᶈਯ㧘ቝ㊁ཅᒄ㧘᫃↰๺↵㧘ችౝ࡞ࡒሶ㧘᫪৻㇢㧘⮮ጟ࿻㧘ጟ↰⧷ਯ㧘⮮ដ⾆ᢅ㧘๺↰␭Ὼ㧘⍹Ⴆ㆐ᄦ㧘ᄢႦዅ㧚㆙㓒ක≮ߩ࠾࡯࠭ߣ࠲࡯ࠥ࠶࠻㧙ጊ㑆࿾ၞߢߩ࿷ቛஜᐽ▤ℂࠪࠬ࠹ࡓᄾ⚂⠪߳ߩࠕࡦࠤ㧙࠻⺞ᩏ㧙㧘ᣣᧄ㆙㓒ක≮ቇળ㔀⹹ 2008 ᐕ㧧4 Ꮞ㧦306㧙307㧚
15㧕 ᧛ጊᱜᙗ㧘ᄐ⋡૫ᐘ㧘ጟ↰⟤Ꮤ㧘㋈ᧁବᚑ㧘ⓄⓍብዏ㧘᫪৻㇢㧘ศ౷ᷕ㧘᫪↰ᶈਯ㧘౗᧻ቁᅢ㧚╙ 4 ࿁᧲ᶏᡰㇱᢎ⢒࠮ࡒ࠽࡯ ࡊࡠࡉ࡟ࡓߢ⠨߃ࠆ∝଀ᬌ⸛ળ㧘ᣣᧄౝ⑼ቇળ㔀⹹ 2008 ᐕ㧧97 Ꮞ㧦2811㧙2819㧚
ේ⪺㧔᰷ᢥ㧕
1㧕 Takahashi M, Minatoguchi S, Nishigaki K, Kawasaki M, Arai M, Uno Y, Fujiwara H. Long-term andstrict blood pressure lowering by imidapril reverses left ventricular hypertrophy in patients withessential hypertension: an evaluation using a novel indicator of burden on the left ventricle.
Hypertens Res. 2006;29:89-94.
2㧕 Lu C, Arai M, Misao Y, Chen X, Wang N, Onogi H, Kobayashi H, Uno Y, Takemura G, Minatoguchi S,
Fujiwara T, Fujiwara H. Autologous bone marrow cell transplantation improves left ventricularfunction in rabbit hearts with cardiomyopathy via myocardial regeneration-unrelated mechanisms.
Heart Vessels. 2006;21:180-187.
3㧕 Suzuki K, Nagashima K, Arai M, Uno Y, Misao Y, Takemura G, Nishigaki K, Minatoguchi S, Watanabe
S, Tei C, Fujiwara H. Effect of granulocyte colony-stimulating factor treatment at a low dose but for along duration in patients with coronary heart disease. Circ J. 2006;70:430-437.
4㧕 Arai M, Misao Y, Nagai H, Kawasaki M, Nagashima K, Suzuki K, Tsuchiya K, Otsuka S, Uno Y,
Takemura G, Nishigaki K, Minatoguchi S, Fujiwara H. Granulocyte colony-stimulating factor: anoninvasive regeneration therapy for treating atherosclerotic peripheral artery disease. Circ J.
2006;70:1093-1098.
5㧕 Isomura Y, Mune T, Morita H, Suwa T, Takada N, Yamamoto Y, Takeda J. Physiologic roles of
11-hydroxydehydrogenase type 2 in kidney. Metabolism. 2006;55:1352-1357.
6㧕 Onogi H, Minatoguchi S, Chen XH, Bao N, Kobayashi H, Misao Y, Yasuda S, Yamaki T, , Maruyama R,
Uno Y, Arai M, Takemura G, Fujiwara H. Edaravone reduces myocardial infarct size and improves
cardiac function and remodelling in rabbits. Clin Exp Pharmacol Physiol. 2006;33:1035-1041.
7㧕 Yamada Y, Sekihara H, Omura M, Yanase T, Takayanagi R, Mune T, Yasuda K, Ishizuka T, Ueshiba H,
Miyachi Y, Iwasaki T, Nakajima A, Nawata H. Changes in serum sex hormone profiles after
short-term low-dose administration of dehydroepiandrosterone (DHEA) to young and elderly persons.
Endocr J. 2007;54:153-162.
8㧕 Sugiyama C, Ishizawa M, Kajita K, Morita H, Uno Y, Matsubara K, Matsumoto M, Ikeda T, Ishizuka T.
Platelet aggregation in obese and diabetic subjects: association with leptin level. Platelets.
2007;18:128-134.
9㧕 Chen X, Minatoguchi S, Arai M, Wang N, Lu C, Narentuoya B, Uno Y, Misao Y, Takemura G, Fujiwara
T, Fujiwara H. Celiprolol, a selective beta1-blocker, reduces the infarct size through production of
nitric oxide in a rabbit model of myocardial infarction. Circ J. 2007;71:574-579.
10㧕 Ishizuka T, Miura A, Kajita K, Matsumoto M, Sugiyama C, Matsubara K, Ikeda T, Mori I, Morita H,
Uno Y, Mune T, Kanoh Y, Ishizawa M. Effect of dehydroepiandrosterone on insulin sensitivity in
Otsuka Long-Evans Tokushima fatty rats. Acta Diabetol. 2007;44:219-226.
11㧕 Kajita K, Mune T, Ikeda T, Matsumoto M, Uno Y, Sugiyama C, Matsubara k, Morita H, Takemura M,
Seishima M, Takeda J, Ishizuka T. Effect of fasting on PPAR and AMPK activity in adipocytes.
Diabetes Res Clin Pract. 2008;81:144-149.
12㧕 Mori I, Ishizuka T, Morita H, Matsumoto M, Uno Y, Kajita K, Ikeda T, Fujioka K, Matsubara K.
Comparison of biochemical data, blood pressure and physical activity between longevity andnon-longevity districts in Japan. Circ J. 2008;72:1680-1684.

IF 2.951

IF 1.043

IF 2.373

IF 2.373
IF 2.647

IF 2.038

IF 1.572

IF 1.915

IF 2.373

IF 1.619

IF 1.823

IF 2.373

4㧚⎇ⓥ⾌₪ᓧ⁁ᴫ
1㧕┹੎⊛⾗㊄1㧕 ⎇ⓥઍ⴫⠪㧦᫪↰ᶈਯ㧘⎇ⓥಽᜂ⠪㧦⍹Ⴆ㆐ᄦ㧘ቝ㊁ཅᒄ㧧ᢥㇱ⑼ቇ⋭⑼ቇ⎇ⓥ⾌⵬ഥ㊄ၮ⋚⎇ⓥ(B)(2)㧦㐳ኼߣ↢ᵴ⠌ᘠ㧙ጘ㒂↢ᵴ⠌ᘠ⺞ᩏ࡮੺౉ࡊࡠࠫࠚࠢ࠻㧙㧧ᐔᚑ 16㧙19 ᐕᐲ㧧14,900 ජ౞(7,600㧦4,000㧦1,900㧦1,400 ජ౞)
2㧕 ⎇ⓥઍ⴫⠪㧦㊁ᣇᢥ㓶㧘⎇ⓥಽᜂ⠪㧦᫪↰ᶈਯ㧘ቝ㊁ཅᒄ㧘㘵↰ብ᮸㧘㘵↰⌀⟤㧘ᮮ↰ᐽᚑ㧘⍹Ⴆ㆐ᄦ㧘ᷡፉḩ㧧⍮⊛ࠢ࡜ࠬ࠲࡯ഃ↢੐ᬺ㧙ࡠࡏ࠹࠶ࠢవ┵ක≮ࠢ࡜ࠬ࠲࡯㧙㧦ක≮⸻ᢿᡰេࠪࠬ࠹
ࡓߩ㐿⊒㧙േ⣂⎬ൻ⸃ᨆ࡮⸻ᢿࠪࠬ࠹ࡓ㧙㧧ᐔᚑ 17㧙20 ᐕᐲ㧧50,409 ජ౞(9,500㧦20,000㧦7,500㧦
13,409 ජ౞)3㧕 ⎇ⓥઍ⴫⠪㧦㈬Ꮞືᄦ㧘⎇ⓥಽᜂ⠪㧦᫪↰ᶈਯ㧘ጟ↰ብၮ㧘㐳⼱Ꮉ㜞ᔒ㧘ᧄ㑆⡡⿠㧘ศ↰ᤩᢅ㧘ㄞ㧙㧙ᱜᰴ㧘ේ㊂ብ㧧࿷ቛක≮߳ߩ㆙㓒ක≮ታ↪ታᣉᚻ㗅ߩ╷ቯ㧧ᐔᚑ 20 ᐕᐲ㧧500 ජ౞
2㧕ฃ⸤⎇ⓥߥߒ
3㧕౒ห⎇ⓥ1㧕 ⍹Ⴆ㆐ᄦ㧘᫪↰ᶈਯ㧘ቝ㊁ཅᒄ㧘᫃↰๺↵㧘᧻ේஜᴦ㧘᧻ᧄ㓷⟤㧘ᳰ↰⾆⧷㧘᫪৻㇢㧦ጘ㒂⋵ౝߩ㐳ኼ࿾ၞߣ㕖㐳ኼ࿾ၞߢߩ㧘り૕߅ࠃ߮↢ᵴ⠌ᘠ(㘩੐㧘ㆇേ╬)ߩ∉ቇ⊛⺞ᩏߦࠃࠆේ࿃ߩ⸃᣿㧧ᐔ
ᚑ 18 ᐕᐲ㧧2,000 ජ౞㧦ࠗ࠮࠶࠻(ᩣ)
2㧕 ⍹Ⴆ㆐ᄦ㧘᫪↰ᶈਯ㧘ቝ㊁ཅᒄ㧘᫃↰๺↵㧘ᳰ↰⾆⧷㧘᫪৻㇢㧘⮮ጟ࿻㧘ችౝ࡞ࡒሶ㧦ᵹേ㘩㐳ᦼ៨ขߦࠃࠆࡔ࠲ࡏ࡝࠶ࠢ∝୥⟲ߩ੍㒐࡮ᡷༀലᨐ㧧ᐔᚑ 19 ᐕᐲ㧧2,970 ජ౞㧦᫪᳗੃ᬺ(ᩣ)
3㧕 ⍹Ⴆ㆐ᄦ㧘᫪↰ᶈਯ㧦❫⛽࡝࠶࠴ᯏ⢻ᕈ㘩ຠࠍ૶↪ߒߚࡔ࠲ࡏኻ╷ലᨐߩᬌ⸽㧧ᐔᚑ 19 ᐕᐲ㧧2,000ජ౞㧦ࠗ࠮࠶࠻(ᩣ)
4㧕 ⍹Ⴆ㆐ᄦ㧘᫪↰ᶈਯ㧘᫃↰๺↵㧘⮮ጟ࿻㧘ችౝ࡞ࡒሶ㧘ᳰ↰⾆⧷㧘᫪৻㇢㧘ጟ↰⧷ਯ㧘⮮ដ⾆ᢅ㧦ࡠ࡯ࡗ࡞࠯࡝࡯฽᦭㘶ᢱߩ㐳ᦼ៨ขߦࠃࠆല⢻࡮ലᨐߩᬌ⸽㧦ᐔᚑ 20 ᐕᐲ㧧2,000 ජ౞㧦ࠗ࠮࠶࠻(ᩣ)
5㧕 ⍹Ⴆ㆐ᄦ㧘᫃↰๺↵㧦ࡠ࡯ࡗ࡞࠯࡝࡯៨ขߦࠃࠆࡔ࠲ࡏ࡝࠶ࠢ∝୥⟲ߩ੍㒐࡮ᡷༀലᨐ㧦ᐔᚑ 20 ᐕᐲ㧧2,970 ජ౞㧦ࠕࡇ(ᩣ)
5㧚⊒᣿࡮․⸵಴㗿⁁ᴫ
1㧕 ㊁ᣇᢥ㓶㧘᫪↰ᶈਯ㧘ቝ㊁ཅᒄ㧦⵬ᱜⵝ⟎(⊒᣿)㧧ᐔᚑ 19 ᐕ(․㗿 2006-003862)
2㧕 㘵↰ብ᮸㧘㘵↰⌀⟤㧘᫪↰ᶈਯ㧘ቝ㊁ཅᒄ㧘ᮮ↰ᐽᚑ㧘㊁ᣇᢥ㓶㧦ⴊ▤ౝ⊹ᯏ⢻᷹ቯⵝ⟎(⊒᣿)㧧ᐔᚑ 20 ᐕ(․㗿 2007-138493)
3㧕 ㊁ᣇᢥ㓶㧘ᮮ↰ᐽᚑ㧘ᴡ᧛ᵗሶ㧘᫪↰ᶈਯ㧘ቝ㊁ཅᒄ㧦↢૕േ⣂⹏ଔᣇᴺ㧘෸߮↢૕േ⣂⹏ଔⵝ⟎(⊒᣿)㧧ᐔᚑ 20 ᐕ(․㗿 2008-015386)
6㧚ቇળᵴേ
1㧕ቇળᓎຬ⍹Ⴆ㆐ᄦ㧦
1㧕 ᣣᧄౝ⑼ቇળ⹏⼏ຬ(㨪⃻࿷)2㧕 ᣣᧄౝ⑼ቇળ᧲ᶏᡰㇱ⹏⼏ຬ(㨪⃻࿷)3㧕 ᣣᧄౝ⑼ቇળ⹺ቯක࡮ኾ㐷ක⹜㛎ᆔຬ(㨪ᐔᚑ 20 ᐕ 9 ᦬)
4㧕 ᣣᧄౝ⑼ቇળኾ㐷කㇱળ᧲ᶏᡰㇱ㐳(㨪⃻࿷)5㧕 ᣣᧄౝ⑼ቇળኾ㐷කㇱળᓎຬ(㨪⃻࿷)6㧕 ᣣᧄ♧ዩ∛ቇળ⹏⼏ຬ(㨪⃻࿷)7㧕 ᣣᧄ♧ዩ∛ቇળ≮㙃ᜰዉ჻⹺ቯᯏ᭴⹺ቯᆔຬ(㨪⃻࿷)8㧕 ᣣᧄ♧ዩ∛ቇળ♧ዩ∛↪⺆㓸✬㓸ᆔຬ㐳(㨪⃻࿷)9㧕 ᣣᧄౝಽᴲቇળઍ⼏ຬ(㨪⃻࿷)10㧕 ᣣᧄౝಽᴲቇળ᧲ᶏᡰㇱ⋙੐(ᐔᚑ 19 ᐕ 4 ᦬㨪⃻࿷)11㧕 ᣣᧄౝಽᴲቇળኾ㐷ක⹜㛎ᆔຬ(㨪ᐔᚑ 20 ᐕ 9 ᦬)
12㧕 ᣣᧄ∛ᘒᩕ㙃ቇળ⹏⼏ຬ(㨪⃻࿷)13㧕 ᣣᧄ㆙㓒ක≮ቇળℂ੐(ᐔᚑ 19 ᐕ 4 ᦬㨪⃻࿷)
ቝ㊁ཅᒄ㧦
1㧕 ᣣᧄౝ⑼ቇળ᧲ᶏᡰㇱ⹏⼏ຬ(㨪⃻࿷)᫪↰ᶈਯ㧦1㧕 ᣣᧄౝ⑼ቇળ᧲ᶏᡰㇱ⹏⼏ຬ(㨪⃻࿷)2㧕 ᣣᧄౝ⑼ቇળ⹺ቯౝ⑼ක࡮✚วౝ⑼ኾ㐷ක⹜㛎໧㗴૞ᚑᆔຬળ਎⹤ੱ(ᐔᚑ 20 ᐕ 10 ᦬㨪⃻࿷)
3㧕 ᣣᧄ♧ዩ∛ቇળ⹏⼏ຬ(ᐔᚑ 20 ᐕ 4 ᦬㨪⃻࿷)
4㧕 ᣣᧄ♧ዩ∛ቇળ♧ዩ∛↪⺆㓸✬㓸ᆔຬ(ᐔᚑ 20 ᐕ 4 ᦬㨪⃻࿷)
5㧕 ᣣᧄౝಽᴲቇળઍ⼏ຬ(㨪⃻࿷)6㧕 ᣣᧄࠬ࠹ࡠࠗ࠼ࡎ࡞ࡕࡦቇળ⹏⼏ຬ(㨪⃻࿷)㧙㧙7㧕 ᣣᧄ∛ᘒᩕ㙃ቇળ⹏⼏ຬ(㨪⃻࿷)᫃↰๺↵㧦1㧕 ᣣᧄౝ⑼ቇળ᧲ᶏᡰㇱ⹏⼏ຬ(ᐔᚑ 19 ᐕ 4 ᦬㨪⃻࿷)2㧕 ᣣᧄౝಽᴲቇળઍ⼏ຬ(㨪⃻࿷)3㧕 ᣣᧄ∛ᘒᩕ㙃ቇળ⹏⼏ຬ(ᐔᚑ 20 ᐕ 4 ᦬㨪⃻࿷)2㧕ቇળ㐿௅⍹Ⴆ㆐ᄦ㧦
1㧕 ╙ 1 ࿁᧲ᶏᡰㇱኾ㐷කㇱળᢎ⢒࠮ࡒ࠽࡯(2006 ᐕ 6 ᦬㧘ฬฎደ)2㧕 ╙ 2 ࿁᧲ᶏᡰㇱኾ㐷කㇱળᢎ⢒࠮ࡒ࠽࡯(2007 ᐕ 2 ᦬㧘ᵤ)3㧕 ╙ 3 ࿁᧲ᶏᡰㇱኾ㐷කㇱળᢎ⢒࠮ࡒ࠽࡯(2007 ᐕ 10 ᦬㧘ฬฎደ)
4㧕 ╙ 4 ࿁᧲ᶏᡰㇱኾ㐷කㇱળᢎ⢒࠮ࡒ࠽࡯(2008 ᐕ 2 ᦬㧘ฬฎደ)
5㧕 ╙ 5 ࿁᧲ᶏᡰㇱኾ㐷කㇱળᢎ⢒࠮ࡒ࠽࡯(2008 ᐕ 6 ᦬㧘ᵿ᧻)
6㧕 ᐔᚑ 20 ᐕᐲᣣᧄ㆙㓒ක≮ቇળቇⴚᄢળ(2008 ᐕ 10 ᦬㧘ጘ㒂)
3㧕ቇⴚ㔀⹹᫪↰ᶈਯ㧦
1㧕 ᣣᧄ㆙㓒ක≮ቇળ㔀⹹㧧✬㓸ᆔຬ(ᐔᚑ 19 ᐕ 4 ᦬㨪⃻࿷)7㧚ቇળ᜗ᓙ⻠Ṷ㧘᜗ᓙࠪࡦࡐࠫࠬ࠻㧘ᐳ㐳⍹Ⴆ㆐ᄦ㧦
1㧕 ╙ 1 ࿁᧲ᶏᡰㇱኾ㐷කㇱળᢎ⢒࠮ࡒ࠽࡯(2006 ᐕ 10 ᦬㧘ฬฎደ㧘ࠪࡦࡐࠫ࠙ࡓ‫∝ࠢ࠶࡝ࡏ࠲ࡔޟ‬୥⟲ 㧙ኾ㐷㗔ၞ߆ࠄߩࡔ࠶࠮࡯ࠫߣ⸛⺰㧙‫ޠ‬ᐳ㐳)2㧕 ╙ 50 ࿁ᣣᧄ♧ዩ∛ቇળᐕᰴቇⴚ㓸ળ(2007 ᐕ 5 ᦬㧘઄บ㧘ᢎ⢒⻠Ṷ‫⚻␹ޟ‬㓚ኂߩ⸻ᢿߣᴦ≮‫ޠ‬ᐳ㐳)
3㧕 ╙ 24 ࿁♧ዩ∛ Up࡮Date ⾫ፉ࠮ࡒ࠽࡯(2007 ᐕ 8 ᦬㧘ᔒ៺㧘᜗ᓙ⻠Ṷ‫ࡦ࡝ࡦࠗޟ‬ᛶ᛫ᕈߩ◲ᤃ⸻ᢿ
ᴺߣ㒢⇇‫ޠ‬Ṷ⠪)
4㧕 ╙ 3 ࿁᧲ᶏᡰㇱኾ㐷කㇱળᢎ⢒࠮ࡒ࠽࡯(2007 ᐕ 10 ᦬㧘ฬฎደ㧘ࠪࡦࡐࠫ࠙ࡓ‫⊒ޟ‬ᾲ∔ᖚ߳ߩฦಽ
㊁߆ࠄߩࠕࡊࡠ࡯࠴‫ޠ‬ᐳ㐳)
5㧕 ╙ 5 ࿁᧲ᶏᡰㇱኾ㐷කㇱળᢎ⢒࠮ࡒ࠽࡯(2008 ᐕ 6 ᦬㧘ฬฎደ㧘ࠪࡦࡐࠫ࠙ࡓ‫ߦࠕࠤ࡝ࡑࠗ࡜ࡊޟ‬߅ߌࠆ−∩∔ᖚߩ⸻ᢿ‫ޠ‬ᐳ㐳)
6㧕 ╙ 25 ࿁♧ዩ∛ Up࡮Date ⾫ፉ࠮ࡒ࠽࡯(2008 ᐕ 8 ᦬㧘ᔒ៺㧘᜗ᓙ⻠Ṷ‫ޟ‬2 ဳ♧ዩ∛ࠍ઻ߞߚ⢽⢌⢄‫ޠ‬Ṷ⠪)7㧕 2nd World Conference on Magic Bullets Celebrating the 100th Anniversary of the Nobel PrizeAward to Paul Ehrich(2008.10, Nurnberg, Special Lecture ̌Dehydroepiandrosterone reduced
adiposity and insulin resistance”)
᫪↰ᶈਯ㧦
1㧕 ╙ 2 ࿁᧲ᶏᡰㇱኾ㐷කㇱળᢎ⢒࠮ࡒ࠽࡯(2007 ᐕ 2 ᦬㧘ᵤ㧘∝଀ᬌ⸛ળ‫ޟ‬ᬌ⸻⊒⷗ߢ 2 ᐕߩ⚻ㆊਛߦ㒶ᓇᄌൻࠍ␜ߒߚ 59 ᱦ↵ᕈ଀‫ޠ‬ᐳ㐳)2㧕 2007 ᐕᐲᣣᧄ㆙㓒ක≮ቇળቇⴚ㓸ળ(2007 ᐕ 10 ᦬㧘ጟጊ㧘ડ↹ࠪࡦࡐࠫ࠙ࡓ‫ޟ‬㆙㓒ක≮ߩࡆࠫࡀࠬࡕ࠺࡞ ࠹࡟ࡋ࡞ࠬࠤࠕߩࡆࠫࡀࠬࡕ࠺࡞᭴▽ߦะߌߡ‫ޠ‬ᐳ㐳)
ቝ㊁ཅᒄ㧦
1㧕 ᐔᚑ 20 ᐕᐲᣣᧄ㆙㓒ක≮ቇળᄢળ(2008 ᐕ 10 ᦬㧘ጘ㒂㧘ࠪࡦࡐࠫ࠙ࡓ‫ޟ‬࿾ၞක≮‫ޠ‬ᐳ㐳)8㧚ቇⴚ⾨╬ߩฃ⾨⁁ᴫ1㧕 ᧻ේஜᴦ㧦╙ 44 ࿁ጘ㒂⋵ౝ⑼කળఝ⑲Ṷ㗴⾨(ᐔᚑ 18 ᐕᐲ)
2㧕 ችፒᷪ㧦╙ 205 ࿁ᣣᧄౝ⑼ቇળ᧲ᶏ࿾ᣇળఝ⑲Ṷ㗴⾨(ᐔᚑ 20 ᐕᐲ)
3㧕 ᳓㊁ᱜᏈ㧦╙ 206 ࿁ᣣᧄౝ⑼ቇળ᧲ᶏ࿾ᣇળఝ⑲Ṷ㗴⾨(ᐔᚑ 20 ᐕᐲ)
4㧕 ᳰ↰⾆⧷㧦ᐔᚑ 20 ᐕᐲᣣᧄ㆙㓒ක≮ቇળఝ⑲⺰ᢥ⾨(ᐔᚑ 20 ᐕᐲ)
5㧕 ᫪৻㇢㧦╙ 48 ࿁ጘ㒂⋵ౝ⑼කળఝ⑲Ṷ㗴⾨(ᐔᚑ 20 ᐕᐲ)㧙㧙9㧚␠ળᵴേ⍹Ⴆ㆐ᄦ㧦
1㧕 ᣣᧄ♧ዩ∛දળ࿖㓙ᆔຬ(㨪⃻࿷)10㧚ႎ๔ᦠ
1㧕 ᫪↰ᶈਯ㧦㖸ჿࠞࠝࠬ⸃ᨆߦࠃࠆࠬ࠻࡟ࠬ⸻ᢿߣ∻๐ࠬࠢ࡝࡯࠾ࡦࠣ㧦(⽷)᧲ᶏ↥ᬺᛛⴚᝄ⥝⽷࿅╙ 17 ࿁ഥᚑ⎇ⓥቢੌႎ๔ᦠ㧦TFT ࠾ࡘ࡯ࠬ 49㧦37㧙43(2006 ᐕ 3 ᦬)
2㧕 ᫪↰ᶈਯ㧦㐳ኼߣ↢ᵴ⠌ᘠ∛ጘ㒂↢ᵴ⠌ᘠ⺞ᩏ࡮੺౉ࡊࡠࠫࠚࠢ࠻㧦ᐔᚑ 16 ᐕ㨪ᐔᚑ 19 ᐕᐲ⑼ቇ⎇ⓥ⾌⵬ഥ㊄ၮ⋚⎇ⓥ(B)⎇ⓥᚑᨐႎ๔ᦠ㧦1㧙73(2008 ᐕ 5 ᦬)
3㧕 ᫪↰ᶈਯ㧦ࠗࡦࡇ࡯࠳ࡦࠬ⸘᷹ߢ↢૕ᯏ⢻ࠍ⸻ᢿ㧍ⴊ▤ౝ⊹/⣻ㇱౝ⤳⢽⢌㧦ࡠࡏ࠹࠶ࠢవ┵ක≮ࠢ࡜ࠬ࠲࡯ᛛⴚࠪ࡯࠭㓸(ᐔᚑ 16 ᐕᐲ㨪ᐔᚑ 20 ᐕᐲ)㧦29㧙30(2008 ᐕ 11 ᦬)
11㧚ႎ㆏1㧕 ቝ㊁ཅᒄ㧘㊁ᣇᢥ㓶㧦5 ಽߢಽ߆ࠆⴊ▤ᐕ㦂 ጘ㒂ᄢ߇ᬌᩏࠪࠬ࠹ࡓ㐿⊒㧦ਛᣣࠬࡐ࡯࠷(2006 ᐕ 5
᦬ 31 ᣣ)2㧕 ᫪↰ᶈਯ㧦ਛㇱߩක≮ ࡔ࠲ࡏ࡝࠶ࠢࠪࡦ࠼ࡠ࡯ࡓ‫ⴊޟ‬ᶧਛߩක⠪‫ࠍޠ‬Ⴧ߿ߖ㧘⺒ᄁᣂ⡞(2006 ᐕ
12 ᦬ 12 ᣣ)3㧕 ቝ㊁ཅᒄ㧘㊁ᣇᢥ㓶㧦േ⣂⎬ൻᬌᩏ 5 ಽߦ⍴❗ ጘ㒂ᄢࠣ࡞࡯ࡊ㐿⊒㧦⺒ᄁᣂ⡞(2007 ᐕ 1 ᦬ 15 ᣣ)
4㧕 ᫪↰ᶈਯ㧦⎇ⓥቶ߆ࠄᄢቇߪ੹‫ޟ‬ஜᐽኼ๮ߣ↢ᵴ⠌ᘠ⠨߃ࠆ‫ޠ‬㧦ጘ㒂ᣂ⡞(2007 ᐕ 1 ᦬ 16 ᣣ)
12㧚⥄Ꮖ⹏ଔ
⹏ଔකቇㇱ߇⒖ォᓟ㧘⻠ᐳ㐿⸳߽⹺߼ࠄࠇ㧘⎇ⓥ㕙ߢߩ⸳஻߿ⅣႺ㕙ߢߩઁ⻠ᐳߣߩࡂࡦ࠺ࠖߪᓢ‫⸃ߦޘ‬ᶖߐࠇߡ߈ߡ޿ࠆ‫ߡߞ઻ߦࠇߘޕ‬㧘✚วౝ⑼⊛ߥ⷗࿾߆ࠄ․⦡ߩ޽ࠆ⎇ⓥ߇┙ߜ਄߇ࠅߟߟ޽ࠅ㧘੹ᓟߪߎࠇࠍߐࠄߦ⊒ዷߐߖߡࠁߊᔅⷐ߇޽ࠆ‫ޕ‬ዋߥ޿ᢎቶຬߩੱᢙࠍൊ᩺ߔࠆߣ㧘ᄢቇ㒮↢ߩ⎇ⓥᜰዉ㧘࿖㓙ቇળߢߩ⊒⴫㧘⺰ᢥᬺ❣ߦ㑐ߒߡߪᮡḰ࡟ࡌ࡞ߢ޽ࠆߣ⠨߃ߡ޿ࠆ‫ߒ߆ߒޕ‬㧘✚ว∛ᘒౝ⑼ቇಽ㊁ߣߒߡ␠ળ⊛ߥ⹺⍮߿⁛┙ᕈࠍ⠨߃ࠆߣ㧘ᄖㇱ⾗㊄₪ᓧ㧔․ߦ⑼ቇ⎇ⓥ⾌⵬ഥ㊄㧕߿㧘․⦡޽ࠆ⺰ᢥᬺ❣㧘⎇ⓥ߿⊒᣿ߦ㑐ߔࠆᣂ⡞ႎ㆏ߪ߹ߛ߹ߛዋߥ޿‫ޕ‬⃻⁁ߩ໧㗴ὐ෸߮ߘߩኻᔕ╷ੱ⊛૛⵨߇චಽߢߥߊ㧘⎇ⓥ┙᩺㧘⎇ⓥ⾌↳⺧㧘࠺࡯࠲෼㓸࡮⸃ᨆ㧘⺰ᢥ⸥タߥߤ⎇ⓥߦ⾌߿ߔᤨ㑆߇߆ߥࠅਇ⿷ߒߡ޿ࠆߩ߇⃻⁁ߢ޽ࠆ‫ޕ‬ᓎഀಽᜂࠍ᣿⏕ൻߒ㧘઀੐ߩ㊀ⶄ߇ዋߥߊߥࠆࠃ߁ߦ⷗⋥ߒ㧘ല₸ൻࠍ⸘ߞߡ⧷⺆⺰ᢥᢙࠍჇ߿ߒߡࠁ߈ߚ޿‫⊛ੱޕ‬ਇ⿷ߦ㑐ߒߡߪ㧘ᣣ㗃ߩ⥃ᐥ⎇ୃ߿⥃ᐥታ⠌ߦജࠍ౉ࠇࠆߎߣߦࠃߞߡ㧘✚วౝ⑼ߩᓎഀ߿㝯ജࠍలಽߦ⹺⼂ߒߡ߽ࠄ޿㧘ᄙߊߩ౉ዪ⠪ࠍㄫ߃ࠄࠇࠆࠃ
߁ߦദജߒߡࠁ߈ߚ޿‫␠ޕ‬ળ⊛ߥ⹺⍮ᐲਇ⿷ߦኻߒߡߪ㧘․ߦ࿾ၞක≮߿⥃ᐥ∉ቇߦߟ޿ߡቇળߢߩ⊒⴫߿⺰ᢥൻߣߣ߽ߦ㧘ᣂ⡞␠߳ߩႎ㆏ଐ㗬߽Ⓧᭂ⊛ߦⴕߞߡࠁ߈ߚ޿‫ߚ߹ޕ‬㧘ࡎ࡯ࡓࡍ࡯ࠫߦࠃࠆᖱႎ
ឭଏߪ᦭ലߥᚻᲑߢ޽ࠆߚ߼㧘ᤚ㕖లታߐߖߡ޿߈ߚ޿‫ޕ‬
੹ᓟߩዷᦸ
2006 ᐕ 4 ᦬߆ࠄකዪ߇㒝ዻ∛㒮 1 㓏߆ࠄකቇㇱᧄ㙚ߦකዪ߇⒖ォߒߚߎߣߦࠃߞߡ㧘කዪߩㄭߊߦ⎇ⓥቶ߇ᜬߡࠆࠃ߁ߦߥߞߚ‫੹ޕ‬ᓟ㧘․ߦၮ␆⊛ߥ⎇ⓥߩㅴ᝞߇ᦼᓙߢ߈ࠆ‫ߚ߹ޕ‬㧘⥃ᐥߩ႐߆ࠄ↢߹ࠇࠆ⇼໧ࠍ⊒┵ߣߒߚ✚วౝ⑼ߣߒߡ․ᓽ⊛ߥ⥃ᐥ⎇ⓥࠍផㅴߒߡࠁ߈ߚ޿‫ߦ․ޕ‬ጘ㒂⋵ౝߩ✚วౝ⑼ක
ߩࡀ࠶࠻ࡢ࡯ࠢࠍᒻᚑߒ㧘ᄙᣉ⸳ߢߩ౒ห⎇ⓥࠍⴕ޿㧘⥃ᐥ⊛ࠛࡆ࠺ࡦࠬࠍ 1 ߟߢ߽⊒ାߒߡࠁ߈ߚ޿‫ޕ‬㧙㧙㧔3㧕⥃ᐥ⮎೷ቇಽ㊁1㧚⎇ⓥߩ᭎ⷐ
⥃ᐥ⮎೷ቇಽ㊁ߦ߅ߌࠆ⎇ⓥ㗄⋡ߪ㧘1㧕ක⮎ຠ╬ߩቯ㊂ᴺߩ⏕┙ߦ㑐ߔࠆ⎇ⓥ㧘2㧕⮎‛૕ౝേᘒߩ⸃
ᨆߦၮߠߊක⮎ຠㆡᱜ૶↪ផㅴߦ㑐ߔࠆ⎇ⓥ㧘3㧕ක⮎ຠߩᣂⷙ೷ဳߩ㐿⊒ߣߘߩ⥃ᐥᔕ↪ߦ㑐ߔࠆ⎇ⓥ㧘
4㧕ක≮ᖱႎࠪࠬ࠹ࡓࠍᵴ↪ߒߚක≮቟ో⏕଻ߦ㑐ߔࠆ⎇ⓥ㧘5㧕᛫߇ࠎ೷ߦኻߔࠆ⠴ᕈ⊒⃻ߩ⚦⢩ౝࡔࠞ࠾࠭ࡓߩ⸃᣿ߦ㑐ߔࠆ⎇ⓥ㧘6㧕᛫߇ࠎ೷ߦࠃࠆ೽૞↪⊒⃻ࡔࠞ࠾࠭ࡓߩ⸃᣿ߣ᦭ലߥᴦ≮ᴺߩ⏕┙ߦ㑐ߔࠆ⎇ⓥ㧘ߥߤߢ޽ࠆ‫߫߃଀ޕ‬㧘ක⮎ຠ╬ߩቯ㊂ߦ㑐ߔࠆ⎇ⓥߢߪ㧘㜞ㅦᶧ૕ࠢࡠࡑ࠻ࠣ࡜ࡈࠖ࡯㧔HPLC㧕
ߣⰯశᬌ಴ེ㧘㔚᳇ൻቇᬌ಴ེ㧘⚡ᄖๆశశᐲ⸘㧘ࠛ࡟ࠢ࠻ࡠࠬࡊ࡟࡯࡮࠲ࡦ࠺ࡓࡑࠬࠬࡍࠢ࠻ࡠࡔ࡯࠲
߿ࠟࠬࠢࡠࡑ࠻ࠣ࡜ࡈࠖ࡯ߥߤߩ᷹ቯᯏེࠍ㚟૶ߔࠆߎߣߦࠃࠅ᭽‫ߥޘ‬ක⮎ຠ߿↢ℂᵴᕈ‛⾰ߩቯ㊂ߦᵴ↪ߒߡ޿ࠆ‫ߚ߹ޕ‬㧘⮎‛૕ౝേᘒߩ⸃ᨆߦၮߠߊක⮎ຠㆡᱜ૶↪ផㅴߦ㑐ߔࠆ⎇ⓥߢߪ㧘ᢇᕆ㗔ၞߦ߅
ߌࠆ㊀∝ᖚ⠪ߢߩ⣢ᯏ⢻ߩᜰᮡߣߒߡࠪࠬ࠲࠴ࡦ C ࠍ᷹ቯߒ㧘ߘߩ୯߆ࠄ♻⃿૕ࠈㆊ㊂ߩផ᷹ᑼ㧘ߐࠄߦߪ᛫⩶⮎ߩⴊਛỚᐲࠍផ᷹ߔࠆᑼࠍዉߊߎߣߦࠃߞߡ᛫⩶⮎ߩᛩਈ㊂߿ᛩਈ㑆㓒ࠍ᳿ቯߔࠆߣ޿ߞߚ
ᬌ⸛ࠍⴕߞߡ޿ࠆ‫ޕ‬ᣂⷙ೷ဳߩ㐿⊒ߦ㑐ߔࠆ⎇ⓥߢߪ㧘ጘ㒂⋵ౝߩડᬺߣߩ౒ห⎇ⓥߢ೙ฯ೷ߩ࠺ࠠࠨࡔ
࠲࠱ࡦ߿ࡊࡠࠢࡠ࡞ࡍ࡜ࠫࡦࠍ฽߻ญ⣧ౝㅦ፣უ⿥⭯ဳࡈࠖ࡞ࡓ೷ࠍ㐿⊒ߒ㧘ߎࠇࠍ᛫߇ࠎ೷ߦࠃࠆᖡ
ᔃ࡮ཌྷฯߩ੍㒐ߣߒߡㆡ↪ߔࠆߚ߼ߩ⎇ⓥࠍㅴ߼ߡ޿ࠆ‫ޕ‬ක≮ᖱႎࠪࠬ࠹ࡓࠍᵴ↪ߒߚක≮቟ో⏕଻ߦ㑐ߔࠆ⎇ⓥߢߪ㧘ࠦࡦࡇࡘ࡯࠲ࠍౝ⬿ߒߚ᛫߇ࠎ೷ᵈ኿⮎ߩᷙว⺞⵾ߩߚ߼ߩ቟ోࠠࡖࡆࡀ࠶࠻ࠍ਎⇇ߢೋ߼ߡ㐿⊒ߒ㧘᛫߇ࠎ೷ߩขࠅ㑆㆑޿߿ᛩਈ㊂㑆㆑޿ߦࠃࠆක≮ㆊ⺋ߩ㒐ᱛߦᓎ┙ߡߡ޿ࠆ‫ߚ߹ޕ‬㧘᛫߇ࠎ೷ߦኻߔࠆ⠴ᕈ⊒⃻ߦ㑐ߔࠆ⎇ⓥߢߪ㧘කቇㇱ߿ጘ㒂⮎⑼ᄢቇߣߩ౒ห⎇ⓥߦ߅޿ߡ㧘ᄢ⣺߇ࠎ⚦⢩ߢߩࠝࠠࠨ࡝ࡊ࡜࠴ࡦߦኻߔࠆ⠴ᕈߦ⚦⢩ౝ࠮࡜ࡒ࠼ઍ⻢㉂⚛ߩࠬࡈࠖࡦࠧࠪࡦࠠ࠽࡯࠯ߩㆊ೾⊒⃻߇㑐ਈߔࠆߎߣࠍ⷗޿಴ߒ㧘࠮࡜ࡒ࠼ߦ㑐ㅪߔࠆ⚦⢩ౝࠪࠣ࠽࡞ߣ⠴ᕈ⊒⃻ߣߩ㑐ㅪߦߟ޿ߡ⎇ⓥࠍㅴ߼ߡ޿ࠆ‫ޕ‬
2㧚ฬ★
ᢎ᝼㧦

દ⮮ ༀⷙ

Yoshinori Itoh3㧚⎇ⓥᚑᨐߩ⊒⴫⪺ᦠ㧔๺ᢥ㧕
1㧕 ᄢ⍹ੌਃ㧘દ⮮ༀⷙ㧚߇ࠎൻቇ≮ᴺ࠮࡯ࡈ࠹ࠖࡑ࠾ࡘࠕ࡞㧦ศ↰↱⟤ሶ✬㧚᧲੩㧦ߓ߶߁㧧2007 ᐕ㧚
2㧕 ቟↰ᶈੑ㧘᧖ጊᱜ㧘દ⮮ༀⷙ㧘 ᩿⟵ඳ(ಽᜂၫ╩)㧚2007 ᐕታ⠌ߦⴕߊ೨ߩⷡ߃ࠆක⮎ຠ㓸㧙᦯⮎ᜰዉߦᓎ┙ߟ㧙㧦᧲੩㧦ᑝᎹᦠᐫ㧧2007 ᐕ㧚
3㧕 ቟↰ᶈੑ㧘દ⮮ༀⷙ(ಽᜂၫ╩)㧚2008 ᐕታ⠌ߦⴕߊ೨ߩⷡ߃ࠆක⮎ຠ㓸㧙᦯⮎ᜰዉߦᓎ┙ߟ㧙㧦᧲੩㧦ᑝᎹᦠᐫ㧧2008 ᐕ㧚
4㧕 ᄢ⍹ੌਃ㧘ᳰᧃ⵨᣿㧘દ⮮ༀⷙ✬㧚߇ࠎൻቇ≮ᴺࡢ࡯ࠢࠪ࡯࠻╙ 3 㧦᧲੩㧦ߓ߶߁㧧2008 ᐕ㧚⪺ᦠ㧔᰷ᢥ㧕
ߥߒ✚⺑㧔๺ᢥ㧕
1㧕 ᧖ጊᱜ㧘 ᩿⟵ඳ㧚∛᳇ߣ⮎ߩ⺑᣿ࠟࠗ࠼ 2006㧙ߘߩઁߩࡎ࡞ࡕࡦ᭽⮎㧘⮎ዪ 2006 ᐕ㧧57 Ꮞ㧦1807
㧙1821㧚
2㧕 ᧻ᶆసᒾ㧘᧖ጊᱜ㧚ᓟ⊒ක⮎ຠߩຠ⾰Ყセ⹜㛎̆ࠝࠩࠣ࡟࡞࠽࠻࡝࠙ࡓᵈ኿೷̆㧘Pharm Tech Japan
2006 ᐕ㧧22 Ꮞ㧦1606㧙1609㧚
3㧕 ᧖ጊᱜ㧘᧻ᶆసᒾ㧘⷏᧛⟤૒ᄦ㧘᦬ጟᔘᄦ㧚ྚਅ࿎㔍ߥᖚ⠪ࠍኻ⽎ߣߒߚੇ῎࠯࡝࡯⵾೷ߩၮ␆ᬌ⸛㧘
Pharmstage 2007 ᐕ㧧7 Ꮞ㧦31㧙34㧚
✚⺑㧔᰷ᢥ㧕
ߥߒේ⪺㧔๺ᢥ㧕
1㧕 ᧻ᶆసᒾ㧘ᨋ⑲᮸㧘᧖ጊᱜ㧘 ᩿⟵ඳ㧚ᓟ⊒ක⮎ຠណ↪ߩߚ߼ߩຠ⾰⹏ଔ̆ࡑ࡟ࠗࡦ㉄ࠛ࠽࡜ࡊ࡝࡞㍤ߦ
߅ߌࠆᬌ⸛̆㧘ක≮⮎ቇ 2006 ᐕ㧧32 Ꮞ㧦306㧙313.
2㧕 ਤ⠀ 㓉㧘ᓟ⮮ජኼ㧘᧖ጊᱜ㧘 ᩿⟵ඳ㧚ICU ߦ߅ߌࠆ⮎೷Ꮷߦࠃࠆක⮎ຠᖱႎឭଏߣߘߩ⹏ଔ㧘ක≮⮎
ቇ 2006 ᐕ㧧32 Ꮞ㧦400㧙406.
3㧕 ਛ᧛శᶈ㧘ᐔ಴⠹⍹㧘ዊ᫪⟵ᢥ㧘᧖ጊᱜ㧘 ᩿⟵ඳ㧚㔚ሶࠞ࡞࠹ߦኻᔕߒߚ TDM ࠪࠬ࠹ࡓߩ㐿⊒㧘TDM⎇ⓥ 2006 ᐕ㧧23 Ꮞ㧦95㧙96㧚
4㧕 ਛ᧛శᶈ㧘੹⷏⟵♿㧘ᷓ๺ടᄹ㧘ᐔ಴⠹⍹㧘᧖ጊᱜ㧘 ᩿⟵ඳ㧚FPIA ᴺࠍၮḰߣߒߚోⴊਛࠪࠢࡠࠬࡐ
࡝ࡦỚᐲߩᲧセ㧘TDM ⎇ⓥ 2006 ᐕ㧧23 Ꮞ㧦233㧙237㧚
5㧕 ጟ቟િੑ㧘ᱞ↰ ⚐㧘ጊᧄ⋿↱⟤㧚ࠗࡦࠬ࡝ࡦߩ቟ో▤ℂ૕೙ᡷༀࠍ⋡⊛ߣߒߚ㒮ౝᮡḰᦠߩ૞ᚑߣߘߩ⹏㧙㧙ଔ㧘ࡊ࡜ࠢ࠹ࠖࠬ 2006 ᐕ㧧23 Ꮞ㧦464㧙468㧚
6㧕 ਛ᧛శᶈ㧘᧻ᶆసᒾ㧘࿯ደᾖ㓶㧘᧖ጊ ᱜ㧚ࡍ࡯ࡄ࡟ࠬ㔚ሶࠞ࡞࠹ߦኻᔕߒߚ TDM ࠪࠬ࠹ࡓߩ㐿⊒㧘TDM⎇ⓥ 2007 ᐕ㧘24 Ꮞ㧦104㧙112㧚
7㧕 ᷓ๺ടᄹ㧘ᓟ⮮ජኼ㧘᧻ᶆసᒾ㧘᧖ጊᱜ㧚⺞೷ߦ㑐ߔࠆᖱႎߩ㔚ሶൻ㧘ᣣᧄ∛㒮⮎೷Ꮷળ㔀⹹ 2007 ᐕ㧧
43 Ꮞ㧦938㧙941㧚
8㧕 ᓟ⮮ජኼ㧘቟↰ᶈੑ㧘᧖ጊᱜ㧚⥃ᐥᬌᩏ࠺࡯࠲ࠍ೑↪ߒߚಣᣇ㐓ᩏᡰេࠪࠬ࠹ࡓߩ㐿⊒ߣߘߩ᦭↪ᕈ㧘ක≮⮎ቇ 2007 ᐕ㧧33 Ꮞ㧦114㧙118㧚
9㧕 ጟ቟િੑ㧘ਛ᧛శᶈ㧘ජ⒳ᐽ৻㧘ᰞ੗ẖ㧘᧖ጊᱜ㧚ᣂ⸳⸘ࠢ࡝࡯ࡦࡌࡦ࠴࡮቟ోᕈࠠࡖࡆࡀ࠶࠻ߣᵈ኿ࠝ࡯࠳ᖱႎࠍ೑↪ߒߚᵈ኿೷⺞⵾㐓ᩏࠪࠬ࠹ࡓߩ㐿⊒㧘ක≮⮎ቇ 2007 ᐕ㧧33 Ꮞ㧦191㧙199㧚
10㧕 ਛ᧛శᶈ㧘ᷓ๺ടᄹ㧘ጤ↰ජ㚅㧘᧛ጟ᣿⟤㧘㑆ች␞ሶ㧘᧖ጊᱜ㧚ᵈ኿⮎᛫≸೷⺞⵾ᡰេࡊࡠࠣ࡜ࡓߩ㐿⊒ߣߘߩ⹏ଔ㧘ක⮎ຠᖱႎቇ 2007 ᐕ㧧8 Ꮞ㧦315㧙319㧚
11㧕 ศጟผ㇢㧘᧻ᶆసᒾ㧘᧖ጊᱜ㧘દ⮮ༀⷙ㧚⣢⒖ᬀ೨ᓟߦ߅ߌࠆಣᣇ⮎೷ߩᄌൻߦ㑐ߔࠆ⺞ᩏ㧘ක≮⮎ቇ 2007
ᐕ㧧33 Ꮞ㧦937㧙941㧚
12㧕 ᧻ᶆసᒾ㧘㘵ේᄢ⒤㧘⍹ේᱜᔒ㧘ዊ᫪ༀᢥ㧘ጊౝᳯ㉿ሶ㧘ᓟ⮮ජኼ㧘દ⮮ༀⷙ㧚߇ࠎᖚ⠪ߩᩕ㙃⁁ᘒߦ㑐ߔࠆ㒮ౝ⺞ᩏ㧘ᣣᧄ∛㒮⮎೷Ꮷળ 2007 ᐕ㧧43 Ꮞ㧦571㧙1574㧚
13㧕 ⷏᧛⟤૒ᄦ㧘᧖ጊᱜ㧘᧻ᶆసᒾ㧘᦬ጟᔘᄦ㧘દ⮮ༀⷙ㧚ྚਅ࿎㔍ᖚ⠪߳ߩㆡᔕࠍ⋡⊛ߣߒߚක⮎ຠߩੇ῎࠯࡝࡯⵾೷ൻߦ㑐ߔࠆၮ␆⊛ᬌ⸛㧘ක≮⮎ቇ 2007 ᐕ㧧33 Ꮞ㧦1007㧙1012㧚
14㧕 ᧃᰴ₺ථ㧘ฎ⾐෹৻㇢㧘ศ↰ታ㧘የ਄᪸ᴕ㧘ਛ᎑৻ᕺ㧘ਛፉ๺ඳ㧘࿦↰ᱜା㧘ᧃ቟ᱜౖ㧘⑺ศ⟤ઍሶ㧘ศᎹቇ㧘દ⮮ༀⷙ㧘ᄢ⍹ੌਃ㧚ISO9001 ຠ⾰▤ℂࠪࠬ࠹ࡓߦၮߠߊ⮎೷ឭଏߦ㑐ߔࠆ㘈ቴḩ⿷⺞ᩏߣᬺോᡷ
ༀ㧘ᣣᧄ∛㒮⮎೷Ꮷળ㔀⹹ 2007 ᐕ㧧43 Ꮞ㧦1543㧙1547㧚
15㧕 ਤ⠀㓉㧘᧖ጊᱜ㧘ጟ቟િੑ㧘ጊౝᳯ㉿ሶ㧘⷏၂⟤ᄹሶ㧘᧻ᶆసᒾ㧘ᓟ⮮ජኼ㧘દ⮮ༀⷙ㧚㔚ሶࠞ࡞࠹ࠪࠬ
࠹ࡓߩ৻Ⅳߣߒߡߩ⮎೷▤ℂᜰዉᡰេࠪࠬ࠹ࡓߩ᭴▽㧘ක≮⮎ቇ 2008 ᐕ㧧34 Ꮞ㧦103㧙111㧚
16㧕 㘵ේᄢ⒤㧘᧻ᶆసᒾ㧘ศ᧛⍮ື㧘ᐔ಴⠹⍹㧘⍹ේᱜᔒ㧘ᓟ⮮ජኼ㧘દ⮮ༀⷙ㧚⢖߇ࠎᖚ⠪ߦ߅ߌࠆ Carboplatinᛩਈ㊂ߩ᳿ቯᣇᴺߣ೽૞↪⊒⃻ߦ㑐ߔࠆ retrospective study㧘ᣣᧄ∛㒮⮎೷Ꮷળ㔀⹹ 2008 ᐕ㧧44 Ꮞ㧦
428㧙431㧚
17㧕 ┄↰ᢅᄦ㧘㊁ਛᢅᴦ㧘⍫㊁⾆ਭ㧘૑᧛ᥓሶ㧘ᨋ⚐㧘દ⮮ༀⷙ㧘ᄢ⍹ੌਃ㧚᛫ MRSA ⮎ߩㆡᱜ૶↪ࠍ⋡ᜰߒߚ⮎‛ⴊਛỚᐲࡕ࠾࠲࡝ࡦࠣታᣉ₸ะ਄߳ߩขࠅ⚵ߺ㧘ᣣᧄ∛㒮⮎೷Ꮷળ㔀⹹ 2008 ᐕ㧧44 Ꮞ㧦277㧙280㧚
18㧕 ጟ቟િੑ㧘ਅ↰ᶈᰵ㧘♿ࡁቯ଻⤿㧘ᱞ↰⚐㧘ጊᧄ⋿↱⟤㧚ࠗࡦࠬ࡝ࡦߩ቟ో▤ℂߦ㑐ߔࠆ㔚ሶࠞ࡞࠹ᯏ⢻ߩ᦭↪ᕈߣ໧㗴ὐ㧘⢈ḩߣ♧ዩ∛ 2008 ᐕ㧧7 Ꮞ(೎ౠ)㧦28㧙35㧚
19㧕 ਅ↰ᶈᰵ㧘ጟ቟િੑ㧘♿ࡁቯ଻⤿㧘ᱞ↰⚐㧘ጊᧄ⋿↱⟤㧚㔚ሶࠞ࡞࠹ᖱႎ߆ࠄಽᨆߔࠆᄢቇ∛㒮ߩ♧ዩ∛∛᫟ᖚ⠪ߩ․ᓽಽᨆߩ⹜ⴕ㨪ᬺോࠍนⷞൻߔࠆ᦭↪ᕈߦߟ޿ߡ㨪㧘⢈ḩߣ♧ዩ∛ 2008 ᐕ㧧7 Ꮞ(೎ౠ)㧦
89㧙93㧚
20㧕 ਤ⠀㓉㧘ዊ᫪ༀᢥ㧘⍹ේᱜᔒ㧘㜞ᯅ㋈ઍ㧘᧻ᶆసᒾ㧘ᓟ⮮ජኼ㧘દ⮮ༀⷙ㧚࡝ࠬࠢ⹏ଔߦࠃࠆ⺞೷ㆊ⺋㒐ᱛኻ╷ߩ᦭ലᕈߩᬌ⸽㧘ᣣᧄ∛㒮⮎೷Ꮷળ㔀⹹ 2008 ᐕ㧧44 Ꮞ㧦1487㧙1490㧚
21㧕 ศ᧛⍮ື㧘ᐔ಴⠹⍹㧘㘵ේᄢ⒤㧘⍹ේᱜᔒ㧘ዊ᫪ༀᢥ㧘ጟ቟િੑ㧘᧻ᶆసᒾ㧘቟↰ᔘม㧘દ⮮ༀⷙ㧚Paclitaxelᛩਈᖚ⠪ߦ߅ߌࠆᛩਈ㊂࡮ᛩਈࠬࠤࠫࡘ࡯࡞ߦၮߠ޿ߚ೽૞↪⸃ᨆ㧘≸ߣൻቇ≮ᴺ 2008 ᐕ㧧35 Ꮞ㧦1721
㧙1726㧚
ේ⪺㧔᰷ᢥ㧕
1㧕 Iihara H, Suzuki T, Kawamura Y, Ohkusu K, Inoue Y, Zhang W, Shah MM, Katagiri Y, Ohashi Y, Ezaki
T. Emerging multiple mutations and high-level fluoroquinolone resistance in methicillin-resistant
Staphylococcus aureus isolated from ocular infections. Diagn Microbiol Infect Dis. 2006;56:297-303.
IF
2㧕 Masaki T, Ohkusu K, Hata H, Fujiwara N, Iihara H, Yamada-Noda M, Nhung PH, Hayashi M, Yuko
Asano Y, Kawamura Y, Ezaki T. Mycobacterium kumamotonense Sp. Nov. recovered from clinicalspecimen and the first isolation report of Mycobacterium arupense in Japan: Novel slowly growing,
nonchromogenic clinical isolates related to Mycobacterium terrae complex. Microbiol Immunol.
2006;50:889-897.
IF
3㧕 Yano T, Itoh Y, Matsuo M, Kawashiri T, Egashira N, Oishi R. Involvement of both tumor necrosis
factor-a-induced necrosis and p53-mediated caspase-dependent apoptosis in nephrotoxicity of cisplatin.
Apoptosis. 2007;12:1901-1909.
IF
4㧕 Shah MM, Iihara H, Noda M, Xiaosong S, Nhung P H, Ohkusu K, Kawamura Y, Ezaki T. DNAJ genesequence-based assay for species identification and phylogenetic grouping in the genus Staphylococcus.
Int J Syst Evol Microbiol. 2007;57:25-30.
IF
5㧕 Kato Z, Nakamura M, Funato M, Kuwabara H, Kondo N. Accidental etizolam ingestion in a child.
Pediatr Emerg Care. 2007;23:472-473
IF
6㧕 Suzuki T, Iihara H, Uno T, Hara Y, Ohkusu K, Hata H, Shudo M, Ohashi Y. Suture-related keratitis
caused by Corynebacterium macginleyi. J Clin Microbiol. 2007;45:3833-3836.
IF7㧕 Nhung PH, Shah MM, Ohkusu K, Noda M, Hata H, Sun XS, Iihara H, Goto K, Masaki T, Miyasaka J,
Ezaki T. The dnaJ gene as a novel phylogenetic marker for identification of Vibrio species. Syst Appl
Microbiol. 2007;30:309-315.
IF8㧕 Iihara H, Niwa T, Shah MM, Nhung PH, Song SX, Hayashi M, Ohkusa K, Itoh Y, Makino S, Ezaki T.
Rapid multiplex immunofluorescent assay to detect antibodies against Burkholderia pseudomallei andtaxonomically closely related nonfermenters. Jpn J Infect Dis. 2007;60:230-234.
IF

㧙㧙

2.448

1.295

3.043

2.384
0.581
3.708

2.514

1.074

9㧕 Wakahara T, Shiraki M, Murase K, Fukushima H, Matsuura K, Fukao A, Kinoshita S, Kaifuku N,
Arakawa N, Tamura T, Iwasa J, Murakami N, Deguchi T, Moriwaki H. Nutritional screening with
Subjective Global Assessment predicts hospital stay in patients with digestive disease. Nutrition.
2007;23:639-643.
10㧕 Ohmori T, Nakamura M, Tada S, Sugiyama T, Itoh Y, Udagawa Y, Hirano K. A highly sensitive assay
for ritodrine in human serum by hydrophilic interaction chromatography-tandem mass spectrometry.
J Chromatogr (B). 2008;861:95-100.
11㧕 Sobue S, Nemoto S, Murakami M, Ito H, Kimura A, Gao S, Furuhata A, Takagi A, Kojima T,
Nakamura M, Itoh Y, Suzuki M, Banno Y, Nozawa Y, Murate T. Implications of sphingosine kinase 1
expression level for the cellular sphingolipid rheostat; relevance as a marker for daunorubicin
sensitivity of leukemia cell. Int J Hematol. 2008;87:266-275.
12㧕 Aki T, Egashira N, Hama M, Yamauchi Y, Yano T, Itoh Y, Oishi R. Characteristics of gabexate
mesilate-induced cell injury in porcine aorta endothelial cells. J Pharmacol Sci. 2008;106:415-422.
13㧕 Aki T, Egashira N, Yamauchi Y, Hama M, Yano T, Itoh Y, Yamada T, Oishi R. Protective effects ofamino acids against gabexate mesilate–induced cell injury in porcine aorta endothelial cells. J
Pharmacol Sci. 2008;107:238-245.
14㧕 Yano T, Itoh Y, Yamada M, Egashira N, Oishi R. Combined treatment with L-carnitine and apan-caspase inhibitor effectively reverses amiodarone-induced injury in cultured human lungepithelial cells. Apoptosis. 2008;13:543-552.
15㧕 Matsuura K, Ohmori T, Nakamura M, Itoh Y, Hirano K. A simple and rapid determination of valproic
acid in human plasma using a non-porous silica column and liquid chromatography with tandem mass
spectrometric detection. Biomed Chromatogr. 2008;22:387-393.

IF 2.104

IF 2.935

IF 1.491
IF 2.408

IF 2.408

IF 3.043

IF 1.663

4㧚⎇ⓥ⾌₪ᓧ⁁ᴫ
1㧕┹੎⊛⾗㊄1㧕 ⎇ⓥઍ⴫⠪㧦દ⮮ༀⷙ㧘⎇ⓥಽᜂ⠪㧦ᄢ⍹ੌਃ㧧⑼ቇ⎇ⓥ⵬ഥ㊄ၮ⋚⎇ⓥ(C)㧦ࠪࠬࡊ࡜࠴ࡦ⣢㓚ኂߦኻߔࠆ⚦⢩ౝࠨࠗࠢ࡝࠶ࠢ AMP ࠍ੺ߔࠆ଻⼔૞↪ߦ㑐ߔࠆ⎇ⓥ㧧ᐔᚑ 17㧙18 ᐕᐲ㧧3,600 ජ౞(2,500㧦1,100 ජ౞)
2㧕 ⎇ⓥઍ⴫⠪㧦ᄢ⍹ੌਃ㧘⎇ⓥಽᜂ⠪㧦દ⮮ༀⷙ㧧⑼ቇ⎇ⓥ⵬ഥ㊄ၮ⋚⎇ⓥ(C)㧦࡛㧙࠼ㅧᓇ೷ߦࠃࠆ
⣢㓚ኂ⊒⃻ᯏᐨߩ⸃᣿ߣ੍㒐╷ߩ⏕┙㧧ᐔᚑ 17㧙18 ᐕᐲ㧧3,400 ජ౞(2,100㧦1,300 ජ౞)
3㧕 ⎇ⓥઍ⴫⠪㧦ᷓ๺ ടᄹ㧧ᢥㇱ⑼ቇ⋭⑼ቇ⎇ⓥ⵬ഥ㊄ᅑബ⎇ⓥ㧦STEC ᴺߦࠃࠆ CYP2C9 ᄙဳ㜞ㅦᬌ಴♽ߩ TDM ߳ߩᔕ↪㧧ᐔᚑ 18 ᐕᐲ㧧480 ජ౞4㧕 ⎇ⓥઍ⴫⠪㧦દ⮮ༀⷙ㧘⎇ⓥಽᜂ⠪㧦ᄢ⍹ੌਃ㧧⑼ቇ⎇ⓥ⵬ഥ㊄ၮ⋚⎇ⓥ(C)㧦⮎೷ߦࠃࠆⴊ▤㓚ኂߩ⊒⃻ᯏᐨ⸃᣿ߣ੍㒐࡮ᴦ≮╷ߩ⏕┙ߦ㑐ߔࠆ⎇ⓥ㧧ᐔᚑ 19㧙20 ᐕᐲ㧧3,400 ජ౞(2,100㧦1,300
ජ౞)5㧕 ⎇ⓥઍ⴫⠪㧦ᄢ⍹ੌਃ㧘⎇ⓥಽᜂ⠪㧦દ⮮ༀⷙ㧧⑼ቇ⎇ⓥ⵬ഥ㊄ၮ⋚⎇ⓥ(C)㧦᛫⩶⮎ߦࠃࠆ⣢㓚ኂ⊒⃻ᯏᐨߩ⸃᣿㧧ᐔᚑ 19㧙20 ᐕᐲ㧧3,400 ජ౞(2,100㧦1,300 ජ౞)
6㧕 ⎇ⓥઍ⴫⠪㧦㘵ේ ᄢ⒤㧧ᢥㇱ⑼ቇ⋭⑼ቇ⎇ⓥ⵬ഥ㊄ᅑബ⎇ⓥ㧦⢖≸ᖚ⠪ߢߩ Carboplatin ᛩਈ㊂᳿ቯߦ߅ߌࠆⴊᷡࠪࠬ࠲࠴ࡦ C ߩ᦭↪ᕈߩᬌ⸛㧧ᐔᚑ 20 ᐕᐲ㧧550 ජ౞7㧕 ⎇ⓥઍ⴫⠪㧦ᄢ᫪ ᥓผ㧧ᢥㇱ⑼ቇ⋭⑼ቇ⎇ⓥ⵬ഥ㊄ᅑബ⎇ⓥ㧦LC-MS/MS ࠍ↪޿ߚ↢૕⹜ᢱ⋥ធᵈ౉ᴺߦࠃࠆ⮎‛ࡂࠗࠬ࡞࡯ࡊ࠶࠻ಽᨆ♽ߩ㐿⊒㧧ᐔᚑ 20 ᐕᐲ㧧550 ජ౞8㧕 ⎇ⓥઍ⴫⠪㧦ᓟ⮮ ජኼ㧧ᢥㇱ⑼ቇ⋭⑼ቇ⎇ⓥ⵬ഥ㊄ᅑബ⎇ⓥ㧦ࡄࠢ࡝࠲ࠠ࠮࡞ߦࠃࠆᧃ᪳␹⚻㓚ኂߦኻߔࠆ−∩ᴦ≮೷ࡁࠗࡠ࠻ࡠࡇࡦߩ⥃ᐥ⎇ⓥ㧧ᐔᚑ 20 ᐕᐲ㧧400 ජ౞
2㧕ฃ⸤⎇ⓥ1㧕 ಴ญ㓉㧦⮎೷ࠍ฽᦭ߒߚน㘩ᕈࡈࠖ࡞ࡓߩ቟ቯᕈߦ㑐ߔࠆ⎇ⓥ㧧ᐔᚑ 18 ᐕᐲ㧧100 ජ౞㧦(ᩣ)࠷ࠠ
ࠝࠞ
2㧕 ಴ญ㓉㧦⮎೷ࠍ฽᦭ߒߚੇ῎࠯࡝࡯⵾೷ߩ㐿⊒ߦ㑐ߔࠆ⎇ⓥ㧧ᐔᚑ 18㧙19 ᐕᐲ㧧600 ජ౞(ⶄᢙᐕᰴᄾ⚂)㧦(ᩣ)࠷ࠠࠝࠞ
3㧕 દ⮮ༀⷙ㧦⮎೷฽᦭ࡈࠖ࡞ࡓ⵾೷ߩ㐿⊒ߦ㑐ߔࠆ⎇ⓥ㧧ᐔᚑ 19 ᐕᐲ㧧600 ජ౞㧦࠷ࠠࠝࠞ (ᩣ)
4㧕 દ⮮ༀⷙ㧦⮎೷฽᦭ࡈࠖ࡞ࡓ⵾೷ߩ㐿⊒ߦ㑐ߔࠆ⎇ⓥ㧧ᐔᚑ 20 ᐕᐲ㧧800 ජ౞㧦࠷ࠠࠝࠞ (ᩣ)
3㧕౒ห⎇ⓥߥߒ㧙㧙5㧚⊒᣿࡮․⸵಴㗿⁁ᴫ1㧕 ජ⒳ᐽ৻㧘 ᩿⟵ඳ㧘᧖ጊᱜ㧘ਛ᧛శᶈ㧘ጟ቟િੑ㧦቟ోࠠࡖࡆࡀ࠶࠻(⊒᣿)㧧ᐔᚑ 18 ᐕ(․㐿
2006-122816)
2㧕 ᧻ᶆసᒾ㧘᧖ጊᱜ㧘 ᩿⟵ඳ㧘᦬ጟᔘᄦ㧘⷏᧛⟤૒↵㧦ౝ᦯⮎(⊒᣿)㧧ᐔᚑ 18 ᐕ(․㗿 2006-206725)
3㧕 ᄢ⍹ੌਃ㧘દ⮮ༀⷙ㧘ᳯ㗡િᤘ㧘⮮੗㇚㇢㧦᛫߇ࠎ೷ߦࠃࠆᧃ᪳␹⚻㓚ኂߩ੍㒐෶ߪシᷫ೷(⊒᣿)㧧
ᐔᚑ 20 ᐕ(․㗿 2008-65399)
6㧚ቇળᵴേ
1㧕ቇળᓎຬ
દ⮮ ༀⷙ㧦1㧕 ᣣᧄ⮎ℂቇળ⹏⼏ຬ(㨪⃻࿷)2㧕 ᣣᧄක≮⮎ቇળ⹏⼏ຬ(㨪⃻࿷)3㧕 ᣣᧄ∛㒮⮎೷Ꮷળઍ⼏ຬ(㨪⃻࿷)4㧕 ᣣᧄ⮎ቇળ᧲ᶏᡰㇱળᐙ੐(㨪⃻࿷)2㧕ቇળ㐿௅
દ⮮ ༀⷙ㧦1㧕 ╙ 29 ࿁ᣣᧄක≮⮎ቇળක≮⮎ቇ౏㐿ࠪࡦࡐࠫ࠙ࡓ(2007 ᐕ 3 ᦬㧘ጘ㒂)
3㧕ቇⴚ㔀⹹
દ⮮ ༀⷙ㧦1㧕 ᣣᧄ∛㒮⮎೷Ꮷળ㔀⹹࿾ၞ✬㓸ᆔຬ(㨪⃻࿷)7㧚ቇળ᜗ᓙ⻠Ṷ㧘᜗ᓙࠪࡦࡐࠫࠬ࠻㧘ᐳ㐳᧖ጊᱜ㧦
1㧕 ╙ 70 ࿁ᣣᧄᓴⅣེቇળ✚ળ࡮ቇⴚᄢળ(ᐔᚑ 18 ᐕ 3 ᦬㧘ฬฎደ ࠦࡔ࠺ࠖࠞ࡞࠮࠶࡚ࠪࡦࠪࡦࡐࠫ
࠙ࡓ‫ޟ‬ᓴⅣེ㗔ၞߩ⮎‛≮ᴺߦ߅ߌࠆ∛㒮ߣ⺞೷⮎ዪߣߩㅪ៤‫ޠ‬ᐳ㐳)2㧕 ╙ 69 ࿁਻Ꮊጊญ⮎ቇᄢળ(ᐔᚑ 18 ᐕ 9 ᦬㧘㣮ఽፉ㧘࡜ࡦ࠴࡚ࡦ࠮ࡒ࠽࡯‫ޟ‬ᓟ⊒ක⮎ຠߦ߅ߌࠆຠ⾰ߩ㊀ⷐᕈ‫ޠ‬Ṷ⠪)
3㧕 ᧲੩ㇺዊᐔ࿾඙⮎೷Ꮷળ⎇ୃળ(ᐔᚑ 18 ᐕ㧘᧲੩㧘‫ޟ‬వ⊒ක⮎ຠߣᓟ⊒ක⮎ຠߩ⮎೷ቇ⊛Ꮕ⇣ߦߟ޿ߡ‫ޠ‬Ṷ⠪)ᓟ⮮ජኼ㧦
1㧕 ╙ 28 ࿁ POS ක≮ቇળᄢળ(ᐔᚑ 18 ᐕ 3 ᦬㧘᧲੩㧘ࠪࡦࡐࠫ࠙ࡓ‫ޟ‬㔚ሶࠞ࡞࠹ᤨઍߦ߅ߌࠆ⸥㍳ߣࠕ࠙࠻ࠞࡓ⹏ଔ‫ޠ‬Ṷ⠪)᧻ᶆసᒾ㧦
1㧕 ╙ 1 ࿁⺞೷ᬺോㆡᱜൻ⎇ୃળ(ᐔᚑ 20 ᐕ㧘ᗲ⍮㧘‫⮎ޟ‬ዪߦ߅ߌࠆຠ⾰▤ℂߦߟ޿ߡ‫ޠ‬Ṷ⠪)
2㧕 ᐔᚑ 20 ᐕᐲ ጘ㒂⮎⑼ᄢቇ㒝ዻ⮎ዪ࡝ࠞ࡟ࡦ࠻⻠ᐳΣ(ᐔᚑ 20 ᐕ㧘ጘ㒂㧘‫✭ޟ‬๺ࠤࠕߦ߅ߌࠆ⮎೷Ꮷߩᓎഀ‫ޠ‬Ṷ⠪)8㧚ቇⴚ⾨╬ߩฃ⾨⁁ᴫ1㧕 ᧖ጊᱜ㧦ᣣᧄක≮⮎ቇળᅑബ⾨(ᐔᚑ 19 ᐕᐲ)
9㧚␠ળᵴേદ⮮ༀⷙ㧦
1㧕 ጘ㒂⋵∛㒮⮎೷Ꮷળ೽ળ㐳(ᐔᚑ 20 ᐕᐲ)
2㧕 ጘ㒂⋵⮎೷Ꮷળℂ੐(ᐔᚑ 20 ᐕᐲ)
10㧚ႎ๔ᦠ
1㧕 દ⮮ༀⷙ㧦ࠪࠬࡊ࡜࠴ࡦ⣢㓚ኂߦኻߔࠆ⚦⢩ౝࠨࠗࠢ࡝࠶ࠢ AMP ࠍ੺ߔࠆ଻⼔૞↪ߦ㑐ߔࠆ⎇ⓥ㧦
ᐔᚑ 17 ᐕᐲ㧙18 ᐕᐲ⑼ቇ⎇ⓥ⵬ഥ㊄ၮ⋚⎇ⓥ(C)⎇ⓥᚑᨐႎ๔ᦠ(⎇ⓥಽᜂ⠪㧦ᄢ⍹ੌਃ)(ᐔᚑ 19
ᐕ 3 ᦬)㧙㧙

2㧕 ᄢ⍹ੌਃ㧦࡛㧙࠼ㅧᓇ೷ߦࠃࠆ⣢㓚ኂ⊒⃻ᯏᐨߩ⸃᣿ߣ੍㒐╷ߩ⏕┙㧦ᐔᚑ 17 ᐕᐲ㧙18 ᐕᐲ⑼ቇ⎇ⓥ⵬ഥ㊄ၮ⋚⎇ⓥ(C)⎇ⓥᚑᨐႎ๔ᦠ(⎇ⓥಽᜂ⠪㧦દ⮮ༀⷙ)(ᐔᚑ 19 ᐕ 3 ᦬)
11㧚ႎ㆏
1㧕 ᧖ጊᱜ㧦⮎ߩ㊂߿⒳㘃㧘PC ߇⼊๔ ⺞ว⋙ᩏࠪࠬ࠹ࡓ㐿⊒ ጘ㒂ᄢߥߤ㧦ᦺᣣᣂ⡞(2006 ᐕ 2 ᦬ 28
ᣣ)2㧕 દ⮮ༀⷙ㧦࠮࡜ࡒ࠼ߣ᛫߇ࠎ೷૞↪តࠆ㧦ጘ㒂ᣂ⡞(2007 ᐕ 8 ᦬ 28 ᣣ)
12㧚⥄Ꮖ⹏ଔ
⹏ଔ⥃ᐥ⮎೷ቇಽ㊁ߢߩᢎຬ߇ᢎ᝼એᄖߦ޿ߥ޿ߣ޿߁⁁ᴫࠍ⠨ᘦߔࠇ߫㧘޽ࠆ⒟ᐲߩ⎇ⓥᚑᨐ߇ᓧࠄࠇ
ߚߣ⠨߃ࠆ‫ߩߘޕ‬ඨ㕙㧘✚⺑߿⪺ᦠ╬ߩၫ╩ߪዋߥ޿‫ߦࠄߐޕ‬㧘ቇળ╬ߩ․೎⻠Ṷ߿ࠪࡦࡐࠫࠬ࠻ߣ޿
ߞߚᬺ❣߇ਇචಽߢ޽ࠆ‫ޕ‬⃻⁁ߩ໧㗴ὐ෸߮ߘߩኻᔕ╷⥃ᐥ⮎೷ቇಽ㊁ߦ߅ߌࠆᢎຬߪᢎ᝼ߩߺߢ޽ࠆߣ޿߁ᷓೞߥੱ᧚ਇ⿷ߦട߃㧘ᢎ᝼߇⮎೷ㇱ㐳ࠍ૬છߔࠆߚ߼㧘චಽߥ⎇ⓥᵴേ߇ⴕ߃ߡ޿ߥ޿ߩ߇⃻⁁ߢ޽ࠆ‫ߩߘޕ‬ኻᔕ╷ߣߒߡߪ㧘ઁಽ㊁ߣߩ౒ห⎇ⓥ
ߩផㅴ㧘ጘ㒂⮎⑼ᄢቇߣߩㅪ៤ࠍផㅴߔࠆᔅⷐ߇޽ࠆ‫ޕ‬੹ᓟߩዷᦸߎࠇ߹ߢታᣉߒߡ߈ߚක⮎ຠߩᣂⷙ೷ဳ㐿⊒㧘ຠ⾰▤ℂ⹜㛎㧘ᣂⷙቯ㊂ᴺߩ㐿⊒╬ߩ⮎೷ቇ⊛⎇ⓥࠍ
ၮ␆ߥࠄ߮ߦ⥃ᐥߩਔಽ㊁ߢዷ㐿ߐߖࠆߣߣ߽ߦ㧘⥃ᐥ⃻႐ߦߡㆣㆄߔࠆක⮎ຠ᦭ኂ੐⽎ߦ㑐ࠊࠆ⊒⃻ࡔࠞ࠾࠭ࡓࠍ⸃᣿ߒ㧘᦭ലߥᴦ≮߽ߒߊߪ੍㒐ኻ╷ࠍ┙᩺ߔࠆߚ߼ߩၮ␆ߥࠄ߮ߦ⥃ᐥ⎇ⓥࠍዷ㐿ߔࠆ‫ޕ‬৻ᣇ㧘ᐔᚑ 21 ᐕᐲߦⴕࠊࠇࠆጘ㒂⮎⑼ᄢቇᣂቇ⥡ߩᧄቇࠠࡖࡦࡄࠬౝ߳ߩ⒖ォࠍᯏߦ⮎⑼ᄢቇߣߩᢎ⢒ߥࠄ߮ߦ⎇ⓥ㕙ߢߩㅪ៤ࠍᒝൻߒ㧘ഃ⮎࡮⢒⮎ߩߚ߼ߩၮ␆ߥࠄ߮ߦ⥃ᐥ⎇ⓥࠍផㅴߔࠆ‫ޕ‬㧙㧙㧔4㧕ක≮⚻ᷣቇಽ㊁1㧚⎇ⓥߩ᭎ⷐ
ᧄಽ㊁ߢߪല₸ᕈ߿౏ᐔᕈߥߤߩⷰὐ߆ࠄ⾗Ḯ㈩ಽ໧㗴ࠍ⠨߃ࠆ⚻ᷣቇࠍߪߓ߼㧘∉ቇ㧘ᔃℂ᷹ቯ╬ߩᣇᴺ⺰ࠍ↪޿ߡ㧘ᦸ߹ߒ޿଻ஜක≮ࠪࠬ࠹ࡓߩ޽ࠅᣇࠍ␜ߔߎߣࠍ⋡⊛ߣߒ㧘ᄢ߈ߊක≮᡽╷෸߮ක≮⹏ଔߦ㑐ߔࠆએਅߩ⎇ⓥࠍⴕߞߡ޿ࠆ‫ޕ‬1㧕ක≮ߦ߅ߌࠆ↢↥ᕈ෸߮ല₸ᕈߦ㑐ߔࠆ⎇ⓥ
ක≮ߦ߅ߌࠆ↢↥ⷐ⚛ߣ↢↥‛ࠍ᣿ࠄ߆ߦߒ㧘ߘࠇࠄࠃࠅ↢↥ᕈᜰᮡ෸߮ല₸ᕈᜰᮡߩ▚಴ࠍⴕ޿㧘ߘߩᓇ㗀ⷐ࿃ࠍ᣿ࠄ߆ߦߔࠆߣߣ߽ߦ㧘ක≮ߩࡄࡈࠜ࡯ࡑࡦࠬᜰᮡ߳ߩᔕ↪ࠍ⎇ⓥߒߡ޿ࠆ‫ߦ․ޕ‬㧘ᕆᕈᦼ∛㒮ߦ᳞߼ࠄࠇࠆ࿷㒮ᣣᢙߩ⍴❗ൻߣක≮ߦ߅ߌࠆ⾰ࠍ෻ᤋߢ߈ࠆࡄࡈࠜ࡯ࡑࡦࠬᜰᮡߩ㐿⊒ࠍ⋡ᮡߣߒߡ޿ࠆ‫ޕ‬2㧕ㆮવሶ⸻ᢿߩ㔛ⷐಽᨆ⎇ⓥ
ฦ⒳ㆮવሶ⸻ᢿߦߟ޿ߡ㧘ߘߩ㔛ⷐଔᩰߩផቯߣ㔛ⷐߦᓇ㗀ߔࠆⷐ࿃ߦߟ޿ߡ⎇ⓥߒߡ޿ࠆ‫ޕ‬
3㧕⸻≮ౝኈ࡮ක≮⾌ಽᨆ⎇ⓥ࡟࠮ࡊ࠻ᖱႎ╬ߩ⥃ᐥ∉ቇ⎇ⓥ߳ߩᔕ↪㧘෸߮㧘ක≮⾌࠺࡯࠲ߩ․ᕈߦᔕߓߚಽᨆᚻᴺࠍ⎇ⓥߒߡ޿ࠆ‫ޕ‬
4㧕੍㒐ක≮ߦኻߔࠆ⾌↪ኻലᨐಽᨆ⎇ⓥ
ᗵᨴ∝ࡢࠢ࠴ࡦ㧘․ቯ଻ஜᜰዉ╬ߩ৻ᰴ੍㒐ߦኻߔࠆ⾌↪ኻലᨐಽᨆߦߟ޿ߡ⎇ⓥߒߡ޿ࠆ‫ޕ‬2㧚ฬ★
ᢎ᝼(૬છ)㧦
ಎᢎ᝼㧦

᳗↰⍮㉿
㜞Ⴆ⋥⢻

Chisato Nagata
Naoyoshi Takatsuka

3㧚⎇ⓥᚑᨐߩ⊒⴫⪺ᦠ㧔๺ᢥ㧕
1㧕 㜞Ⴆ⋥⢻㧚ක≮ኾ㐷⡯ߩߚ߼ߩක≮⚻ᷣቇ㧦ක≮⚻༡ᢎ⢒ද⼏ળ✬㧚ක≮ࡑࡀࠫࡔࡦ࠻㧘᧲੩㧦ᣣ⚻ࡔ࠺ࠖࠞ࡞㐿⊒㧧2008 ᐕ㧦58㧙82.
⪺ᦠ㧔᰷ᢥ㧕
∉ቇ࡮੍㒐කቇಽ㊁ෳᾖ✚⺑㧔๺ᢥ㧕
∉ቇ࡮੍㒐කቇಽ㊁ෳᾖ✚⺑㧔᰷ᢥ㧕
ߥߒේ⪺㧔๺ᢥ㧕
1㧕 㜞Ⴆ⋥⢻㧘⷏᧛๟ਃ㧚౉㒮ක≮ࠨ࡯ࡆࠬߩ↢↥ᕈ⹏ଔߦ↪޿ࠆࠕ࠙࠻ࡊ࠶࠻ᜰᮡߩᅷᒰᕈ⹏ଔ㧙৻ᐥᒰߚࠅᐕ㑆ㅌ㒮ᖚ⠪ᢙߣ∛ᐥ೑↪₸ߩᲧセ㧙㧘∛㒮▤ℂ 2006 ᐕ㧧43 Ꮞ㧦103㧙115㧚
2㧕 ጯ↰⎇૞㧘ᩑේᶈ᣿㧘㜞Ⴆ⋥⢻㧘ᓟ⮮ബ㧚ㆇേ⠌ᘠ㧘▵㈬⠌ᘠ㧘⦟޿㘩੐⠌ᘠߩታ〣ߦᓇ㗀ߔࠆⷐ࿃ߩಽ
ᨆ㧘ක≮ߣ␠ળ 2007 ᐕ㧧17 Ꮞ㧦329㧙338㧚
3㧕 㜞Ⴆ⋥⢻㧘⷏᧛๟ਃ㧚ࠝ࡯࠳࡝ࡦࠣࠪࠬ࠹ࡓ߇∛㒮↢↥ᕈ㧘ല₸ᕈߦ෸߷ߔᓇ㗀ߩ⹏ଔ㧘ක≮⚻ᷣ⎇ⓥ
2008 ᐕ㧧20 Ꮞ㧦15㧙33.
ේ⪺㧔᰷ᢥ㧕
∉ቇ࡮੍㒐කቇಽ㊁ෳᾖ

4㧚⎇ⓥ⾌₪ᓧ⁁ᴫ
1㧕┹੎⊛⾗㊄∉ቇ࡮੍㒐කቇಽ㊁ෳᾖ
2㧕ฃ⸤⎇ⓥߥߒ
3㧕౒ห⎇ⓥߥߒ㧙㧙5㧚⊒᣿࡮․⸵಴㗿⁁ᴫߥߒ
6㧚ቇળᵴേ
1㧕ቇળᓎຬ
᳗↰⍮㉿㧦∉ቇ࡮੍㒐කቇಽ㊁ෳᾖ
2㧕ቇળ㐿௅
ߥߒ
3㧕ቇⴚ㔀⹹
ߥߒ
7㧚ቇળ᜗ᓙ⻠Ṷ㧘᜗ᓙࠪࡦࡐࠫࠬ࠻㧘ᐳ㐳᳗↰⍮㉿㧦∉ቇ࡮੍㒐කቇಽ㊁ෳᾖ㜞Ⴆ⋥⢻㧦
1㧕 ጘᄢ࡮ච౐↥ቇㅪ៤ක≮⚻༡ࠪࡦࡐࠫ࠙ࡓ(2007 ᐕ 6 ᦬㧘ጘ㒂㧘‫ޟ‬ା㗬ߐࠇࠆ∛㒮ߣߪ‫ޠ‬Ṷ⠪)8㧚ቇⴚ⾨╬ߩฃ⾨⁁ᴫ᳗↰⍮㉿㧦∉ቇ࡮੍㒐කቇಽ㊁ෳᾖ
9㧚␠ળᵴേ㜞Ⴆ⋥⢻㧦
1㧕 ጘ㒂⋵଻㒾⠪ද⼏ળ(ක≮⾌ಽᨆ⋧⺣)(㨪⃻࿷)2㧕 ጘ㒂⋵࿖଻ㅪวળ↢ᵴ⠌ᘠ∛੍㒐ኻ╷ᬌ⸛ᆔຬળ(ࠕ࠼ࡃࠗࠩ࡯)(㨪⃻࿷)3㧕 ጘ㒂⋵ᓟᦼ㜞㦂⠪ක≮ᐢၞㅪวㆇ༡ᙣ⹤ળᆔຬ(㨪⃻࿷)4㧕 ෘ↢ഭ௛⋭ ․ቯஜ⸻࡮․ቯ଻ஜᜰዉߦ㑐ߔࠆᬌ⸛ળ ᴦ≮ਛߩ⠪ߦኻߔࠆ଻ஜᜰዉߩലᨐߦ㑐ߔࠆ WG ᆔຬ(㨪⃻࿷)᳗↰⍮㉿㧦∉ቇ࡮੍㒐කቇಽ㊁ෳᾖ
10㧚ႎ๔ᦠ
1㧕 ጊᧄ⋿↱⟤㧘♿ࡁቯ଻⤿㧘㋈ᧁᐽਯ㧘㜞Ⴆ⋥⢻㧦ක≮ᖱႎ▤ℂࠪࠬ࠹ࡓߣ⸻ᢿࡕ࠺࡞㧙♧ዩ∛㧙㧦
ᐔᚑ 17 ᐕᐲ⚻ᷣ↥ᬺ⋭ක≮⚻༡ੱ᧚⢒ᚑᢎ⢒ࡊࡠࠣ࡜ࡓ㐿⊒ࡊࡠࠫࠚࠢ࠻ታ❣ႎ๔ᦠ(㜞ᐲක≮ᢎ⢒ࠦࡦ࠰࡯ࠪࠕࡓ(ઍ⴫࡮ጊᧄኈᱜ(ᄢ㒋ᄢቇ)))㧦141㧙176(2006 ᐕ 3 ᦬)
2㧕 ੹੗⼾㧘㜞Ⴆ⋥⢻㧘ᄢᣣᐽผ㧦࠹ࠠࠬ࠻ ╙ 1 ┨ක≮⚻ᷣቇߩၮ␆⍮⼂㧦ᐔᚑ 17 ᐕᐲ⚻ᷣ↥ᬺ⋭ක≮⚻༡ੱ᧚⢒ᚑᢎ⢒ࡊࡠࠣ࡜ࡓ㐿⊒ࡊࡠࠫࠚࠢ࠻ታ❣ႎ๔ᦠ(㜞ᐲක≮ᢎ⢒ࠦࡦ࠰࡯ࠪࠕࡓ(ઍ⴫࡮ጊᧄኈᱜ(ᄢ㒋ᄢቇ)))㧦191㧙240(2007 ᐕ 3 ᦬)
3㧕 㜞Ⴆ⋥⢻㧘Ꮉญ㗅ᢘ㧘㜞ᯅቁᄦ㧘♿ࡁቯ଻⤿㧘ጊᧄ⋿↱⟤㧦ࠤ࡯ࠬᢎ᧚ ᕆᕈᦼ∛㒮⚻༡ߦ߅ߌࠆ
∛ᐥࡑࡀࠫࡔࡦ࠻㧙․ቯᯏ⢻∛㒮ᶖൻེᄖ⑼ߩࠤ࡯ࠬ㧙㧦ᐔᚑ 17 ᐕᐲ⚻ᷣ↥ᬺ⋭ක≮⚻༡ੱ᧚⢒ᚑᢎ⢒ࡊࡠࠣ࡜ࡓ㐿⊒ࡊࡠࠫࠚࠢ࠻ታ❣ႎ๔ᦠ(㜞ᐲක≮ᢎ⢒ࠦࡦ࠰࡯ࠪࠕࡓ(ઍ⴫࡮ጊᧄኈᱜ(ᄢ㒋ᄢቇ)))㧦578㧙619(2007 ᐕ 3 ᦬)
4㧕 㐳ἑᷡ㧘㜞Ⴆ⋥⢻㧘♿ࡁቯ଻⤿㧘ጊᧄ⋿↱⟤㧦ᕆᕈᦼ∛㒮⚻༡ߦ߅ߌࠆᚻⴚㇱࡑࡀࠫࡔࡦ࠻=․ቯᯏ
⢻∛㒮ᚻⴚቶߩࠤ࡯ࠬ=㧦ᐔᚑ 19 ᐕᐲ⚻ᷣ↥ᬺ⋭ࠨ࡯ࡆࠬ↥ᬺੱ᧚⢒ᚑ੐ᬺ ∛㒮ᬺോࡑࡀࠫࡔࡦ
࠻ߦ㑐ߔࠆࠤ࡯ࠬࠬ࠲࠺ࠖᢎ᧚㐿⊒ࡊࡠࠫࠚࠢ࠻ႎ๔ᦠ(ઍ⴫࡮ጊᧄ⋿↱⟤)(2008 ᐕ 3 ᦬)
11㧚ႎ㆏∉ቇ࡮੍㒐කቇಽ㊁ෳᾖ㧙㧙

12㧚⥄Ꮖ⹏ଔ
⹏ଔ
ᬺ❣Ⓧ਄ߍߣࡑࡦࡄࡢ࡯㧘⎇ⓥ⾌ߩ⏕଻ࠍ⋡ᜰߔᔅⷐ߇޽ࠆ‫ޕ‬⃻⁁ߩ໧㗴ὐ෸߮ߘߩኻᔕ╷ࡑࡦࡄࡢ࡯ߦ㒢ࠅ߇޽ࠆߚ߼㧘ᄢቇ㒮ᢎ⢒ࠍㅢߒߡቇ↢ߩ⥝๧ࠍ༐⿠ߒ㧘ߎߩಽ㊁ߦ៤ࠊࠆ⠪ࠍ⢒ߡߡ޿߈ߚ޿‫ߚ߹ޕ‬ක≮⾌╬ߩ࠺࡯࠲߳ߩࠕࠢ࠮ࠬߪ㒢ࠄࠇߡ޿ࠆߚ߼㧘ߘߩ⏕଻߇ᦨ㊀ⷐ⺖㗴ߢ޽ࠆ‫ޕ‬ߘߩ㓙㧘୘ੱᖱႎ଻⼔ߦ⇐ᗧߔࠆߎߣߪ൩⺰ߩߎߣߢ޽ࠆ‫ߪߦࠄߐޕ‬᰷ᢥ⺰ᢥࠍჇ߿ߔᔅⷐ߇޽ࠆ‫ᧄޕ‬
ಽ㊁ߩ⎇ⓥߪක≮೙ᐲߦ〯ߺㄟ߻ߚ߼⺰ᢥౝኈ߇࿖ౝߦ㒢ቯߐࠇࠆ௑ะ߇޽ࠆ߇㧘᰷ᢥ⹹߳ߩᛩⓂࠍ⛮⛯⊛ߦⴕ߁੍ቯߢ޽ࠆ‫ޕ‬੹ᓟߩዷᦸක≮ࠬ࠲࠶ࡈਇ⿷ߦࠃࠆක≮፣უ߇ต߫ࠇࠆࠃ߁ߦߥߞߡ㧘࿖ߪක≮⾌ᛥ೙ߩᣇ㊎ࠍᡷ߼ࠆߎߣߣߥ
ߞߚ‫ࠄ߇ߥߒ߆ߒޕ‬㧘⚻ᷣߩవⴕ߈ߪਇㅘ᣿ߢ޽ࠅ㧘੹ᓟ߽ක≮⽷Ḯߩ⏕଻ߦߪਇ⏕ቯⷐ⚛߇ઃ߈߹ߣ
߁߽ߩߣᕁࠊࠇࠆ‫ޕ‬᡿ߦ㧘㜞㦂ൻߣක≮ߩ⾰߳ߩᏗ᳞߇ㅴዷߔࠆ㒢ࠅ㧘ක≮ߦኻߔࠆ⚻ᷣ⊛ಽᨆⷞὐߩ
㊀ⷐᕈߪߎࠇ߆ࠄ߽㜞߹ߞߡ޿ߊ߽ߩߣ⠨߃ࠄࠇࠆ‫ޕ‬
ᧄಽ㊁ߪ౨㗡ߦㅀߴߚߣ߅ࠅ㧘ක≮᡽╷ߣක≮⹏ଔߦ㑐ߔࠆ⎇ⓥࠍਥ૕ߣߒߡ޿ࠆ‫੹ޕ‬ᓟߪකቇ♽⎇ⓥ⑼ߦ޽ࠆ೑ὐࠍࠃࠅ↢߆ߒ㧘⥃ᐥಽ㊁ߣߩ౒ห⎇ⓥࠍჇ߿ߒߡ޿߈ߚ޿‫ޕ‬හߜක≮ᛛⴚ߿࿾ၞක≮ឭଏ૕೙ߩ޽ࠅᣇ╬ߦߟ޿ߡࠛࡆ࠺ࡦࠬࠍ␜ߒߡ޿߈㧘଻ஜක≮᡽╷෸߮ක≮⃻႐߳ߩᖱႎㆶరࠍㅴ߼ߡ
޿ߊᚲሽߢ޽ࠆ‫ޕ‬㧙㧙㧔5㧕ᢇᕆ࡮ἴኂකቇಽ㊁1㧚⎇ⓥߩ᭎ⷐ
ᄖ⊛ଚⷅ೙ᓮߦߟ޿ߡၮ␆⎇ⓥ㧘⥃ᐥ⎇ⓥࠍㅢߓߡ㧘࿖㓙⊛ߦㅢ↪ߔࠆ⥄┙ߒߚ⎇ⓥ⠪ࠍ⢒ᚑߔࠆߎߣ
ࠍ⋡⊛ߣߔࠆ‫ౕޕ‬૕⊛ߥ࠹࡯ࡑߣߒߡߪ㧘ᄖ்㧘࡚ࠪ࠶ࠢ㧔฽߻ᢌⴊ∝㧕㧘ᢇᕆ៝ㅍ㧘ᢇᕆක≮ᖱႎߥߤߦߟ޿ߡߩ⥃ᐥኾ㐷ಽ㊁ߦ߅ߌࠆ⸻ᢿ㧘ᴦ≮ߦ㑐ߔࠆ߽ߩ߿㧘ᢇᕆකቇ㗔ၞߦ߅ߌࠆᄖ்㧘ᢌⴊ∝ߥߤߩᄖ⊛ଚⷅߩታ㛎ࡕ࠺࡞ࠍ૞ᚑߒߡၮ␆⊛ߥ⍮⷗ࠍᓧࠆ‫ޕ‬
2㧚ฬ★
ᢎ᝼㧦
ಎᢎ᝼㧦
ಎᢎ᝼㧦
⻠Ꮷ㧦
⥃ᐥ⻠Ꮷ㧦
⥃ᐥ⻠Ꮷ㧦
⥃ᐥ⻠Ꮷ㧦
⥃ᐥ⻠Ꮷ㧦
⥃ᐥ⻠Ꮷ㧦
⥃ᐥ⻠Ꮷ㧦
⥃ᐥ⻠Ꮷ㧦
⥃ᐥ⻠Ꮷ㧦
⥃ᐥ⻠Ꮷ㧦
කຬ㧦
කຬ㧦
කຬ㧦
කຬ㧦
කຬ㧦
කຬ㧦
කຬ㧦
කຬ㧦
කຬ㧦
කຬ㧦
කຬ㧦
කຬ㧦
කຬ㧦

ዊୖ⌀ᴦ
⼾↰ ᴰ
ዊႮା੺
⊕੗㇌ඳ
㊄↰⧷Ꮘ
ศ↰⋭ㅧ
ᾢ↰ᕺ੺
ᷰㆺፏ㊂
ศ↰㓉ᶈ
Ⴧ↰೰ብ
㐳ደ⡡৻㇢
㥲⮮ผᦶ
࿯੗ᥓ┨
ട⮮ਭ᥏
ฬ⍮ ␽
᧻෹዁⚐
⧯ේ๺ᒾ
᪀ේ⑲ᰴ
⍹㤥శ♿
ਛፉ⾫ᙗ
ർᎹ㗅৻
ਛ㊁ᔒ଻
ศ⋿ ቁ
ᮮጊߜߪࠆ
ጊ↰ᴺ㗼
┻↰ ໪

Shinji Ogura
Izumi Toyoda
Shinsuke Ojio
Kunihiro Shirai
Hidemi Kanada
Shouzo Yoshida
Keisuke Kumada
Takatomo Watanabe
Takahiro Yoshida
Takahiro Masuda
Souitiro Nagaya
Shiro Saito
Tomoaki Doi
Katou Hisaaki
Shou Nachi
Masasumi Matutomo
Kazuhiko Wakahara
Shuji Kuwabara
Mitunori Ishiguro
Masanori Nakashima
Junichi Kitagawa
Shiho Nakano
Takashi Yoshizane
Chiharu Yokoyama
Noriaki Yamada
Hiromu Takeda

(ᓴⅣ∛ᘒቇ)(ᓴⅣ∛ᘒቇ)(ᢛᒻᄖ⑼ቇ)(ዊఽ∛ᘒቇ)(ᓴⅣ∛ᘒቇ)(㜞ᐲవㅴᄖ⑼ቇ)(㜞ᐲవㅴᄖ⑼ቇ)(ᢛᒻᄖ⑼ቇ)(ዊఽ∛ᘒቇ)(⣖␹⚻ᄖ⑼ቇ)(ᶖൻེ∛ᘒቇ)(ᶖൻེ∛ᘒቇ)(ᓴⅣ∛ᘒቇ)(ᓴⅣ∛ᘒቇ)

3㧚⎇ⓥᚑᨐߩ⊒⴫⪺ᦠ㧔๺ᢥ㧕
1㧕 ዊୖ⌀ᴦ㧚๭ๆེ♽∔ᖚ㧙᳇㆏⇣‛㧙㧦ᄢ㒋㧦MC ࡔ࠺ࠖࠞ಴ 㧧2006 ᐕ㧦196㧙203㧚
2㧕 ጊ↰ታ⾆ੱ㧘⼾↰ᴰ㧘ศ᧛⚩৻㧘ጤ㑆੧㧘ᅏኹᢘ㧘ዊୖ⌀ᴦ㧚ኾ㐷කߦ᳞߼ࠄࠇࠆᦨᣂߩ⍮⼂㧨⣖ⴊ▤㓚ኂ㧪⣖තਛᢇᕆߦ߅ߌࠆ⣖තਛೋᦼ⸻≮(ISLS)ࠦ࡯ࠬߩ㊀ⷐᕈ㧦᧲੩㧦ࡔ࠺ࠖࠞ಴ 㧧2007 ᐕ㧦945㧙952㧚
3㧕 ᾢ↰ᕺ੺㧚੹ᣣߩᴦ≮ᜰ㊎㧙๭ๆ♽ߩ✕ᕆಣ⟎ ᳇▤ᝌ▤ᴺ㧙㧦᧲੩㧦කቇᦠ㒮㧧2008 ᐕ㧦78㧙80㧚
4㧕 ⼾↰ᴰ㧚ߔߋߦᓎ┙ߟ⣖␹⚻ᄖ⑼ᢇᕆࡂࡦ࠼ࡉ࠶ࠢ㧙CHAPTER3 ✕ᕆᴦ≮‫ޟ‬㜞૕᷷‫ޠ‬‫ޟ‬ૐ૕᷷‫ޠ‬㧦᧲੩㧦ࡔ࠺ࠖࠞ಴ 㧧2008 ᐕ㧦302㧙307㧚
5㧕 ᾢ↰ᕺ੺㧘⼾↰ᴰ㧘ዊୖ⌀ᴦ㧘⑔↰లብ㧚㗡ㇱᄖ்㧦᦬ೀ࡟ࠫ࠺ࡦ࠻㧘᧲੩㧦කቇ಴ 㧧2008 ᐕ㧦29㧙34㧚
‫ߣ߽ߟ޿ޟ‬㆑߁‫ߣޠ‬㕙ળ⠪߇⸷߃ߚᄛ㧘ᖚ⠪ߪᕆᄌ㧘ᔃ஗ᱛߦ㧙⋴⼔Ꮷ㧘⎇ୃකߩߚ߼ߩᕆᄌኻ
6㧕 ᾢ↰ᕺ੺㧚ᔕ 101 ߩ㋕ೣ㧙㧘᧲੩㧦ᾖᨋ␠㧧2008 ᐕ㧦46㧙47㧚
7㧕 ዊୖ⌀ᴦ㧚߳߈࿾࡮㔌ፉߩ޽ࠆㇺ㆏ᐭ⋵ߩᢇᕆක≮૕೙ߩ⃻⁁ߣ޽ࠅᣇ㧙ᢇᕆක≮ᡷ㕟㧙ᓎഀಽᜂ㧘ㅪ៤㧘㓸⚂ൻߣಽᢔ㧙㧘᧲੩㧦᧲੩ᴺ઎಴ 㧧2008 ᐕ㧦75㧙87㧚
8㧕 ኹᧄ⾆⧷㧘ዊୖ⌀ᴦ㧚㜞ᰴᢇ๮ᢇᕆ㧦ዊఽ⑼ቇ ╙ 3 㧘᧲੩㧦කቇᦠ㒮㧧2008 ᐕ㧦259㧙265㧚
9㧕 ᾢ↰ᕺ੺㧚੹ᣣߩᴦ≮ᜰ㊎㧙๭ๆ♽ߩ✕ᕆಣ⟎ ᳇▤ᝌ▤ᴺ㧙㧦᧲੩㧦කቇᦠ㒮㧧2008 ᐕ㧦78㧙80㧚
10㧕 ㊄↰⧷Ꮖ⋙⸶㧚ACLS ࡊࡠࡃࠗ࠳㧙ࡑ࠾ࡘࠕ࡞ AHA ࠟࠗ࠼࡜ࠗࡦ 2005 ᐕḰ᜚ᣣᧄ⺆ 㧘᧲੩㧦ᩣᑼળ␠ࠪ࠽ࠫ㧙㧧2008 ᐕ㧦199㧙210㧚
11㧕 ዊୖ⌀ᴦ㧚ᢛᒻᄖ⑼࡮ᒻᚑᄖ⑼ᚻⴚ߅ࠃ߮ᾲ்ߩ✕ᕆ㤗㈮ ✕ᕆ㤗㈮ߩᔃᓧ㧙ߎߎ߇⢄ᔃ࡮߅ߐ߃ߤߎ㧍㧙㧘᧲੩㧦స⺈ၴ಴ 㧧2008 ᐕ㧦117㧙137㧚
12㧕 ᾢ↰ᕺ੺㧘⼾↰ᴰ㧘ዊୖ⌀ᴦ㧘⑔↰లብ㧚㗡ㇱᄖ்㧦᦬ೀ࡟ࠫ࠺ࡦ࠻㧘᧲੩㧦කቇ಴ 㧧2008 ᐕ㧦29㧙34㧚㧙㧙

13㧕 ዊୖ⌀ᴦ㧚߳߈࿾࡮㔌ፉߩ޽ࠆㇺ㆏ᐭ⋵ߩᢇᕆක≮૕೙ߩ⃻⁁ߣ޽ࠅᣇ㧙ᢇᕆක≮ᡷ㕟㧙ᓎഀಽᜂ‫ޔ‬ㅪ៤‫ޔ‬㓸⚂ൻߣಽᢔ㧙㧘᧲੩㧦᧲੩ᴺ઎಴ 㧧2008 ᐕ㧦75㧙87㧚
14㧕 ኹᧄ⾆⧷㧘ዊୖ⌀ᴦ㧚㜞ᰴᢇ๮ᢇᕆ ዊఽ⑼ቇ ╙ 3 㧘᧲੩㧦කቇᦠ㒮㧧2008 ᐕ㧦259㧙265㧚⪺ᦠ㧔᰷ᢥ㧕
1㧕 ߥߒ✚⺑㧔๺ᢥ㧕
1㧕 ዊୖ⌀ᴦ㧚SIRS㧘ATΥ㧙SAC ߩᴦ≮ᚢ⇛㧙㧘Pharma Medica ೎ౠ 2006 ᐕ㧧70㧙79㧚
2㧕 ⊕੗㇌ඳ㧚⣺▤ᯏ⢻߆ࠄߺߚ㊀∝ᕆᕈ⤟Ἳߦኻߔࠆ㓸ቇ⊛ᴦ≮㧘ᣣᧄ⣻ㇱᢇᕆකቇળ㔀⹹ 2006 ᐕ㧧26
Ꮞ㧦2㧚
3㧕 ዊୖ⌀ᴦ㧚ᢇ๮ක≮㧙᷷᡿⍮ᣂ㧙㧘ጘ㒂⋵කᏧળකቇ㔀⹹ 2006 ᐕ㧧19 Ꮞ㧦59㧙61㧚
4㧕 ዊୖ⌀ᴦ㧚ታ〣 ᢇᕆක≮㧙╙Τ┨ ᢇᕆಣ⟎㧙࠺ࡊ࡝࠼ࡑࡦ㧘ᣣᧄකᏧળ㔀⹹ 2006 ᐕ㧧135 Ꮞ㧦82
㧙83㧚
5㧕 ዊୖ⌀ᴦ㧚ࡃࠗࠝ࠹ࡠⵍἴ⠪ߩᕆᕈᦼࠤࠕߩᜰ㊎㧘ᢇᕆ࡮㓸ਛᴦ≮ࠞࠗ࠼࡜ࠗࡦ 2006 ᐕ㧧18 Ꮞ㧦792
㧙793㧚
6㧕 ട⮮ਭ᥏㧘ዊୖ⌀ᴦ㧚ᢌⴊ∝㧘medicina 2006 ᐕ㧧43 ᏎჇೀภ㧦535㧙538㧚
7㧕 ⋧ᒁ⋿ᐘ㧘ዊୖ⌀ᴦ㧚㑐໪テ㧚᪢၂ୃ㧚࡚ࠪ࠶ࠢߦ߅ߌࠆ⥄ᓞ␹⚻♽ߩᓎഀ㧘ICU ߣ CCU 2006 ᐕ㧧29
Ꮞ㧦1015㧙1023㧚
8㧕 ጟᧄᅢม㧘ዊୖ⌀ᴦ㧚ၮ␆∔ᖚߦኻߔࠆᴦ≮㧘ᣣᧄⴊᩖᱛⴊቇળ⹹ 2006 ᐕ㧧17 Ꮞ㧦294㧙297㧚
9㧕 ዊୖ⌀ᴦ㧚∛ᘒ೎ߦߺߚ DIC ߩ⸻ᢿߣᴦ≮㧘ᴦ≮ቇ 2007 ᐕ㧧41 Ꮞ㧦249㧙251㧚
10㧕 ᾢ↰ᕺ੺㧘⼾↰ᴰ㧘ዊୖ⌀ᴦ㧘⑔↰లብ㧚ᶖ㒐㒐ἴࡋ࡝ߩ㒢⇇ߣ࠼ࠢ࠲㧙ࡋ࡝ߣߩදജ૕೙ߩ᭴▽ߦߟ޿ߡ㧙ᧄ㇌ߦ߅ߌࠆᢇᕆࡋ࡝ᵴേߣߘߩዷᦸ㧘ᣣᧄ⥶ⓨක≮ቇળ㔀⹹ 2008 ᐕ㧧9 Ꮞ㧦1㧙5㧚✚⺑㧔᰷ᢥ㧕1㧕 ߥߒේ⪺㧔๺ᢥ㧕
1㧕 ౎ᐈ๺ᙗ㧘᧻ᯅᑧᄈ㧘ട⮮㓷ᐽ㧘ዊୖ⌀ᴦ㧚㊀∝ᗵᨴ∝ᓟߦ⊒∝ߒߚ⣺⣶╭⤥∴ߩ 2 ଀㧘ᣣᧄᄖ⑼♽ㅪวቇળ⹹ 2006 ᐕ㧧31 Ꮞ㧦253㧙257㧚
2㧕 ⼾↰ ᴰ㧘ട⮮ਭ᥏㧘᧻ᯅᑧᄈ㧘⊕੗㇌ඳ㧘㊄↰⧷Ꮘ㧘ዊୖ⌀ᴦ㧘ጟ↰⋿ੱ㧚ጘ㒂ᄢቇ∛㒮ߦ߅ߌࠆ㒐ἴࡋ࡝ߩ࠼ࠢ࠲࡯ࡋ࡝⊛ᵴ↪ߩ⃻⁁㧙Using of Fire fighting Helicopters Performed a Doctor Helicopter
in Gifu University Hospital㧙㧘ᣣᧄ⥶ⓨක≮ቇળ㔀⹹ 2006 ᐕ㧧7 Ꮞ㧦12㧙15㧚
3㧕 ጊ↰ ᔀ㧘ㄭ⮮ᶈผ㧘࿯੗ᥓ┨㧘દ⮮ᘕ৻㧘ጊᧄ⋥᮸㧘ᳯේ⧷ବ㧘ධ㙚 ⻞㧘⍹ේ ື㧘಴ญ 㓉㧚Vascularaccess intervention therapy ߩᣧᦼᣉⴕߪ‫ߩ࠻ࡦࡖࠪޔ‬ᕆᕈ㐽㎮ߣౣᑪⴚࠍᷫዋߐߖࠆ߆㧫㧘ᴲዩ♿ⷐ
2006 ᐕ㧧52 Ꮞ㧦699㧙703㧚
4㧕 ട⮮ ብ㧘ᧁ᧛ᤘᄦ㧘૒‫ᧁޘ‬੫㧘㊄ሶ⋥ਯ㧘ᱞ↰ቬ๺㧘㋈ᧁ ᔘ㧘ፉፒୃᰴ㧘⪤ේ┨ཅ㧘ዊୖ⌀ᴦ㧘Ḵญ㓉ม㧘᧻ጟື਽㧘ዊ㊁⑲ᢥ㧘᧻ᶆ⻞ੑ㧘᧻ፉ৻⧷㧚ά✢਄㛽்ਇฬ⍎ߥ㗖㜑៊்(SCIWORA)ߦ㑐ߔࠆᄙᣉ⸳ᓟࠈะ߈⺞ᩏ㧘ᣣᧄᄖ்ቇળ⹹ 2006 ᐕ㧧20 Ꮞ㧦333㧙339㧚
5㧕 ዊୖ⌀ᴦ㧚ጘ㒂ဳᢇᕆἴኂකቇࡋ࡝ࠍ↪޿ߚࡔ࠺ࠖࠞ࡞ࠦࡦ࠻ࡠ࡯࡞㧘∛㒮೨ᢇᕆ⸻≮⎇ⓥળ⹹ 2006
ᐕ㧧1 Ꮞ㧦47㧙55㧚
6㧕 ዊୖ⌀ᴦ㧘ઁቇⴚᮡḰൻᆔຬ㧚EBM ߦၮߠߊ DIC ࠟࠗ࠼࡜ࠗࡦ૞ᚑߦะߌߡߩ⺞ᩏ⎇ⓥ㧘ᣣᧄⴊᩖᱛⴊ
ቇળ⹹ 2006 ᐕ㧧17 Ꮞ㧦278㧙330㧚
7㧕 ⑔ጟᙗᵏ㧘Ⴆᧄ⼾ਭ㧘᫪↰ୃਯ㧘ዊୖ⌀ᴦ㧚㊀∝଀ߦኻߔࠆ࠹ࠗࠦࡊ࡜࠾ࡦߩ⽶⩄ᛩਈ㊂ߦߟ޿ߡߩᬌ⸛㧘
TDM ⎇ⓥ 2006 ᐕ㧧23 Ꮞ㧦6㧙9㧚
8㧕 Ⴧᩕᚑᵏ㧘቟⮮౏㓉㧘⼾↰ᴰ㧘᫪⟵㓶㧘ዊୖ⌀ᴦ㧘ਛᩮᘮᄥ㧘⪤ේᓼᐽ㧘㜞ᯅ⟵ੱ㧘಴ญ㓉㧚వᄤᕈ⣢⋃ዩ▤⒖ⴕㇱ⁜⓰∝ߦว૬ߒߚᄖ்ᕈ⣢៊்ߩ 1 ଀㧘ᢇᕆකቇ 2007 ᐕ㧧31 Ꮞ㧦111㧙113㧚
9㧕 ⊕੗㇌ඳ㧚㊀∝ᕆᕈ⤟Ἳߩᴦ≮㧘⥃ᐥ↹௝ 2007 ᐕ㧧23 Ꮞ㧦544㧙554㧚
10㧕 ⊕੗㇌ඳ㧘⼾↰ᴰ㧘ศ↰⋭ㅧ㧘㊄↰⧷Ꮘ㧘ᾢ↰ᕺ੺㧘ጊ↰ታ༑ੱ㧘ศ↰㓉ᶈ㧘ട⮮ਭ᥏㧘࿯੗ᥓ┨㧘ਛ㊁ᔒ଻㧘┻↰໪㧘ጊ↰ᴺ㗼㧘ዊୖ⌀ᴦ㧘᧻ᯅᑧᄈ㧚ᄖ்ᖚ⠪ߦ߅ߌࠆ౉㒮ᓟᗵᨴᕈว૬∝ߩෂ㒾࿃ሶߦߟ޿
ߡߩᬌ⸛㧘ᣣᧄᄖ்ቇળ㔀⹹ 2008 ᐕ㧧22 Ꮞ㧦403㧙409㧚ේ⪺㧔᰷ᢥ㧕
1㧕 Kato M, Tanaka Y, Toyoda I, Ogura S, Yoshimura S, Iwata T. Delayed lower cranial nerve
palsy(Collet-Sicard syndrome) after head injury. Injury Extra. 2006;37:104-108.
IF 1.211
2㧕 Matsuhashi N, Mizoguchi T, Kanematsu M, Kondo H, Goshima S, Mitsuishi N, Yoshimura K, Ogiso T,
Tawada M, Kuwabara S, Ikegame Y, Kato M, Shirai K, Yamaguchi H, Toyoda I, Ogura S. A case ofdelayed rectal stenosis from severe pelvic fracture with massive bleeding successfully treated bybilateral internal iliac TAE: Report on a patient survival. Int J Colorectal Dis. 2006;22:853-4.
IF 1.848
3㧕 Matsuhashi N, Satake S, Yawata K, Asakawa E, MizoguchiT, Kanematsu M, Kondo H, Yasuda I,
Nonaka K, Tanaka C, Misao A, Ogura S. Volvulus of the gall bladder diagnosed byultrasonography,computed tomography, coronal magnetic resonance imaging and magnetic resonancecholangiópancreatography. World Gastroenterol. 2006;12:4599-4601.
IF 3.318

㧙㧙4㧕 Takamatsu T, Ogura S, Tamura S, Hayamizu S. GEMSIS, An introduction of Intelligent Information
Support System for Emergency and Disaster Medicine. J Health Tech Appl. 2007;5:12-17.
5㧕 Takai S, Tokuda H, Hanai T, Harada A, Yasuda E, Kato H, Ogura S, Ohta T, Kozawa O. Negative
Regulatoin by p70 S6 kinase of FGF-2-Stimulated VEGF Release Through Stress-Activated Protein
Kinase/c-Jun N-Terminal Kinase in Osteoblasts. J Bone Miner Res. 2007;5:337-346.
6㧕 Yamauchi J, Takai S, Matsushima-Nishiwaki R, Hanai Y, Doi T, Kato H, Ogura S, Kato K, Tokuda H,
Kozawa O. -epigallocatechin gallate inhibits prostaglandin D2-stimulated HSP27 induction via
suppression of the p44/p42 MAP kinase pathway in osteoblasts. Prostaglandins Leukot Essent Fatty
Acids. 2007;77:173-9.
7㧕 Kato H, Kimura A, Sasaki R, Kaneko N, Takeda M, Hagiwara A, Ogura S, Mizoguchi T, Matsuoka T,
Ono H, Matsuura K, Matsushima K, Kushimoto S. Cervical Spinal Cord Injury Without Bony Injury-A Multicenter Retrospective Study of Emergency and Critical Care Centers in Japan. J Trauma Inj
Infect Crit Care. 2008;65:373-379.
8㧕 Kato H, Takai S, Matsushima-Nishiwaki R, Adachi S, Minamitani C, Otsuka T, Tokuda H, Akamatsu
S, Doi T, Ogura S, Kozawa O. HSP27 phosphorylation is correlated with ADP-induced platelet granulesecretion. Arc Biochem Biophys. 2008;475:80-86.
9㧕 Tokuda H, Takai S, Hanai Y, Harada A, Matsushima-Nishiwaki R, Kato H, Ogura S, Kozawa O.
Potentiation by platelet-derived growth factor-BB of FGF-2-stimulated VEGF release in osteoblasts. J
Bone Miner Metab. 2008;26:335-341.

IF 6.635

IF 2.000

IF 2.334

IF 2.969

IF 1.4254㧚⎇ⓥ⾌₪ᓧ⁁ᴫ
1㧕┹੎⊛⾗㊄1㧕 ⎇ⓥઍ⴫⠪㧦ጊ↰ᔀ㧧⑼ቇ⎇ⓥ⾌⵬ഥ㊄ ⧯ᚻ⎇ⓥ(B)㧦ⴊᶧਛ‫ ⩶⚦ޔ‬DNA‫ޔ‬mRNA ቯ㊂ߦࠃࠆ‫ޔ‬ᢌⴊ∝ߩㄦㅦ⸻ᢿߣ㧘᛫⩶⮎ߩലᨐ್ቯ㧧ᐔᚑ 18㧙19 ᐕᐲ㧧1,100 ජ౞2㧕 ⎇ⓥઍ⴫⠪㧦ട⮮㓷ᐽ㧧⑼ቇ⎇ⓥ⾌⵬ഥ㊄ ⧯ᚻ⎇ⓥ(B)㧦ࠨࠗ࠻ࠞࠗࡦ࡮ࡃ࡜ࡦࠬ߆ࠄ⷗ߚ㊀∝ᗵᨴ∝ߩ∛ᘒ⸃ᨆߣᴦ≮ᛶ᛫ᕈㆮવሶߩหቯ㧧ᐔᚑ 18㧙19 ᐕᐲ㧧1,600 ජ౞3㧕 ⎇ⓥઍ⴫⠪㧦᧻ᯅᑧᄈ㧧⑼ቇ⎇ⓥ⾌⵬ഥ㊄ ⧯ᚻ⎇ⓥ(B)㧦ᢌⴊ∝ߦ߅ߌࠆࠕࡐ࠻࡯ࠪࠬߣࠨࠗ࠻ࠞ
ࠗࡦࡀ࠶࠻ࡢ࡯ࠢ෸߮ㆮવሶᄙဳߩ⸃ᨆ㧧ᐔᚑ 18㧙19 ᐕᐲ㧧1,700 ජ౞
2㧕ฃ⸤⎇ⓥ1㧕 ዊୖ⌀ᴦ㧦Hepatocyte ߦ߅ߌࠆࠕࡦ࠴࠻ࡠࡦࡆࡦ↥↢⢻ߦኻߔࠆࠣ࡜ࡓ㓁ᕈ⩶࡮㒶ᕈ⩶ೝỗߦࠃࠆ↢↥ᕈᓮࡔࠞ࠾࠭ࡓߩᬌ⸛㧧ᐔᚑ 17㧙19 ᐕᐲ㧧230 ජ౞(230㧦0㧦0 ජ౞)㧦ZLB ࡌ࡯࡝ࡦࠣ(ᩣ)
2㧕 ዊୖ⌀ᴦ㧘᫪↰໪ਯ㧦㔚᳇ೝỗᯏ⢻ઃ߈ᒢᕈࠬ࠻࠶ࠠࡦࠣߩ㕒⣂ⴊᩖ∝ߦኻߔࠆ੍㒐ലᨐߩᬌ⸛㧧ᐔᚑ 18 ᐕᐲ㧧2,000 ජ౞㧦ࠝࡓࡠࡦࡋ࡞ࠬࠤࠕ(ᩣ)
3㧕 ዊୖ⌀ᴦ㧘⼾↰ ᴰ㧘ട⮮ਭ᥏㧦ࡈࠖ࠾ࡃ࠶ࠢࠬὐṢ↪ 0.25g ૶↪ᚑ❣⺞ᩏ㧧ᐔᚑ 18 ᐕᐲ㧧300,300౞㧦Ⴎ㊁⟵⵾⮎(ᩣ)
4㧕 ዊୖ⌀ᴦ㧦ࠪࡌ࡟ࠬ࠲࠶࠻࠽࠻࡝࠙ࡓ᳓๺‛Ꮢ⽼ᓟ⥃ᐥታ㛎 ోりᕈἻ∝෻ᔕ∝୥⟲ߦ઻߁ᕆᕈ⢖㓚ኂߦኻߔࠆࠝ࡯ࡊࡦ⹜㛎(ࠪࡌ࡟ࠬ࠲࠶࠻࠽࠻࡝࠙ࡓ᳓๺‛ᛩਈ㇭)㧧ᐔᚑ 17㧙18 ᐕᐲ㧧932,400౞㧦ዊ㊁⮎ຠᎿᬺ(ᩣ)
5㧕 Hepatocyte ߦ߅ߌࠆࠕࡦ࠴࠻ࡠࡦࡆࡦ↥↢⢻ߦኻߔࠆࠣ࡜ࡓ㓁ᕈ⩶࡮㒶ᕈ⩶ೝỗߦࠃࠆ↢↥೙ᓮࡔࠞ࠾࠭ࡓߩᬌ⸛㧧ᐔᚑ 17㧙19 ᐕᐲ㧧230 ජ౞(230㧦0㧦0 ජ౞)㧦ZLB ࡌ࡯࡝ࡦࠣ(ᩣ)
6㧕 ዊୖ⌀ᴦ㧦ᄖ⑼ᢇᕆ㗔ၞߦ߅ߌࠆᷓ࿷ᕈ⌀⩶∝ߦ߆ࠎߔࠆ⺞ᩏ㧧ᐔᚑ 20㧙21 ᐕᐲ㧧154 ජ౞㧦੍㒐කቇ੐ᬺਛᄩળ
3㧕౒ห⎇ⓥߥߒ
5㧚⊒᣿࡮․⸵಴㗿⁁ᴫߥߒ
6㧚ቇળᵴേ
1㧕ቇળᓎຬዊୖ⌀ᴦ㧦
1㧕 ᣣᧄᢇᕆකቇળ⹏⼏ຬ࡮⣖ᱫ⤳ེឭଏߦ㑐ߔࠆᆔຬ✬㓸ᆔຬળᆔຬ(㨪⃻࿷)2㧕 ᣣᧄ㓸ਛᴦ≮කቇળ⹏⼏ຬ(㨪⃻࿷)3㧕 ᣣᧄ Shock ቇળ⹏⼏ຬ(㨪⃻࿷)㧙㧙4㧕 ᣣᧄ⥶ⓨක≮ቇળ⹏⼏ຬ࡮ᩏ⺒ᆔຬ(㨪⃻࿷)5㧕 ᣣᧄᄖ்ቇળ⹏⼏ຬ࡮዁᧪⸘↹ᆔຬ࡮ኾ㐷ක⹺ቯᆔຬ(㨪⃻࿷)6㧕 ᣣᧄᢇᕆකቇળ᧲ᶏ࿾ᣇળ⋙੐(㨪⃻࿷)7㧕 ᣣᧄ⥃ᐥᢇᕆකቇળ዁᧪⸘↹ᬌ⸛ᆔຬ࡮࠻࡝ࠕ࡯ࠫ࠽࡯ࠬ⢒ᚑᬌ⸛ዊᆔຬળᆔຬ(㨪⃻࿷)8㧕 ᣣᧄ㓸࿅ἴኂකቇળ⑺⪲ේ੐ઙ⺞ᩏ․೎ᆔຬળᆔຬ(ᐔᚑ 20 ᐕᐲ㨪⃻࿷)⼾↰ᴰ㧦
1㧕 ᣣᧄᢇᕆකቇળਛㇱ࿾ᣇળᐙ੐(㨪⃻࿷)2㧕 ᣣᧄ␹⚻ᄖ்ቇળ✬㓸ᐙ੐(㨪⃻࿷)3㧕 ᣣᧄ⣖␹⚻ᄖ⑼ᢇᕆකቇળᐙ੐(㨪⃻࿷)ᾢ↰ᕺ੺㧦1㧕 ᣣᧄᢇᕆකቇળ⹏⼏ຬ(㨪⃻࿷)2㧕 ᣣᧄ⥃ᐥᢇᕆකቇળ⹏⼏ຬ(㨪⃻࿷)ዊႮା੺㧦1㧕 CCT2008 ⹏⼏ຬ(㨪⃻࿷)2㧕 ᧲ᶏ࡜ࠗࡉ⎇ⓥળᐙ੐(㨪⃻࿷)ศ↰⋭ㅧ㧦1㧕 ᣣᧄᢇᕆකቇળ㑐᧲࿾ᣇળᐙ੐(㨪⃻࿷)2㧕ቇળ㐿௅ዊୖ⌀ᴦ㧦
1㧕 JATEC ጘ㒂ࠦ࡯ࠬ(ᐔᚑ 18 ᐕ 5 ᦬㧘ጘ㒂)2㧕 ᣣᧄᢇᕆකቇળਛㇱ࿾ᣇળ✚ળ࡮ቇⴚ㓸ળ(ᐔᚑ 19 ᐕ 11 ᦬㧘ጘ㒂)3㧕 JATEC ጘ㒂ࠦ࡯ࠬΤ(ᐔᚑ 20 ᐕ 5 ᦬㧘ጘ㒂)
3㧕ቇⴚ㔀⹹ዊୖ⌀ᴦ㧦
1㧕 ᣣᧄᢇᕆකቇળਛㇱ࿾ᣇળ✚ળ࡮ቇⴚ㓸ળ⹹(ᐔᚑ 19 ᐕ 11 ᦬㨪⃻࿷)2㧕 ᣣᧄᢇᕆකቇળ㧧✬㓸ᆔຬ(㨪⃻࿷)7㧚ቇળ᜗ᓙ⻠Ṷ㧘᜗ᓙࠪࡦࡐࠫࠬ࠻㧘ᐳ㐳ዊୖ⌀ᴦ㧦
1㧕 The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society(ᐔᚑ 18 ᐕ 3᦬㧘ฬฎደ㧘ࠪࡦࡐࠫ࠙ࡓ‫ޟ‬ἴኂᤨߩᓴⅣེ∔ᖚ‫ޠ‬ᐳ㐳)2㧕 ╙ 20 ࿁ᣣᧄᄖ்ቇ(ᐔᚑ 18 ᐕ 5 ᦬㧘ฬฎደ㧘࡜ࡦ࠴࡚ࡦ࠮ࡒ࠽࡯‫ޟ‬ᱛⴊ࡮TAE㧘ઁ‫ޠ‬ᐳ㐳)
3㧕 ╙ 20 ࿁ᣣᧄᄖ்ቇ(ᐔᚑ 18 ᐕ 5 ᦬㧘ฬฎደ㧘࡜ࡦ࠴࡚ࡦ࠮ࡒ࠽࡯‫ޟ‬ᢇᕆ㗔ၞߦ߅ߌࠆ๭ๆਇోߩ∛ᘒߣᴦ≮ᚢ⇛‫ޠ‬Ṷ⠪)
4㧕 ╙ 9 ࿁ᣣᧄ⥃ᐥᢇᕆකቇળ✚ળ(ᐔᚑ 18 ᐕ 5 ᦬㧘⋓ጟᏒ㧘ࠪࡦࡐࠫ࠙ࡓ‫ޟ‬ጘ㒂ᢇᕆක≮ᖱႎ౒᦭េ
ഥࠪࠬ࠹ࡓ(GEMSIS)ߩ㐿⊒‫ޠ‬Ṷ⠪)
5㧕 ╙ 66 ࿁ਅํᏒකᏧળቇⴚ⻠Ṷળ(ᐔᚑ 18 ᐕ 6 ᦬㧘ਅํ㧘․೎⻠Ṷ‫ޟ‬ᢇᕆ㗔ၞߦ߅ߌࠆ๭ๆ▤ℂ‫ޠ‬Ṷ⠪)
6㧕 ╙ 1 ࿁ጘ㒂ᢇᕆ㓸ਛᴦ≮࠮ࡒ࠽࡯(ᐔᚑ 18 ᐕ 6 ᦬㧘ጘᄢ∛㒮㧘․೎⻠Ṷ‫ޟ‬ᢌⴊ∝ᕈ DIC ߩⴊ▤ౝ⊹⚦⢩଻⼔ᚢ⇛‫ޠ‬ᐳ㐳)7㧕 ╙ 14 ࿁ᣣᧄ㓸ਛᴦ≮කቇળ᧲ᶏർ㒽࿾ᣇળ(ᐔᚑ 18 ᐕ 6 ᦬㧘ንጊ㧘࡜ࡦ࠴࡚ࡦ࠮ࡒ࠽࡯‫ޟ‬ᢌⴊ∝ߣᕆᕈ⢖㓚ኂߩᴦ≮‫ޠ‬Ṷ⠪)8㧕 ╙ 8 ࿁ጘ㒂ᄢቇᢇᕆකቇ⻠Ṷળ(ᐔᚑ 18 ᐕ 7 ᦬㧘ጘᄢ∛㒮㧘․೎⻠Ṷ‫ޟ‬ᕆᕈᦼ DIC ⸻ᢿၮḰߣ DIC
ᴦ≮ࠟࠗ࠼࡜ࠗࡦ‫ޠ‬ᐳ㐳)9㧕 ╙ 4 ࿁ᢇᕆ㗔ၞᗵᨴኻ╷࠮ࡒ࠽࡯(ᐔᚑ 18 ᐕ 8 ᦬㧘ጘ㒂㧘․೎⻠Ṷ‫ޟ‬MRSA ᗵᨴ∝ߣ VCM ⠴ᕈ⩶‫ޠ‬ᐳ㐳)
10㧕 ╙ 2 ࿁࿾ၞක≮ㅪ៤⻠Ṷળ(ᐔᚑ 18 ᐕ 9 ᦬㧘㜞⍮㧘⻠Ṷળ‫ޟ‬ᢇᕆ㗔ၞߦ߅ߌࠆᕆᕈ๭ๆਇో‫ޠ‬Ṷ⠪)㧙㧙

11㧕 ╙ 9 ࿁ጘ㒂ᄢቇᢇᕆකቇ⻠Ṷળ(ᐔᚑ 18 ᐕ 11 ᦬㧘ጘᄢ∛㒮㧘․೎⻠Ṷ‫ޟ‬1)੩ᄢ∛㒮ೋᦼ⸻≮࡮ᢇᕆㇱߩ⃻⁁ 2)಴ⴊᕈ࡚ࠪ࠶ࠢᓟߩ⣺㑆⤑࡝ࡦࡄᶧਛߦሽ࿷ߔࠆ⢽⾰ࡔ࠺ࠗࠛ࡯࠲࡯ߩᬌ⸛‫ޠ‬ᐳ㐳)12㧕 ᣣᧄ㓸࿅ἴኂකቇળ(ᐔᚑ 19 ᐕ 1 ᦬㧘ฬฎደ㧘ࠪࡦࡐࠫ࠙ࡓ‫ޟ‬ᢇᕆක≮ᖱႎ౒᦭ᡰេࠪࠬ࠹ࡓ(GEMSIS)ࠍ↪޿ߚࡑࠬࠡࡖࠩ࡝ࡦࠣᖱႎવ㆐ࠪࠬ࠹ࡓ㧙GEMSIS ╙ 3 ႎ㧙Ṷ⠪)
13㧕 ో࿖࿖┙ᄢቇ∛㒮ᢇᕆㇱㅪ⛊ද⼏ળ(ᐔᚑ 19 ᐕ 2 ᦬㧘᧻ᧄ㧘ࠪࡦࡐࠫ࠙ࡓ‫ޟ‬ጘ㒂ᄢቇකቇㇱ㒝ዻ∛㒮ߩ૶๮࡮ߘߩࠦࠬ࠻ߣࡄࡈࠜ࡯ࡑࡦࠬ‫ޠ‬Ṷ⠪)
14㧕 ╙ 34 ࿁ᣣᧄ㓸ਛᴦ≮ቇળቇⴚ✚ળ(ᐔᚑ 19 ᐕ 3 ᦬㧘␹ᚭ㧘ࡢ࡯࡚ࠢࠪ࠶ࡊ‫ޟ‬ICU ߦ߅ߌࠆ㔚ሶࠞ࡞࠹ߩᎿᄦ‫ޠ‬ᐳ㐳)15㧕 ╙ 34 ࿁ᣣᧄ㓸ਛᴦ≮ቇળቇⴚ✚ળ(ᐔᚑ 19 ᐕ 3 ᦬㧘␹ᚭ㧘ࡢ࡯࡚ࠢࠪ࠶ࡊ‫ޟ‬㓸ਛᴦ≮ߩ㔚ሶࠞ࡞࠹ߩᎿᄦ‫ޠ‬Ṷ⠪)
16㧕 ╙ 10 ࿁ᣣᧄ⥃ᐥᢇᕆකቇ✚ળ࡮ቇⴚ㓸ળ(ᐔᚑ 19 ᐕ 5 ᦬㧘␹ᚭ㧘ࡄࡀ࡞࠺ࠖࠬࠞ࠶࡚ࠪࡦ‫ޟ‬ⓨ᷼ἴኂᤨක≮૕೙ߩᣂߒ޿᭎ᔨߣߘࠇࠍᡰេߔࠆᖱႎࠪࠬ࠹ࡓ(GEMSIS)╙ 4 ႎ‫ޠ‬Ṷ⠪)17㧕 ╙ 21 ࿁ᣣᧄᄖ்ቇળ(ᐔᚑ 19 ᐕ 5 ᦬㧘ජ⪲㧘‫ޟ‬⣻ㇱᄖ்Σ(ታ⾰⤳ེ៊்)‫ޠ‬ᐳ㐳)18㧕 ߳߈࿾࡮㔌ፉᢇᕆක≮⎇ⓥળ╙ 11 ࿁ቇⴚ㓸ળ(ᐔᚑ 19 ᐕ 10 ᦬㧘㜞⍮㧘ࠪࡦࡐࠫ࠙ࡓ‫ޟ‬ጘ㒂⋵ߩ߳߈࿾ᢇᕆක≮ߩ⏕଻‫ޠ‬Ṷ⠪)
19㧕 ╙ 35 ࿁ᣣᧄᢇᕆකቇળ(ᐔᚑ 19 ᐕ 10 ᦬㧘ᄢ㒋㧘⻠Ṷ‫ޟ‬Frontier4‫ޟ‬ᢌⴊ∝ߩ∛ᘒߣᴦ≮̆Surviving
Sepsis Campaign guidelines ߩ∛ᘒ↢ℂቇ⊛⸃㉼̆‫ޠ‬ᐳ㐳)20㧕 ╙ 35 ࿁ᣣᧄᢇᕆකቇળ(ᐔᚑ 19 ᐕ 10 ᦬㧘ᄢ㒋㧘࠮࠶࡚ࠪࡦ‫ޟ‬࿾ၞක≮ߣᢇᕆක≮ߩធὐࠍᡰេߔ
ࠆᢇᕆක≮ᖱႎᡰេࠪࠬ࠹ࡓ GEMSIS㧙╙ 5 ႎ㧙‫ޠ‬Ṷ⠪)
21㧕 ᢇᕆࠞࡦࡈࠔ࡟ࡦࠬ(ᐔᚑ 19 ᐕ 10 ᦬㧘㕒ጟ㧘․೎⻠Ṷ‫ޟ‬ᢇᕆ㗔ၞߦ߅ߌࠆ๭ๆ▤ℂ‫ޠ‬Ṷ⠪)22㧕 ╙ 11 ࿁ጘ㒂ᄢቇᢇᕆකቇ⻠Ṷળ(ᐔᚑ 20 ᐕ 5 ᦬㧘ጘ㒂㧘‫ޟ‬ἴኂᤨߦ߅ߌࠆ∛㒮ߩᓎഀ㨪੹ߛ߆ࠄ⹤ߖࠆ࿾ਅ㋕ࠨ࡝ࡦ੐ઙߩ෻⋭ὐ㨪‫ޠ‬ᐳ㐳)23㧕 ࿖㓙ᄖ்ࠞࡦࡈࠔ࡟ࡦࠬ(ᐔᚑ 20 ᐕ 5 ᦬㧘ጘ㒂㧘․೎⻠Ṷ‫ޟ‬࿾ᣇߦ߅ߌࠆᄖ்ක≮૕೙ߩ⏕┙‫ޠ‬ᐳ㐳)24㧕 ᣣᧄ㤗㈮⑼ቇળ╙ 55 ࿁ቇⴚ㓸ળ(ᐔᚑ 20 ᐕ 6 ᦬㧘␹ᄹᎹ㧘‫ޟ‬Multiple Trauma Management‫ޠ‬ᐳ㐳)25㧕 ╙ 3 ࿁ጘ㒂ᢇᕆ㓸ਛᴦ≮࠮ࡒ࠽㧙(ᐔᚑ 20 ᐕ 8 ᦬㧘ጘ㒂㧘․೎⻠Ṷ‫ޟ‬2008 ᐕᢌⴊ∝߅ࠃ߮ DIC ▤ℂߩേะ‫ޠ‬ᐳ㐳)26㧕 ጊ᪸ᢇᕆ㓸ਛᴦ≮ࡈࠜ㧙࡜ࡓ 2008(ᐔᚑ 20 ᐕ 9 ᦬㧘↲ᐭ㧘᜗ᓙ⻠Ṷ‫ޟ‬㓸ਛᴦ≮ߦ߅ߌࠆ๭ๆ▤ℂߣᴦ≮ᚢ⇛‫ޠ‬Ṷ⠪)27㧕 ╙ 36 ࿁ᣣᧄᢇᕆකቇળ✚ળ࡮ቇⴚ㓸ળ(ᐔᚑ 20 ᐕ 10 ᦬㧘ർᶏ㆏㧘ࡢ㧙࡚ࠢࠪ࠶ࡊ‫⥃ޟ‬ᐥ⎇ୃᔅୃൻߦ߅ߌࠆᢇᕆߩ⎇ୃലᨐะ਄ߩᎿᄦ‫ޠ‬ᐳ㐳)28㧕 ጘ㒂ᢇᕆᄖ்࠮ࡒ࠽㧙(ᐔᚑ 20 ᐕ 11 ᦬㧘ጘ㒂㧘․೎⻠Ṷ‫ޟ‬⣄ᬁ‫ޔ‬⣄㜑៊்ߩᕆᕈᦼᴦ≮‫ޠ‬ᐳ㐳)29㧕 ╙ 15 ࿁ᣣᧄ⥶ⓨක≮ቇળ(ᐔᚑ 20 ᐕ 11 ᦬㧘᧻ᳯᏒ㧘‫ޟ‬ਛᨔ␹⚻࡮ᓴⅣེ‫ޠ‬ᐳ㐳)⼾↰ᴰ㧦
1㧕 The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society(ᐔᚑ 18 ᐕ 3᦬㧘ฬฎደ㧘ࠪࡦࡐࠫ࠙ࡓ‫ޟ‬Emergency System for Circulatory Diseases During Disasters andAssociated Problems From the Standpoint of Emergency‫ޠ‬Ṷ⠪)
2㧕 ╙ 21 ࿁ᣣᧄ␹⚻ᢇᕆቇળቇⴚ㓸ળ(ᐔᚑ 19 ᐕ 6 ᦬㧘੩ㇺ㧘⻠Ṷ‫ޟ‬ጘ㒂⋵ߦ߅ߌࠆ⣖තਛೋᦼ⸻≮(ISLS)ࠦ࡯ࠬ㐿௅ߩ⃻⁁ߣ੹ᓟ‫ޠ‬Ṷ⠪)
3㧕 ╙ 13 ࿁᧲ᶏ MODS ⎇ⓥળ(ᐔᚑ 19 ᐕ 12 ᦬㧘ጘ㒂㧘‫ޟޟ‬ἴኂ‫ޠ‬㒮ᄖߩἴኂኻ╷ߦߟ޿ߡ‫ޠ‬ᐳ㐳)⊕੗㇌ඳ㧦
1㧕 ╙ 34 ࿁ᣣᧄ㓸ਛᴦ≮කቇળቇⴚ✚ળ(ᐔᚑ 19 ᐕ 3 ᦬㧘␹ᚭ㧘ࠪࡦࡐࠫ࠙ࡓ‫ޟ‬㊀∝ᕆᕈ⤟Ἳ(SAP)ߦ
߅ߌࠆ⤳ེ㓚ኂߦኻߔࠆἻ∝ߣಝ࿕✢ṁ♽‫ޠ‬Ṷ⠪)
2㧕 ╙ 107 ࿁ᣣᧄᄖ⑼ቇળቯᦼቇⴚ㓸ળ(ᐔᚑ 19 ᐕ 4 ᦬㧘ᄢ㒋㧘ࠪࡦࡐࠫ࠙ࡓ‫ޟ‬ᒰ㒮ᢇ๮࠮ࡦ࠲࡯ߦ߅
ߌࠆ㊀∝ᕆᕈ⤟Ἳߦኻߔࠆᴦ≮ᚢ⇛ߩᬌ⸛㨪ෘ↢ഭ௛⋭㊀∝ᐲ stage ಽ㘃೎‫᧻ޔ‬㊁ CT grade ಽ㘃೎ߦ㨪‫ޠ‬Ṷ⠪)3㧕 ╙ 21 ࿁ᣣᧄᄖ்ቇળ(ᐔᚑ 19 ᐕ 5 ᦬㧘ජ⪲㧘⻠Ṷ‫ޟ‬ᒰ㒮ᢇ๮ᢇᕆ࠮ࡦ࠲࡯ߦ߅ߌࠆᄖ்ᖚ⠪ߩ౉㒮ᓟᗵᨴ∝ว૬∝ߩᬌ⸛‫ޠ‬Ṷ⠪)
4㧕 ╙ 62 ࿁ᣣᧄᶖൻེᄖ⑼ቇળቇⴚ㓸ળ(ᐔᚑ 19 ᐕ 7 ᦬㧘᧲੩㧘⻠Ṷ‫ޟ‬㊀∝ᕆᕈ⤟Ἳߦ߅ߌࠆᗵᨴᕈว
૬∝ߩᬌ⸛‫ޠ‬Ṷ⠪)
5㧕 ╙ 1 ࿁᧲ᶏᢇ๮ᢇᕆ SBMN ⎇ⓥળቇⴚ⻠Ṷળ(ᐔᚑ 19 ᐕ 9 ᦬㧘ฬฎደ㧘ࠪࡦࡐࠫ࠙ࡓ‫ޟ‬㊀∝ᕆᕈ⤟㧙㧙Ἳߦኻߔࠆᩕ㙃▤ℂ‫ޠ‬Ṷ⠪)
6㧕 ╙ 35 ࿁ᣣᧄᢇᕆකቇળ(ᐔᚑ 19 ᐕ 10 ᦬㧘ᄢ㒋㧘ࡢ࡯࡚ࠢࠪ࠶ࡊ‫ޟ‬㊀∝ᕆᕈ⤟Ἳߦ߅ߌࠆᗵᨴᕈว
૬∝ߦኻߔࠆᴦ≮ᚢ⇛‫ޠ‬Ṷ⠪)7㧕 ╙ 20 ࿁ᣣᧄᄖ⑼ᗵᨴ∝ቇળ(ᐔᚑ 19 ᐕ 11 ᦬㧘᧲੩㧘⻠Ṷ‫ޟ‬ᄖ்ᖚ⠪ߩ౉㒮ᓟᗵᨴ∝ߦߟ޿ߡߩᬌ
⸛‫ޠ‬Ṷ⠪)
8㧕 ╙ 36 ࿁ᣣᧄᢇᕆකቇળ✚ળ࡮ቇⴚ㓸ળ(ᐔᚑ 20 ᐕ 10 ᦬㧘ർᶏ㆏㧘ࠪࡦࡐࠫ࠙ࡓ‫ޟ‬㊀∝ᄖ்ߩ಴ⴊ
ߦኻߔࠆᴦ≮ᚢ⇛㨪✕ᕆᚻⴚߣ⚻ࠞ࠹࡯࠹࡞⊛േ⣂Ⴇᩖⴚ(TAE)ߣߩ૬↪≮ᴺߩᬌ⸛㨪‫ޠ‬Ṷ⠪)ᾢ↰ᕺ੺㧦
1㧕 ╙ 10 ࿁ᣣᧄ⥃ᐥᢇᕆකቇળ✚ળ(ᐔᚑ 19 ᐕ 5 ᦬㧘␹ᚭ㧘ࠪࡦࡐࠫ࠙ࡓ‫࡞ࡃࡦࡏޟ‬ᯏ⢵૕⌕㒽ߦ߅ߌࠆኻᔕ‫ޠ‬Ṷ⠪)2㧕 ╙ 35 ࿁ᣣᧄᢇᕆකቇળ(ᐔᚑ 19 ᐕ 10 ᦬㧘ᄢ㒋㧘‫ޟ‬ᢇᕆක≮૕೙‫ޠ‬ᐳ㐳)
3㧕 ╙ 15 ࿁ᣣᧄ⥶ⓨක≮ቇળ✚ળ(ᐔᚑ 20 ᐕ 11 ᦬㧘ፉᩮ㧘ࠪࡦࡐࠫ࠙ࡓ‫ޟ‬ᶖ㒐㒐ἴࡋ࡝ߣ࠼ࠢ࠲࡯ࡋ
࡝ࠍᅤ૗ߦ᦭ലᵴ↪ߔߴ߈߆‫ޠ‬Ṷ⠪)㜞᧻㇌ᒾ㧦
1㧕 ╙ 21 ࿁ᄥᐔᵗቇⴚળ⼏(ᐔᚑ 19 ᐕ 6 ᦬㧘ᴒ✽㧘‫ޟ‬GEMSIS, An introduction of Intelligent Information
Support System for Emergency and Disaster Medicine By Prof Kunihiko Takamatsu‫ޠ‬Ṷ⠪)ศ↰⋭ㅧ㧦‫ޟ‬㊀∝ᕆᕈ⤟Ἳࠍว૬ߒߚ᦭ᯏῂਛ
1㧕 ╙ 18 ࿁ᣣᧄᕆᕈⴊᶧᵺൻቇળቇⴚ㓸ળ(ᐔᚑ 19 ᐕ 10 ᦬㧘ᄢಽ㧘
Ქߩ 1 ଀‫ޠ‬Ṷ⠪)㐳ደ⡡৻㇢㧦
1㧕 ╙ 34 ࿁ᣣᧄ㓸ਛᴦ≮කቇળቇⴚ✚ળ(ᐔᚑ 19 ᐕ 3 ᦬㧘␹ᚭ㧘ࠪࡦࡐࠫ࠙ࡓ‫ޟ‬ጘ㒂ᄢቇකቇㇱ㒝ዻ∛㒮 ICU/HCU ߦ߅ߌࠆ㔚ሶࠞ࡞࠹ㆇ↪ߩ⃻⁁‫ޠ‬Ṷ⠪)ฬ⍮ ␽㧦
1㧕 ╙ 3 ࿁ ICLS ࠪࡦࡐࠫ࠙ࡓ(1st announcement)(ᐔᚑ 19 ᐕ 9 ᦬㧘ฬฎደ㧘ࠪࡦࡐࠫ࠙ࡓ‫ޟ‬ALS ᵴേࠍᐢ߼ࠆὑߩᣇᴺ⺰ ࠟࠗ࠼࡜ࠗࡦᡷቯᓟߩጘ㒂⋵ਅߩ⃻⁁㨪ACLS ጘ㒂ߩᵴേࠍㅢߒߡ㨪‫ޠ‬Ṷ⠪)8㧚ቇⴚ⾨╬ߩฃ⾨⁁ᴫߥߒ9㧚␠ળᵴേዊୖ⌀ᴦ㧦
1㧕 ╙ 28 ᦼ᧲੩ᶖ㒐ᐡᢇᕆᬺോᙣ⹤ળᆔຬ(㨪⃻࿷)2㧕 ጘ㒂⋵࿖᳃଻⼔ද⼏ળᆔຬ(㨪⃻࿷)3㧕 ጘ㒂⋵ࡔ࠺ࠖࠞ࡞ࠦࡦ࠻ࡠ࡯࡞ද⼏ળᆔຬ(㨪⃻࿷)4㧕 ጘ㒂⋵ᶖ㒐ᬺോᐢၞൻᬌ⸛ᆔຬળᆔຬ(㨪⃻࿷)5㧕 ጘ㒂⋵ᐢၞἴኂ࡮ᢇᕆක≮ᖱႎࠪࠬ࠹ࡓㆇ༡ᆔຬળᆔຬ(㨪⃻࿷)6㧕 ጘ㒂Ꮢᢇᕆᬺോኻ╷ද⼏ળᆔຬ(㨪⃻࿷)7㧕 NPO ᴺੱጘ㒂ᢇᕆἴኂක≮⎇ⓥ㐿⊒ᯏ᭴Ᏹോℂ੐(㨪⃻࿷)8㧕 ጘ㒂᧲ᵗකቇ⎇ⓥળ਎⹤ੱ(㨪⃻࿷)9㧕 ጘ㒂⋵࿾㔡㒐ἴⴕേ⸘↹ࡈࠜࡠ࡯ࠕ࠶ࡊᆔຬળᆔຬ(㨪⃻࿷)⼾↰ᴰ㧦
1㧕 ጘ㒂Ꮢᢇᕆᬺോ㜞ᐲൻᬌ⸛ᆔຬળᆔຬ(㨪⃻࿷)2㧕 ጘ㒂࿾ၞࡔ࠺ࠖࠞ࡞ࠦࡦ࠻ࡠ࡯࡞ද⼏ળᆔຬ(㨪⃻࿷)
3㧕 NPO ᴺੱጘ㒂ᢇᕆἴኂක≮⎇ⓥ㐿⊒ᯏ᭴ℂ੐(㨪⃻࿷)ศ↰㓉ᶈ㧦1㧕 ጘ㒂࿾ၞࡔ࠺ࠖࠞ࡞ࠦࡦ࠻ࡠ࡯࡞૕೙ଥࠆᬌ⸽කᏧ(2007㨪⃻࿷)㧙㧙㜞ᰴᢇ๮ᴦ≮࠮ࡦ࠲࡯㧦1㧕 ࠗࡆ࠺ࡦࠬࡍࠪࡖ࡞ NOKIA ࠬࡁ࡯ࡏ࡯࠼ FIS ࡢ࡯࡞࠼ࠞ࠶ࡊ 2008GIFU/GUJO ᄢળ DMAT 㓌
ຬᵷ㆜(2008 ᐕ 2 ᦬ 22 ᣣ㨪2 ᦬ 24 ᣣ)
10㧚ႎ๔ᦠ
1㧕 ዊự໪ᰴ㧘⑔↰లብ㧘㋈Ꮉᱜਯ㧘ዊୖ⌀ᴦ㧘㜞ጊ㓳ੱ㧘੹㆏⧷⑺㧘Ỉ↰ദ㧦߳߈࿾࡮㔌ፉᢇᕆක≮૕೙ߦ߅ߌࠆᢇᕆක≮ᯏ㑐ߩㅪ៤ߣᖚ⠪ߣක≮⾗Ḯߩ㓸⚂ൻߦ㑐ߔࠆ⎇ⓥ㧦ෘ↢ഭ௛⑼ቇ⎇ⓥ⾌⵬ഥ㊄ ಽᜂ⎇ⓥႎ๔ᦠ(⑔↰⃰)㧦97㧙107(2007 ᐕ 3 ᦬ 1 ᣣ)
11㧚ႎ㆏
1㧕 ዊୖ⌀ᴦ㧦࿯ᦐ࡜ࠫࠝ߆ࠊࠄ 㧦ጘ㒂࡜ࠫࠝ(2006 ᐕ 1 ᦬ 1 ᣣ㨪⃻࿷ Ფ᦬ 1 ࿁)
2㧕 ዊୖ⌀ᴦ㧦Weekly file ߉߰ ߉߰ࠍࠃ߻ 㜞ᐲᢇ๮ᢇᕆ࠮ࡦ࠲࡯⹺ቯ㧦ጘ㒂᡼ㅍ(2006 ᐕ 2 ᦬ 10 ᣣ)
3㧕 ጊ↰ታ⾆ੱ㧦4 ᣣߦో࿖⧎Ἣᄢળ ක≮࠴࡯ࡓᧄㇱߦᓙᯏ ጘ㒂ᄢਁ৻ߦ஻߃㧦ጘ㒂ᣂ⡞(2007 ᐕ 8
᦬ 2 ᣣ)
4㧕 ዊୖ⌀ᴦ㧦ᢇᕆක≮ߪᤨ㑆ߣߩ㑵޿㧦ጘ㒂ᣂ⡞(2007 ᐕ 10 ᦬ 28 ᣣ)
5㧕 ዊୖ⌀ᴦ㧦ᢇᕆක≮ߪᤨ㑆ߣߩ㑵޿㧦ਛᣣᣂ⡞(2007 ᐕ 10 ᦬ 30 ᣣ)
6㧕 ዊୖ⌀ᴦ㧦ഥ߆ࠆ๮ഥߌࠆ૶๮㧦⺒ᄁᣂ⡞(2008 ᐕ 1 ᦬ 4 ᣣ)
7㧕 ዊୖ⌀ᴦ㧦ᢇᕆߦᰳ߆ߖߧሽ࿷㧦ጘ㒂ᣂ⡞(2008 ᐕ 1 ᦬ 5 ᣣ)
8㧕 ዊୖ⌀ᴦ㧦ᕆ∛ੱᗐቯߒ៝ㅍ⸠✵㧦ጘ㒂ᣂ⡞(2008 ᐕ 1 ᦬ 23 ᣣ)
9㧕 ዊୖ⌀ᴦ㧦ᢇᕆߚࠄ޿࿁ߒ㒐ߍ㧦⺒ᄁᣂ⡞(2008 ᐕ 1 ᦬ 25 ᣣ)
10㧕 ዊୖ⌀ᴦ㧦࠾ࡘ㧙ࠬ 9㧦NHK(2008 ᐕ 3 ᦬ 10 ᣣ)
11㧕 ዊୖ⌀ᴦ㧦ႎ㆏ࠬ࠹㧙࡚ࠪࡦ㧦࠹࡟ࡆᦺᣣ(2008 ᐕ 3 ᦬ 20 ᣣ)
12㧕 ዊୖ⌀ᴦ㧦ࡎ࠶࠻ࠗࡉ࠾ࡦࠣ㧦NHK(2008 ᐕ 6 ᦬)
13㧕 ዊୖ⌀ᴦ㧦ႎ㆏ࠬ࠹㧙࡚ࠪࡦ㧦࠹࡟ࡆᦺᣣ(2008 ᐕ 10 ᦬ 20 ᣣ)
14㧕 ዊୖ⌀ᴦ㧦ἴኂႎ㆏࠼ࠠࡘࡔࡦ࠲࡝㧙㧦ᣣᧄ࠹࡟ࡆ(2008 ᐕ 12 ᦬ 7 ᣣ)
15㧕 ዊୖ⌀ᴦ㧦․࠳ࡀ ᅧᇚᢇᕆ૕೙㨪ߥߗጘ㒂⋵ߢ߁߹ߊ޿ߞߡ޿ࠆߩ߆㨪㧦ࡈࠫ࠹࡟ࡆ(2008 ᐕ 12
᦬ 8 ᣣ)
16㧕 ዊୖ⌀ᴦ㧦ࡎ࠶࠻ࠗࡉ࠾ࡦࠣ ੍▚ડ↹࡮ᢇᕆࠪࠬ࠹ࡓ㧦NHK(2008 ᐕ 12 ᦬ 22 ᣣ)
12㧚⥄Ꮖ⹏ଔ
⹏ଔ೨ㅀߩ⋡⊛ߦᴪߞߚ⎇ⓥࠍዷ㐿ߔࠆḰ஻߇ᢛ޿ᆎ߼ߡ߅ࠅ㧘⃻⁁ߢߩ⹏ଔߪࠃ߁߿ߊ෸╙ὐߢ޽ࠆ‫ޕ‬⃻⁁ߩ໧㗴ὐ෸߮ߘߩኻᔕ╷⥃ᐥᬺോ߇ᄙᔔߢ޽ࠅ㧘⎇ⓥߩߚ߼ߩᤨ㑆ࠍขࠅߠࠄ޿ߩ߇⃻⁁ߢ޽ࠆ‫੹ޕ‬ᓟߪ⥃ᐥ㕙ࠍ߅ࠈߘ߆ߦ
ߒߥ޿▸࿐ߢ㧘ࠬ࠲࠶ࡈࠍჇടߒߡ⎇ⓥࠍዷ㐿ߒߚ޿‫ޕ‬੹ᓟߩዷᦸ೨⸥ߩࠃ߁ߥ⃻⁁ߢ޽ࠆ߇㧘ᓢ‫ߦޘ‬ᢎ⢒ࠬ࠲࠶ࡈ߇Ⴧടߒߡ߅ࠅ੹ᓟߪߐࠄߦၮ␆⻠ᐳߣ߽ࠦ࡜ࡏ࡟
࡯࠻ߒߡ⎇ⓥࠍଦㅴߒߚ޿‫ޕ‬㧙㧙㧔6㧕ᴺකቇಽ㊁1㧚⎇ⓥߩ᭎ⷐ
ߎࠇ߹ߢߣห᭽‫ޕ‬ᴺක∛ℂቇ⊛ߥ⎇ⓥߣߒߡߪ㧘ᓥ᧪ߪᱫᓟߩⷺ⤑ᷙỘߩߚ߼㧘⌒⃿ࠍ೪಴ߒߥߌࠇ߫
ⷰኤߢ߈ߥ߆ߞߚ⌒ౝᚲ⷗ࠍ⌒⑼ᚻⴚ⊛ߦ㐿⊒ߐࠇߚవ┵ᓘ߇ 0.9 mm ߩౝⷞ㏜ࠍ↪޿ߡ⸃೬ᤨߦⷰኤߒ㧘⌒ᐩ಴ⴊ╬ߩ⊒↢ߣᱫ࿃߿ฃߌߚ៊்ߣߩ㑐ଥ㧘ߘߩᗧ⟵╬ߦߟ޿ߡᬌ⸛ߒ㧘⌒ᐩ಴ⴊߪ㗡⬄ౝ಴ⴊ߿㗪ㇱ࿶ㄼߦࠃࠆ⓸ᕷᱫ଀╬ߦ㜞㗫ᐲߦ⹺߼ࠄࠇࠆߩߦኻߒ㧘߁ߞⴊ੃㗡ߪ㗡⬄ౝ಴ⴊᱫ଀ߢߪ⹺߼ࠄࠇࠆ߇㧘㗪ㇱ࿶ㄼߦࠃࠆ⓸ᕷᱫ଀ߢߪ⹺߼ࠄࠇߥ޿ߎߣࠍ᣿ࠄ߆ߦߒ㧘߹ߚ㧘ṃᱫ଀ߦ߅޿ߡ߽㜞㗫ᐲߦ⌒ᐩ಴ⴊ߇⹺߼ࠄࠇࠆߎߣࠍᣂ⍮⷗ߣߒߡႎ๔ߔࠆߎߣ߇ߢ߈ߚ‫ߚ߹ޕ‬㧘⓭ὼᱫߩේ࿃ߣߒߡߩ౰േ⣂ᄸᒻߩᗧ⟵߿⥌๮⊛ਇᢛ⣂ߦ߅ߌࠆᔃ⤳ߩ⚵❱ቇ⊛ᄌൻߦߟ޿ߡ╬ߩ⎇ⓥࠍⴕߞߚ‫ޕ‬DNA ᄙဳߦ㑐ߔࠆ⎇ⓥߢߪ㧘ࡒ࠻ࠦࡦ࠼࡝ࠕ DNA 㜞ᄌ⇣㗔ၞߩႮၮ㈩೉⸃ᨆߥࠄ߮ߦ STR㧔short tandem repeat㧕ᄙဳߩ಴⃻㗫ᐲ߿ᄙဳ᭴ㅧߩ⸃ᨆࠍⴕ޿㧘DNA 㐓ቯߦ߅޿ߡᔅⷐߣߥࠆ㧘ጘ㒂⋵࿷૑ߩᣣᧄੱ㓸࿅ࠍኻ⽎ߣߒߚ࠺࡯࠲
ࡌ࡯ࠬࠍ᭴▽ߔࠆߎߣ߇ߢ߈ߚ‫ߚ߹ޕ‬㧘ࡒ࠻ࠦࡦ࠼࡝ࠕ DNA HVIII 㗔ၞߦሽ࿷ߔࠆ length heteroplasmyߩ᭴ㅧࠍ⸃ᨆߒ㧘ߘߩᴺකቇ⊛ᔕ↪ߦߟ޿ߡ⎇ⓥߒߚ߶߆㧘X ᨴ⦡૕਄ߩ STR ᐳ૏ߩᣣᧄੱ㓸࿅ߦ߅ߌࠆ㜞ᐲߥ᭴ㅧᄙဳࠍ᣿ࠄ߆ߦߒ㧘ߘߩੱ㘃ㆮવቇ⊛⸃ᨆ߽ⴕߞߚ‫ޕ‬
2㧚ฬ★
ᢎ᝼㧦
ഥᢎ㧦

ᱞౝᐽ㓶
᳗੗ ᷕ

Yasuo Bunai
Atsushi Nagai

3㧚⎇ⓥᚑᨐߩ⊒⴫⪺ᦠ㧔๺ᢥ㧕
ߥߒ⪺ᦠ㧔᰷ᢥ㧕
ߥߒ✚⺑㧔๺ᢥ㧕
1㧕 ਛጊ㓷ᒄ㧘ਛᎹ ⡡㧘㕍ᧁᐽඳ㧘ട⮮Ⓑሶ㧘㥲⮮৻ਯ㧘㜞᎑ᐘ↵㧘ᚭ⧛ ഃ㧘⊛႐᪞ᰴ㧘ዊ଻ౝବ㓷㧘ർፉඳਯ㧘ዊᨋᐾᰴ㧘ੳᔒ↰ඳม㧘ᱞౝᐽ㓶㧘ጊධ⽵ᄦ㧚੃ᐜఽ⓭ὼᱫ∝୥⟲(SIDS)⸻ᢿߩᚻᒁ߈ ᡷ⸓╙
2 㧘ᣣᧄ SIDS ቇળ㔀⹹ 2006 ᐕ㧧6 Ꮞ㧦73㧙97㧚
2㧕 ᱞౝᐽ㓶㧚⓸ᕷ߹ߚߪ⯦ᓙߣ⓭ὼᱫ㧘ᣣᧄ SIDS ቇળ㔀⹹ 2007 ᐕ㧧7 Ꮞ㧦44㧙47㧚
✚⺑㧔᰷ᢥ㧕
ߥߒේ⪺㧔๺ᢥ㧕
ߥߒේ⪺㧔᰷ᢥ㧕
1㧕 Tsujinaka M, Bunai Y. Postmortem ophthalmologic examination by endoscopy. Am J Forensic Med
Pathol. 2006;27:287-291.
2㧕 Nagai A, Nakamura I, Bunai Y. Analysis of the HVI, HVII and HVIII regions of mtDNA in 400
unrelated Japanese. Prog Forensic Genet. 2006;11:139-141.
3㧕 Endo S, Matsunaga T, Horie K, Tajima K, Bunai Y, Carbone V, El-Kabbani O, Hara A. Enzymaticcharacteristics of an aldo-keto reductase family protein (AKR1C15) and its localization in rat tissues.
Arch Biochem Biophys. 2007;465:136-147.
4㧕 Bunai Y, Akaza K, Tsujinaka M, Nakamura I, Nagai A, Jiang W-X, Mizoguchi Y, Ohya I. Sudden death
due to undiagnosed intracranial hemangiopericytoma. Am J Forensic Med Pathol. 2008;29:170-172.
5㧕 Bunai Y, Akaza K, Jiang WX, Nagai A. Fatal hyperthermia associated with excited delirium during anarrest. Leg Med. 2008;10:306-309.
6㧕 Chen H, Shoumura S, Emura S, Bunai Y. Regional variations of vertebral trabecular bone
microstructure with age and gender. Osteoporos Int. 2008;19:1473-1483.
7㧕 Nagai A, Bunai Y. Analysis of mtDNA HVIII length heteroplasmy. Forensic Science International:
Genetics Supplement Series. 2008;1:290-291.

㧙㧙

IF 0.603

IF 2.969
IF 0.603

IF 3.893

4㧚⎇ⓥ⾌₪ᓧ⁁ᴫ
1㧕┹੎⊛⾗㊄1㧕 ⎇ⓥઍ⴫⠪㧦ᱞౝᐽ㓶㧧⑼ቇ⎇ⓥ⾌⵬ഥ㊄ၮ⋚⎇ⓥ(C)(2)⌒⑼↪ౝⷞ㏜ࠍ↪޿ߡߩᴺක೬ᬌ଀ߦ߅ߌ
ࠆ⌒ᐩᚲ⷗ߩᗧ⟵ߩᬌ⸛㧧ᐔᚑ 19㧙20 ᐕᐲ㧧1,840 ජ౞(1,040 ජ౞㧦800 ජ౞)
2㧕ฃ⸤⎇ⓥ1㧕 ᱞౝᐽ㓶㧦⮎Ქ‛ᬌᩏ╬ฃ⸤੐ᬺ⾌㧧ᐔᚑ 18 ᐕᐲ㧧3,611 ජ౞㧦ጘ㒂⋵⼊ኤᧄㇱ
2㧕 ᱞౝᐽ㓶㧦⮎Ქ‛ᬌᩏ╬ฃ⸤੐ᬺ⾌㧧ᐔᚑ 19 ᐕᐲ㧧5,156 ජ౞㧦ጘ㒂⋵⼊ኤᧄㇱ
3㧕 ᱞౝᐽ㓶㧦⮎Ქ‛ᬌᩏ╬ฃ⸤੐ᬺ⾌㧧ᐔᚑ 20 ᐕᐲ㧧3,270 ජ౞(12 ᦬⃻࿷)㧦ጘ㒂⋵⼊ኤᧄㇱ3㧕౒ห⎇ⓥߥߒ
5㧚⊒᣿࡮․⸵಴㗿⁁ᴫߥߒ
6㧚ቇળᵴേ
1㧕ቇળᓎຬᱞౝᐽ㓶㧦
1㧕 ᣣᧄᴺකቇળ⹏⼏ຬ(㨪⃻࿷)2㧕 ᴺක∛ℂ⎇ⓥળㆇ༡ᆔຬ(㨪⃻࿷)3㧕 ᣣᧄ SIDS ቇળ⹏⼏ຬ(㨪⃻࿷)4㧕 ᣣᧄ SIDS ቇળ∝଀ᬌ⸛ᆔຬ(㨪⃻࿷)5㧕 ᣣᧄ SIDS ቇળ⸻ᢿၮḰᬌ⸛ᆔຬ(㨪⃻࿷)2㧕ቇળ㐿௅ᱞౝᐽ㓶㧦
1㧕 ╙ 14 ࿁ᣣᧄ SIDS(੃ᐜఽ⓭ὼᱫ∝୥⟲)ቇળቇⴚ㓸ળ(ᐔᚑ 20 ᐕ 3 ᦬㧘ጘ㒂)
3㧕ቇⴚ㔀⹹
ᱞౝᐽ㓶㧦
1㧕 ᴺක∛ℂ㧧✬㓸ᆔຬ㐳(㨪⃻࿷)2㧕 Legal Medicine㧧Editorial Board(㨪⃻࿷)7㧚ቇળ᜗ᓙ⻠Ṷ㧘᜗ᓙࠪࡦࡐࠫࠬ࠻㧘ᐳ㐳ᱞౝᐽ㓶㧦
1㧕 ᴺක∛ℂ⎇ⓥળ╙ 13 ࿁ᄐᦼ࠮ࡒ࠽࡯(2006 ᐕ 7 ᦬㧘ጘ㒂㧘․೎⻠ṶΣ‫♧ޟ‬ዩ∛ౝಽᴲ∔ᖚߦࠃࠆ⓭ὼᱫ‫ޠ‬ᐳ㐳)2㧕 ᴺක∛ℂ⎇ⓥળ╙ 13 ࿁ᄐᦼ࠮ࡒ࠽࡯(2006 ᐕ 7 ᦬㧘ጘ㒂㧘․೎⻠ṶΥ‫ޟ‬SIDS ߣవᄤઍ⻢⇣Ᏹ‫ޠ‬ᐳ㐳)
3㧕 ╙ 13 ࿁ᣣᧄ SIDS(੃ᐜఽ⓭ὼᱫ∝୥⟲)ቇળቇⴚ㓸ળ(2007 ᐕ 3 ᦬㧘⑔ጟ㧘ࠪࡦࡐࠫ࠙ࡓ‫੃ޟ‬ᐜఽ⓭ὼᱫ∝୥⟲ߩ⊒↢ⷐ࿃ߣ੍㒐㧙㘃✼∔ᖚ‫ޔ‬੐᡿ᱫ߿⯦ᓙߣߩ㐓೎߽฽߼ߡ㧙‫ޠ‬Ṷ⠪)
4㧕 ╙ 14 ࿁ᣣᧄ SIDS(੃ᐜఽ⓭ὼᱫ∝୥⟲)ቇળቇⴚ㓸ળ(2008 ᐕ 3 ᦬㧘ጘ㒂㧘ᢎ⢒⻠Ṷ‫੹ޟ‬ᣣߩᐜఽ࡮
ఽ┬⯦ᓙߣߘߩ⢛᥊‫ޠ‬ᐳ㐳)᳗੗ ᷕ㧦
1㧕 ᣣᧄᲫ㜬⟤ኈቇળ╙ 2 ࿁ቇⴚᄢળ(2008 ᐕ 2 ᦬㧘ᵿ᧻㧘ᢎ⢒⻠Ṷ‫ޟ‬Ძ㜬ߣ⊹⤏㧙േ‛ߩਇᕁ⼏㧙‫ޠ‬ᐳ㐳)
2㧕 ᣣᧄᲫ㜬⟤ኈቇળ╙ 2 ࿁ቇⴚᄢળ(2008 ᐕ 2 ᦬㧘ᵿ᧻㧘ᢎ⢒⻠Ṷ‫ⴊޟ‬ᶧߢⷫሶࠍ᳿߼ࠆ‫ޠ‬ᐳ㐳)
3㧕 ᣣᧄᲫ㜬⟤ኈቇળ╙ 2 ࿁ቇⴚᄢળ(2008 ᐕ 2 ᦬㧘ᵿ᧻㧘ᢎ⢒⻠Ṷ‫ޟ‬㜬ߩᲫ 1 ᧄߢ“޽ߥߚ”߇ࠊ߆ࠆ㧙Ძ㜬ߣ DNA ಽᨆ㧙‫ޠ‬Ṷ⠪)㧙㧙8㧚ቇⴚ⾨╬ߩฃ⾨⁁ᴫߥߒ9㧚␠ળᵴേᱞౝᐽ㓶㧦
1㧕 ጘ㒂⋵౏ኂክᩏળᆔຬ(㨪⃻࿷)10㧚ႎ๔ᦠߥߒ11㧚ႎ㆏
1㧕 ᱞౝᐽ㓶㧦⓸ᕷ࡮⯦ᓙ㧙ᓸ⚦ߥᄌൻߦ߽ᵈᗧ߇ᔅⷐ㧦Medical Tribune(2007 ᐕ 5 ᦬ 17 ᣣ)
12㧚⥄Ꮖ⹏ଔ
⹏ଔᐕ㑆 70㨪80 ૕ߩᴺක⸃೬ߩ㐓ቯࠍབྷ⸤ߐࠇߡ߅ࠅ㧘⸃೬߿ߘߩᓟߩᬌᩏ㧘㐓ቯᦠ૞ᚑ╬ߩߚ߼⎇ⓥߩ
ߚ߼ߩᤨ㑆߇೙⚂ߐࠇߡ޿ࠆ߇㧘ߘࠇߥࠅߩᚑᨐࠍ޽ߍࠄࠇߚߣᕁߞߡ޿ࠆ‫ޕ‬⃻⁁ߩ໧㗴ὐ෸߮ߘߩኻᔕ╷ᴺකቇಽ㊁ߢߪ㧘⃻࿷ 2 ฬߩᢎຬ߇ᢎ⢒࡮⎇ⓥ࡮ታോߦᓥ੐ߒߡ߅ࠅ㧘⎇ⓥߥߤߩ㕙ߢߪ࿖ౝᄖ߆ࠄ
⋧ᔕߩ⹏ଔࠍฃߌߡ޿ࠆ‫ࠄ߇ߥߒ߆ߒޕ‬㧘⎇ⓥ㗔ၞ߇߿߿࿕ቯൻߒߡ߈ߡ޿ࠆߎߣߪุ߼ߕ㧘߹ߚ㧘ੱ੐߇࿕ቯൻߒߟߟ޽ࠆߣ޿߁໧㗴ὐ߽޽ࠆ‫ߢߎߘޕ‬㧘੹ᓟߪቇᄖߣߩ౒ห⎇ⓥࠍ⋡ᜰߒߥ߇ࠄ㧘ቇ໧ߩㅴᱠߦೣߒᣂߒ޿⎇ⓥᚻᴺࠍขࠅ౉ࠇ㧘ᤨઍߩ௑ะߦೣߒߡ⎇ⓥಽ㊁ࠍᐢߍࠆᔅⷐ߇޽ࠆߣ⠨߃ࠄࠇࠆ‫ޕ‬߹ߚ㧘ᧄಽ㊁ߦᣂߒ޿ᕷ็ࠍᒁ߈⿠ߎߔߚ߼ߦ㧘ᄢቇ㒮↢߇౉ቇߒ߿ߔ޿ⅣႺߣ⸳஻ࠍᢛ߃ࠆߎߣ߇ᕆ
ോߢ޽ࠆߣ⠨߃ࠄࠇࠆ‫ޕ‬੹ᓟߩዷᦸᴺක∛ℂቇ⊛ߥ⎇ⓥߣߒߡ㧘੹ᓟᄖ்ߩ∛ℂ㧘․ߦ㧘ฃ்ᓟᣧᦼߦ⿠ߎࠆᄌൻߦߟ޿ߡ㧘ಽሶ∛ℂቇ
⊛⎇ⓥࠍᆎ߼ߚ޿‫ޕ‬DNA ᄙဳߦ㑐ߔࠆ⎇ⓥߢߪ㧘ᒁ߈⛯߈ᣣᧄੱ㓸࿅ߦ߅ߌࠆ DNA ᄙဳߩ࠺࡯࠲ࡌ࡯
ࠬൻࠍㅴ߼ࠆߣߣ߽ߦ㧘୘ੱ⼂೎ߦ᦭↪ߥ DNA ᄙဳ㗔ၞߩᬌ⸛ߥࠄ߮ߦ DNA ᄙဳߩࠃࠅല₸⊛ߥᬌ಴ᴺߩ㐿⊒╬㧘਎⇇ߩ⿲൓ߦㆃࠇߕ㧘⎇ⓥࠍផㅴߒߡ޿߈ߚ޿‫ޕ‬㧙㧙㧔7㧕↥ᬺⴡ↢ቇಽ㊁1㧚⎇ⓥߩ᭎ⷐ
ⴡ↢ቇߪᐢ޿ᗧ๧ߢߩⅣႺߣࡅ࠻ߩ㑐ࠊࠅࠍ⸃ᨆߒ㧘ࡅ࠻ߩஜᐽߩ଻ᜬ࡮Ⴧㅴߦነਈߔࠆߎߣࠍ⋡⊛ߣߒߚታቇߢ޽ࠆ‫↢ⴡޕ‬ቇߪ൮᜝⊛ߥᔕ↪⑼ቇߢ޽ߞߡ㧘ၮ␆කቇߦዻߔࠆ߽ߩߢߪߥߊ㧘␠ળකቇߩ৻ಽ
㊁ߢ޽ࠆ‫ޕ‬ᓥߞߡ㧘␠ળߩⷐ⺧ߦⓍᭂ⊛ߦ╵߃ߡ޿߆ߥߊߡߪߥࠄߥ޿ኋ๮ߦ޽ࠆ‫⃻ޕ‬࿷ߩ↥ᬺⴡ↢ቇಽ㊁ߩ⎇ⓥౝኈߪ㧘⡯႐ߦ߅ߌࠆታ〣ᵴേࠍㅢߓߚ߽ߩߢ㧘એਅߩࠃ߁ߥ⎇ⓥࠍⴕߞߡ޿ࠆ‫ޕ‬
㧔1㧕ᑪ⸳ഭ௛⠪㧘㔚ᩇ㔚✢Ꮏ੐ᓥ੐⠪ߥߤߩደᄖഭ௛⠪ࠍኻ⽎ߦஜᐽ໧㗴㧘૞ᬺⅣႺ㧘ഭ௛᧦ઙߩᬌ⸛
ࠍⴕ޿㧘ᔟㆡ⡯႐ߠߊࠅߩߚ߼ߩ⎇ⓥ㧘
㧔2㧕ᾲਛ∝㧘ᝄേ㓚ኂ㧘㛍㖸ᕈ㔍⡬ߩ੍㒐ߩ⎇ⓥ㧘
㧔3㧕ฦ⒳⡯႐ߦ߅ߌࠆ⣶∩ࠍߪߓ߼ߣߒߚ╭㛽ᩰ♽㓚ኂ੍㒐ߩ⎇ⓥ㧘
㧔4㧕⡯႐ߩࡔࡦ࠲࡞ࡋ࡞ࠬߩ⎇ⓥ㧘
㧔5㧕කᏧࠍߪ
ߓ߼ߣߒߚක≮ᓥ੐⠪ߩஜᐽ㓚ኂ੍㒐ߩ⎇ⓥࠍⴕߞߡ޿ࠆ‫ޕ‬
2㧚ฬ★
ಎᢎ᝼㧦 ੗ᄹᵄ⦟৻

Ryoichi Inaba

3㧚⎇ⓥᚑᨐߩ⊒⴫⪺ᦠ㧔๺ᢥ㧕
1㧕 ੗ᄹᵄ⦟৻㧚ഭ௛ⴡ↢ኻ╷ߩၮᧄ㧦↥ᬺ଻ஜࡂࡦ࠼ࡉ࠶ࠢ✬㓸ᆔຬળ✬㧘↥ᬺ଻ஜࡂࡦ࠼ࡉ࠶ࠢ ᡷ⸓ 4㧘᧲੩㧦ഭ௛⺞ᩏળ㧧2006 ᐕ㧦7.
2㧕 ੗ᄹᵄ⦟৻㧚‫ޟ‬ஜᐽߠߊࠅߩߚ߼ߩㆇേᜰ㊎ 2006‫ߡ޿ߟߦޠ‬㧦↥ᬺ଻ஜࡂࡦ࠼ࡉ࠶ࠢ✬㓸ᆔຬળ✬㧘↥ᬺ଻ஜࡂࡦ࠼ࡉ࠶ࠢ ᡷ⸓ 5 㧘᧲੩㧦ഭ௛⺞ᩏળ㧧2007 ᐕ㧦35.
3㧕 ੗ᄹᵄ⦟৻㧚⡯႐ߩஜᐽ▤ℂ㧘ጘ㒂㧘(⽷)ጘ㒂⋵Ꮢ↸᧛ⴕ᡽ᖱႎ࠮ࡦ࠲࡯㧘2007 ᐕ㧦1㧙27.
4㧕 ੗ᄹᵄ⦟৻㧚‫ޟ‬቟ⴡᴺ਄ߩஜ⸻࡮଻ஜᜰዉߣ․ቯஜ⸻࡮․ቯ଻ஜᜰዉ‫ޠ‬㧦↥ᬺ଻ஜࡂࡦ࠼ࡉ࠶ࠢ✬㓸ᆔຬળ✬㧘↥ᬺ଻ஜࡂࡦ࠼ࡉ࠶ࠢ ᡷ⸓ 6 㧘᧲੩㧦ഭ௛⺞ᩏળ㧧2008 ᐕ㧦24.
⪺ᦠ㧔᰷ᢥ㧕
ߥߒ✚⺑㧔๺ᢥ㧕
1㧕 ੗ᄹᵄ⦟৻㧚ㆮ〔⊒ជ⃻႐ߩഭ௛⽶ᜂ㧙ᄐᦼߩᾲਛ∝ኻ╷㧙㧘ഭ௛ߩ⑼ቇ 2006 ᐕ㧧61 Ꮞ㧦626㧙629㧚
2㧕 ੗ᄹᵄ⦟৻㧚ㆮ〔⊒ជ⃻႐ߩഭ௛⽶ᜂ㧙౻ᦼߩ㒐ኙኻ╷㧙㧘ഭ௛ߩ⑼ቇ 2007 ᐕ㧧62 Ꮞ㧦174㧙176.
✚⺑㧔᰷ᢥ㧕
ߥߒේ⪺㧔๺ᢥ㧕
1㧕 ੗ᄹᵄ⦟৻㧘ᐢἑਁቲሶ㧘㤥Ꮉᷕ৻㧘੗਄⋿ੱ㧘ጤ↰ᒄᢅ㧚ᄢቇ↢ද⺞ℂ႐ᓥᬺຬߩᄐᦼߩ⥄ⷡ∝⁁ߣᥤᾲኻ╷㧘ᣣᧄ⡯ᬺ࡮ἴኂකቇળળ⹹ 2006 ᐕ㧧54 Ꮞ㧦18㧙24.
2㧕 ੗ᄹᵄ⦟৻㧘੗਄⋿ੱ㧚ၒ⬿ᢥൻ⽷⊒ជ⺞ᩏᯏ㑐ߦ߅ߌࠆഭ௛቟ోⴡ↢▤ℂߩታᘒ ╙ 2 ႎ㧘ᣣᧄ⡯ᬺ࡮ἴኂකቇળળ⹹ 2006 ᐕ㧧54 Ꮞ㧦262㧙267.
3㧕 ੗ᄹᵄ⦟৻㧘ᣣ⟎ᢕᏈ㧚⥄ᴦ૕ߦ߅ߌࠆ቟ోⴡ↢▤ℂᵴേߩታᘒ㧘ᣣᧄ⡯ᬺ࡮ἴኂකቇળળ⹹ 2007 ᐕ㧧
55 Ꮞ㧦39㧙48.
4㧕 ੗ᄹᵄ⦟৻㧘ᐢἑਁቲሶ㧘ዊ㊁᩵ሶ㧘㤥Ꮉᷕ৻㧘੗਄⋿ੱ㧚ደᄖ㔚ᩇ㔚✢Ꮏ੐ᓥ੐⠪ߩᄐᦼߩ⥄ⷡ∝⁁ߣᥤᾲኻ╷㧘ᣣᧄ⡯ᬺ࡮ἴኂකቇળળ⹹ 2007 ᐕ㧧55 Ꮞ㧦105㧙112.
5㧕 ੗ᄹᵄ⦟৻㧘ᮮጊ๺ੳ㧚⵾ㅧᎿ႐↵ᕈഭ௛⠪ߩ⡯႐ߩࡔࡦ࠲࡞ࡋ࡞ࠬኻ╷ߦ߅ߌࠆ࿾ၞߩ♖␹⑼࡮ක≮ᯏ㑐ߦኻߔࠆ㊀ⷞᐲߣḩ⿷ᐲߦ㑐ߔࠆ⺞ᩏ㧘ᣣᧄ⡯ᬺ࡮ἴኂකቇળળ⹹ 2007 ᐕ㧧55 Ꮞ㧦128㧙135.
6㧕 ੗ᄹᵄ⦟৻㧘㤥Ꮉᷕ৻㧘੗਄⋿ੱ㧚ᄢቇ∛㒮කᏧߩ㔌⡯㗿ᦸߣൕോ⁁ᴫ㧘ᣣᏱ↢ᵴ⠌ᘠ߅ࠃ߮⡯ᬺᕈࠬ࠻࡟ࠬߣߩ㑐ଥ㧘ᣣᧄ⡯ᬺ࡮ἴኂකቇળળ⹹ 2007 ᐕ㧧55 Ꮞ㧦219㧙225.
7㧕 ੗၂ㅢੱ㧘㒋ᧄ৻ᦶ㧘੗ᄹᵄ⦟৻㧚ᄐᦼߦ߅ߌࠆ಄ᚱⅣႺਅߩࠬ࡯ࡄ࡯ࡑ࡯ࠤ࠶࠻ᅚᕈᓥᬺຬࠍኻ⽎ߣߒߚ⫳᳇᷷ᾲࠪ㧙࠻ߩㆡ↪ലᨐ㧘ᣣᧄ⡯ᬺ࡮ἴኂකቇળળ⹹ 2007 ᐕ㧧55 Ꮞ㧦233㧙238.
8㧕 ੗ᄹᵄ⦟৻㧘੗਄⋿ੱ㧘ጤ↰ᒄᢅ㧚ᑪ‛⸃૕૞ᬺ⠪ߦ߅ߌࠆ౻ᦼߩ⥄ⷡ∝⁁⺞ᩏ ╙ 2 ႎ㧘ᣣᧄ⡯ᬺ࡮ἴኂකቇળળ⹹ 2007 ᐕ㧧55 Ꮞ㧦253㧙259.
9㧕 㤥Ꮉᷕ৻㧘੗਄⋿ੱ㧘੗ᄹᵄ⦟৻㧘ጤ↰ᒄᢅ㧚ࡔࡦ࠲࡞ࡋ࡞ࠬਇ⺞⠪߳ߩኻᔕ੐଀ࠍㅢߓߡ⡯႐ߢߩ໧㗴ὐࠍ⠨߃ࠆ㧘ᣣᧄ⡯ᬺ࡮ἴኂකቇળળ⹹ 2008 ᐕ㧧56 Ꮞ㧦53㧙61.
10㧕 ੗ᄹᵄ⦟৻㧘㤥Ꮉᷕ৻㧘੗਄⋿ੱ㧚᳃᦭ᨋᬺഭ௛⠪ߦ߅ߌࠆ౻ᦼߩ⥄ⷡ∝⁁ߣ㒐ኙኻ╷㧘ᣣᧄ⡯ᬺ࡮ἴኂකቇળળ⹹ 2008 ᐕ㧧56 Ꮞ㧦192㧙197.
ේ⪺㧔᰷ᢥ㧕
1㧕 Inaba R, Mirbod SM. Comparison of subjective symptoms and hot prevention measures in summer
between traffic control workers and construction workers in Japan. Ind Health. 2007;45:91-99.
IF 0.792㧙㧙4㧚⎇ⓥ⾌₪ᓧ⁁ᴫ
1㧕┹੎⊛⾗㊄1㧕 ⎇ⓥઍ⴫⠪㧦ᮮጊ๺ੳ(ਃ㊀ᄢቇᄢቇ㒮කቇ♽⎇ⓥ⑼)㧘⎇ⓥಽᜂ⠪㧦੗ᄹᵄ⦟৻㧧ෘ↢ഭ௛⑼ቇ⎇ⓥ
⾌⵬ഥ㊄㧦ഭ௛⠪ߩࡔࡦ࠲࡞ࡋ࡞ࠬኻ╷ߦ߅ߌࠆ࿾ၞ଻ஜ࡮ක≮ߣߩㅪ៤ߩ޽ࠅᣇߦ㑐ߔࠆ⎇ⓥ㧧
ᐔᚑ 16㧙18 ᐕᐲ㧧3,000 ජ౞(1,000㧦1,000㧦1,000 ජ౞)
2㧕 ⎇ⓥઍ⴫⠪㧦ᮮጊ๺ੳ(ਃ㊀ᄢቇᄢቇ㒮කቇ♽⎇ⓥ⑼)㧘⎇ⓥಽᜂ⠪㧦੗ᄹᵄ⦟৻㧧ෘ↢ഭ௛⑼ቇ⎇ⓥ
⾌⵬ഥ㊄㧦ഭ௛⠪ߩࡔࡦ࠲࡞ࡋ࡞ࠬਇ⺞ߩ੍㒐ߣᣧᦼᡰេ࡮੺౉ߩ޽ࠅᣇߦ㑐ߔࠆ⎇ⓥ㧧ᐔᚑ 20 ᐕᐲ㧧600 ජ౞2㧕ฃ⸤⎇ⓥߥߒ
3㧕౒ห⎇ⓥ1㧕 ੗ᄹᵄ⦟৻㧦߼ߋࠅ࠭ࡓ᷷ᾲࡄࡢ࡯ක≮ᯏེ෸߮ߘߩ᷷ᾲ㑐ㅪ㐿⊒ຠߩㆡ↪ലᨐ⺞ᩏ෸߮໪⊒㧧ᐔ
ᚑ 19 ᐕᐲ㧙20 ᐕᐲ㧧500 ජ౞㧦⧎₺ࡄ࡯࠰࠽࡞ࡋ࡞ࠬࠤࠕ⎇ⓥᚲ
5㧚⊒᣿࡮․⸵಴㗿⁁ᴫߥߒ
6㧚ቇળᵴേ
1㧕ቇળᓎຬ
੗ᄹᵄ⦟৻㧦
1㧕 ᣣᧄⴡ↢ቇળ⹏⼏ຬ(㨪⃻࿷)2㧕 ᣣᧄ↥ᬺⴡ↢ቇળઍ⼏ຬ(㨪⃻࿷)3㧕 ᣣᧄ᳃ᣖⴡ↢ቇળ⹏⼏ຬ(㨪⃻࿷)4㧕 ᣣᧄ᷷ᴰ᳇୥‛ℂකቇળ⹏⼏ᆔຬ(㨪⃻࿷)2㧕ቇળ㐿௅
ߥߒ
3㧕ቇⴚ㔀⹹
੗ᄹᵄ⦟৻㧦
1㧕 ᣣᧄ᷷ᴰ᳇୥‛ℂකቇળ㔀⹹㧧✬㓸ᆔຬ(ᐔᚑ 19 ᐕ 5 ᦬㨪⃻࿷)7㧚ቇળ᜗ᓙ⻠Ṷ㧘᜗ᓙࠪࡦࡐࠫࠬ࠻㧘ᐳ㐳੗ᄹᵄ⦟৻㧦
1㧕 ╙ 3 ࿁੤ㅢ⑼ቇࠪࡦࡐࠫ࠙ࡓ㧙⡯ᬺㆇォᚻࠍ߅ߘ߁∛᳇(ᐔᚑ 20 ᐕ 2 ᦬㧘᧲੩㧘‫ࠢ࠶࡜࠻ޟ‬ㆇォᚻߩ⌁᳇⊒∝ߣ੤ㅢ੐᡿‫ޠ‬Ṷ⠪)8㧚ቇⴚ⾨╬ߩฃ⾨⁁ᴫߥߒ9㧚␠ળᵴേ
੗ᄹᵄ⦟৻㧦
1㧕 ᑪ⸳ᬺߦ߅ߌࠆஜᐽߠߊࠅߩ޽ࠅᣇߦ㑐ߔࠆ⺞ᩏ⎇ⓥᆔຬળᆔຬ(ᐔᚑ 18 ᐕᐲ)
2㧕 ᝄേ㓚ኂ╬ߩ㒐ᱛߦଥࠆ૞ᬺ▤ℂߩ޽ࠅᣇᬌ⸛ળᆔຬ(ෘ↢ഭ௛⋭)(ᐔᚑ 19 ᐕᐲ)
3㧕 ጘ㒂⋵⥄ὼⅣႺ଻ోᆔຬળᆔຬ(ᐔᚑ 20 ᐕᐲ)
4㧕 ጘ㒂ᏒⅣႺክ⼏ળᆔຬ(ᐔᚑ 20 ᐕᐲ)
5㧕 ↥ᬺ଻ஜ⋧⺣ຬ(ጘ㒂↥ᬺ଻ஜផㅴ࠮ࡦ࠲࡯)(ᐔᚑ 20 ᐕᐲ)
6㧕 ഭ௛ⴡ↢ᜰዉක(ጘ㒂ഭ௛ዪ)(ᐔᚑ 20 ᐕᐲ)
7㧕 ጘ㒂⋵ⅣႺᓇ㗀⹏ଔክᩏળᆔຬ(ᐔᚑ 20 ᐕᐲ)㧙㧙10㧚ႎ๔ᦠ
1㧕 ੗ᄹᵄ⦟৻㧦ഭ௛⠪ߩ⡯႐ߩࡔࡦ࠲࡞ࡋ࡞ࠬኻ╷ߦ߅ߌࠆ࿾ၞߩ♖␹⑼࡮ක≮ᯏ㑐ߦኻߔࠆ㊀ⷞᐲߣḩ⿷ᐲߦ㑐ߔࠆ⺞ᩏ ߘߩ 2㧦ᐔᚑ 17 ᐕᐲෘ↢ഭ௛⑼ቇ⎇ⓥ⾌⵬ഥ㊄ ✚᜝࡮ಽᜂ⎇ⓥႎ๔ᦠ㧦
97㧙111(2006 ᐕ 3 ᦬)
2㧕 ੗ᄹᵄ⦟৻㧦ഭ௛⠪ߩ⡯႐ߩࡔࡦ࠲࡞ࡋ࡞ࠬኻ╷ߦ߅ߌࠆ࿾ၞߩ♖␹⑼࡮ක≮ᯏ㑐ߦኻߔࠆ㊀ⷞᐲߣḩ⿷ᐲߦ㑐ߔࠆ⺞ᩏ ߘߩ 3㧦ᐔᚑ 18 ᐕᐲෘ↢ഭ௛⑼ቇ⎇ⓥ⾌⵬ഥ㊄ ✚᜝࡮ಽᜂ⎇ⓥႎ๔ᦠ㧦
73㧙94(2007 ᐕ 3 ᦬)
11㧚ႎ㆏
1㧕 ੗ᄹᵄ⦟৻㧘੗၂ㅢੱ㧦‫ޟ‬ㇱಽ᷷߼‫ޠ‬಄߃ㆊ߉㒐ߋ㧦⼛⾬ᣂ⡞(2008 ᐕ 8 ᦬ 27 ᣣ)
12㧚⥄Ꮖ⹏ଔ
⹏ଔ᭎ⷐߦ␜ߒߚᒰಽ㊁ߩ⎇ⓥࠍታᣉߒ㧘⺰ᢥࠍ૞ᚑߒߚ‫⺰ޕ‬ᢥߦߟ޿ߡ㧘ో૕ߩᢙߪචಽߛߣ⠨߃ࠄࠇࠆ߇㧘᰷ᢥ⺰ᢥ߇ዋߥ޿ߩߢ㧘ߎߩὐߩ޿ߞߘ߁ߩദജ߇ᔅⷐߢ޽ࠆ‫ޕ‬ᄖㇱ⾗㊄ߦߟ޿ߡߪ㧘ෘ↢ഭ௛⑼ቇ⎇ⓥ⾌⵬ഥ㊄㧘౒ห⎇ⓥ㧘ᅑቇነઃ㊄ࠍᓧߚ߇㧘੹ᓟᢥㇱ⑼ቇ⋭߆ࠄߩ⑼ቇ⎇ⓥ⾌⵬ഥ㊄ࠍ₪ᓧߔࠆᔅⷐ߇޽ࠆ‫␠ޕ‬ળᵴേߦߟ޿ߡߪචಽⴕࠊࠇߡ޿ࠆߣ⠨߃ߡ޿ࠆ‫ޕ‬⃻⁁ߩ໧㗴ὐ෸߮ߘߩኻᔕ╷ᢎຬ߇ 1 ฬߢࡑࡦࡄࡢ࡯ߦ໧㗴߇޽ࠅ㧘߹ߚ⎇ⓥቶ߇ᚻ⁜ߥߚ߼ታ㛎⊛⎇ⓥ߇߶ߣࠎߤߢ߈ߥ޿ߣ޿
߁໧㗴ὐ߇޽ࠆ‫ࠍࠇߎޕ‬ᛂ㐿ߔࠆߚ߼ߦᄢቇ㒮౉ቇߩ൘⺃߿㧘ઁಽ㊁㧘ઁᣉ⸳ߣߩ౒ห⎇ⓥߦജࠍ౉ࠇ
ߡ޿ࠆ‫ޕ‬
੹ᓟߩዷᦸ੹ᓟߣ߽㧘⡯႐ߩታ〣ᵴേࠍㅢߓߚ⎇ⓥࠍⴕ޿㧘ߘߩᚑᨐࠍ⡯႐ߦㆶరߒߚ޿‫ޕ‬ᒰ㕙㧘ᢎຬߩჇຬߪ
ᦸ߼ߥ޿ߩߢ㧘↥ᬺⴡ↢ߩ㊀ⷐᕈࠍᒝߊ⸷߃㧘߹ߚᄢቇ㒮↢㧘⎇ⓥ↢ߩฃߌ౉ࠇ߿ઁಽ㊁㧘ઁᣉ⸳ߣߩ
౒ห⎇ⓥߢᒰಽ㊁ߩ⊒ዷߩᵴ〝ࠍ⷗಴ߒߚ޿‫ޕ‬㧙㧙㧔8㧕කቇᢎ⢒ቇಽ㊁1㧚⎇ⓥߩ᭎ⷐ
ᐔᚑ 20 ᐕᐲ㧔2008 ᐕ 4 ᦬㧕ࠃࠅጘ㒂ᄢቇᄢቇ㒮කቇ♽⎇ⓥ⑼ක≮▤ℂቇ⻠ᐳߦ‫ޟ‬කቇᢎ⢒ቇ‫ޠ‬ಽ㊁߇㐿⻠ߐࠇߚ‫ޕ‬කቇᢎ⢒ቇߪ㧘කቇ࡮ක≮ᢎ⢒ಽ㊁ߦ߅ߌࠆᄙ㕙⊛ߥ⺖㗴ࠍⓥ᣿ߒ㧘ലᨐ⊛ߥᢎ⢒ᣇᴺࠍ⎇ⓥߔࠆቇ໧㗔ၞߢ޽ࠅ㧘කቇ࡮ක≮ᢎ⢒ࠍⴕ߁ߚ߼ߩౕ૕⊛⍮⼂߿ࠬࠠ࡞ߩ⠌ᓧࠍ߼ߑߒߡ޿ࠆ‫⺖ᧄޕ‬⒟ࠍୃੌߒߚ⠪ߪ㧘කቇᢎ⢒ቇߩኾ㐷ኅߣߒߡ㧘ᢎຬ࡮කᏧ࡮ቇ↢╬ࠍᜰዉߔࠆ⢻ജࠍ᦭ߒ㧘ᢎ⢒ࠪࠬ࠹ࡓࠍ⥄ࠄ᭴▽࡮ᡷༀߒ㧘⎇ⓥࠍㆀⴕߢ߈ࠆߎߣࠍ⋡ᮡߣߔࠆ‫ޕ‬කቇᢎ⢒㐿⊒⎇ⓥ࠮ࡦ࠲࡯ߪో࿖౒ห೑↪ᣉ⸳ߣߒߡᵴേߒߡ߅ࠅ㧘੹ᓟ㧘ో࿖߆ࠄߩᄢቇ㒮ᢎ⢒Ꮧᦸ⠪ߩฃߌ⋁ߣߒߡ߽ᯏ⢻ߒߡⴕ߈ߚ޿ߣ⠨߃ߡ
޿ࠆ‫ޕ‬
2㧚ฬ★
ᢎ᝼(૬છ)㧦 ㋈ᧁ ᐽਯ
ᢎ᝼(૬છ)㧦 ⮮ፒ ๺ᒾ
ᢎ᝼(૬છ)㧦 ਤ⠀ 㓷ਯ

Yasuyuki Suzuki
Kazuhiko Fujisaki
Masayuki Niwa

3㧚⎇ⓥᚑᨐߩ⊒⴫⪺ᦠ㧔๺ᢥ㧕
1㧕 ㋈ᧁᐽਯ㧚කቇᢎ⢒㧦ዊఽ⑼ቇ╙ 3 㧘᧲੩㧦කቇᦠ㒮㧧2008 ᐕ㧦309㧙313㧚
2㧕 ㋈ᧁᐽਯ㧘⮮ፒ๺ᒾ㧘ਤ⠀㓷ਯ✬㧚ᣂߒ޿කቇᢎ⢒ߩᵹࠇ̉07 ⑺́╙ 26 ࿁කቇᢎ⢒࠮ࡒ࠽࡯ߣࡢ࡯ࠢࠪ
࡚࠶ࡊߩ⸥㍳́㧘ฬฎደ㧦ਃᕺ␠㧧2008 ᐕ㧦1㧙100㧚
3㧕 ⮮ፒ๺ᒾ㧚ⴕേᄌኈࠍ߁ߥ߇ߔߚ߼ߩ㕙ធࠬࠠ࡞́଻ஜᜰዉኻੱេഥࠬࠠ࡞ߩቇ⠌́㧦ᣣᧄ↢ᵴදห⚵วㅪวળක≮ㇱળ㧧2008 ᐕ㧦1㧙45㧚
4㧕 ㋈ᧁᐽਯ㧘⮮ፒ๺ᒾ㧘ਤ⠀㓷ਯ✬㧚ᣂߒ޿කቇᢎ⢒ߩᵹࠇ̉08 ౻́╙ 27 ࿁කቇᢎ⢒࠮ࡒ࠽࡯ߣࡢ࡯ࠢࠪ
࡚࠶ࡊߩ⸥㍳́㧘ฬฎደ㧦ਃᕺ␠㧧2008 ᐕ㧦1㧙130㧚
5㧕 ㋈ᧁᐽਯ㧘⮮ፒ๺ᒾ㧘ਤ⠀㓷ਯ✬㧚ᣂߒ޿කቇᢎ⢒ߩᵹࠇ̉08 ᤐ́╙ 28 ࿁කቇᢎ⢒࠮ࡒ࠽࡯ߣࡢ࡯ࠢࠪ
࡚࠶ࡊߩ⸥㍳́㧘ฬฎደ㧦ਃᕺ␠㧧2008 ᐕ㧦1㧙152㧚
6㧕 ⮮ፒ๺ᒾ㧚ᖚ⠪́ක≮⠪㑐ଥ́㧦ᣣᧄ↥ᬺࠞ࠙ࡦ࠮࡝ࡦࠣቇળ✬㧚↥ᬺࠞ࠙ࡦ࠮࡝ࡦࠣㄉౖ㧦㊄ሶᦠᚱ㧧2008 ᐕ㧦74㧚⪺ᦠ㧔᰷ᢥ㧕
1㧕 Suzuki Y, Niwa M, Shibata T, Chirasak K, Ariyawardana A, Ramesh JC, Evans P, Takahashi Y.
Internet PBL: International Collaborative Learning Experiences In: Oon-Seng Tan, ed. Problem-based
Learning in E-learning Breakthroughs. Singapore: Thomson Learning;2007:131-146.
✚⺑㧔๺ᢥ㧕
1㧕 Ꮉ਄ߜ߭ࠈ㧘⮮ፒ๺ᒾ㧚ᮨᡆᖚ⠪ߩߚ߼ߩ‫ߩޠ࠻࡯ࠪࠢ࡯ࡢࠢ࠶ࡃ࠼࡯ࠖࡈޟ‬ឭ᩺㧘කቇᢎ⢒ 2008 ᐕ㧧
39 Ꮞ㧦417㧙420㧚
2㧕 ᮯ↰⟤㓶㧘ጟ↰శᒄ㧘੖ච፲⚛ሶ㧘ችፒᓀሶ㧘⌀㍿㒽ᄥ㇢㧘⮮ፒ๺ᒾ㧘ർ᧛㓉ᙗ㧘㜞ጊᥓሶ㧘ᄥ↰⢻㧘₹⟎ବᤩ㧘ኹ᎑ศ଻㧘㒙ㇱᥓᕺሶ㧘ፉ↰ᤘੳ㧘ዊᴰ⑲᮸㧚㜞╬ᢎ⢒ᡷ㕟ߩ⋧੕ⴕὑಽᨆ́ࡆ࠺ࠝ࡮ࠛࠬࡁࠣ
࡜ࡈࠖ࡯⎇ⓥߩ⁓޿ߣᎿቇㇱㇺᏒᎿቇṶ⠌ߩታ㓙́㧘ᄢቇᢎ⢒⎇ⓥࠫࡖ࡯࠽࡞ 2008 ᐕ㧧5 ภ㧦93㧙104㧚✚⺑㧔᰷ᢥ㧕
ߥߒේ⪺㧔๺ᢥ㧕
1㧕 ㋈ᧁᐽਯ㧘㜞ᯅቁ㓶㧘ਛ⇌㦖ବ㧘ᅏጊ⋿♿ሶ㧘᧻የ㓷ᢥ㧘ႇ ⵨ᐘ㧘੖ච፲㓉㧘ᴡ㊁㓁৻㧘ฎᎹ ẋ㧘ේኼ㇢㧚ᣣᧄዊఽ⑼ቇળᢎ⢒ᆔຬળႎ๔ ዊఽ⑼ත೨⥃ᐥታ⠌ߦ㑐ߔࠆࠕࡦࠤ࡯࠻⺞ᩏ⚿ᨐ㧘ᣣᧄዊఽ⑼ቇ
ળ㔀⹹ 2008 ᐕ㧧112 Ꮞ㧦793㧙801㧚
2㧕 㒙ㇱᕺሶ㧘⮮ፒ๺ᒾ㧘઻ାᄥ㇢㧚ᮨᡆᖚ⠪ߩදജࠍᓧߚり૕⸻ኤታ⠌ߩ੹ᓟߩᣇะᕈ㧘ᣣᧄ଻㒾ක≮ⴕേ⑼ቇቇળᐕႎ 2008 ᐕ㧧23 Ꮞ㧦59㧙73㧚ේ⪺㧔᰷ᢥ㧕
1㧕 Evans P, Suzuki Y. “Beyond Competence”. Why Should Outcomes be Adopted in Favour ofCompetences? Medical Education (Japan). 2008;39:87-91.
2㧕 Evans P, Suzuki Y.̌Beyond Competence̍, Assessment for Capability. Medical Education (Japan).
2008;39:93-96.
3㧕 Evans P, Suzuki Y, Begg M, Lam W. Can medical students from two cultures learn effectively from ashared web-based learning environment? Medical Education. 2008;42:27-33.
IF 2.562㧙㧙4㧚⎇ⓥ⾌₪ᓧ⁁ᴫ
1㧕┹੎⊛⾗㊄1㧕 ⎇ⓥઍ⴫⠪㧦㜞ᯅఝਃ㧘⎇ⓥදജ⠪㧦ਤ⠀㓷ਯ㧧⍮⊛ࠢ࡜ࠬ࠲࡯ഃᚑ੐ᬺ㧦‫ࡑ࡯࠹ޟ‬Σ㧦ૐଚⷅᓸ⚦ᚻⴚᡰេ࡮ᢎ⢒⸠✵ࠪࠬ࠹ࡓߩ㐿⊒㧦ක≮ᢎ⢒⸠✵ࡠࡏ࠶࠻‫ޠ‬㧧ᐔᚑ 19㧙20 ᐕᐲ㧧46,432 ජ౞(23,200㧦23,232 ජ౞)
2㧕 ⎇ⓥઍ⴫⠪㧦㋈ᧁᐽਯ㧧ᐔᚑ 19 ᐕᐲ ⃻ઍ⊛ᢎ⢒࠾࡯࠭ข⚵ᡰេࡊࡠࠣ࡜ࡓ(⃻ઍ GP)㧦‫⥃ޟ‬ᐥකቇ
ᢎ⢒ࠍᒝൻะ਄ߐߖࠆ ICT㧦e-Learning ߢၭ߁කߩᔃߣᛛ‫ޠ‬㧧ᐔᚑ 19㧙21 ᐕᐲ㧧69,973 ජ౞(23,993㧦21,980㧦24,000 ජ౞)
3㧕 ⎇ⓥઍ⴫⠪㧦㋈ᧁᐽਯ㧘⎇ⓥಽᜂ⠪㧦ട⮮ᥓ⟤㧘㒙ㇱᕺሶ㧧ᢥㇱ⑼ቇ⋭⑼ቇ⎇ⓥ⵬ഥ㊄ၮ⋚⎇ⓥ(C)(2)㧦
ዊఽ㗔ၞߦ߅ߌࠆቴⷰ⊛⥃ᐥ⢻ജ⹏ଔࠪࠬ࠹ࡓߩ㐿⊒㧧ᐔᚑ 20㧙22 ᐕᐲ㧧4,800 ජ౞(2,300㧦1,100㧦
700 ජ౞)4㧕 ⎇ⓥઍ⴫⠪㧦ᮯ↰⟤㓶(ᓼፉᄢቇ✚ว⑼ቇㇱ)㧘⎇ⓥಽᜂ⠪㧦⮮ፒ๺ᒾ㧧ᢥㇱ⑼ቇ⋭⑼ቇ⎇ⓥ⵬ഥ㊄ၮ⋚⎇ⓥ(B)(2)㧦㜞╬ᢎ⢒ᡷ㕟ߩࠦࡒࡘ࠾ࠤ࡯࡚ࠪࡦಽᨆ́⃻႐ߦ߅ߌࠆᢥൻᄌኈߩ⾰⊛ᬌ⸛́㧧ᐔᚑ
18㧙20 ᐕᐲ㧧14,500 ජ౞(5,100㧦4,800㧦4,800 ජ౞)
5㧕 ⎇ⓥઍ⴫⠪㧦㋈ᧁን㓶(ฬฎደᄢቇකቇㇱ㒝ዻ∛㒮✚ว⸻≮ㇱ)㧘⎇ⓥಽᜂ⠪㧦㒙ㇱᕺሶ㧘઻ାᄥ㇢㧧ᢥㇱ⑼ቇ⋭⑼ቇ⎇ⓥ⵬ഥ㊄ၮ⋚⎇ⓥ(C)(2)㧦ᣣᧄߩකቇᢎ⢒ߦ߅ߌࠆ 6 ᐕ㑆⛔วဳⴕേ⑼ቇᢎ⢒ࡊࡠࠣ࡜ࡓߩ㐿⊒ߦ㑐ߔࠆ⎇ⓥ㧧ᐔᚑ 18㧙20 ᐕᐲ㧧3,400 ජ౞(1,300㧦900㧦1,200 ජ౞)
6㧕 ⎇ⓥઍ⴫⠪㧦ᬀ᧛๺ᱜ(ฬฎደᄢቇකቇㇱකቇᢎ⢒࠮ࡦ࠲࡯)㧘⎇ⓥಽᜂ⠪㧦㒙ㇱᕺሶ㧘⨃ᧁ৾㚅㧧ᢥ
ㇱ⑼ቇ⋭⑼ቇ⎇ⓥ⵬ഥ㊄ၮ⋚⎇ⓥ(C)(2)㧦කቇ↢ߩ‫ޟ‬ᱫߩᢎ⢒‫ߩ߳ޠ‬ᮨᡆᖚ⠪ዉ౉ߩᢎ⢒⊛ലᨐߩ⎇ⓥ㧧ᐔᚑ 19㧙20 ᐕᐲ㧧2,870 ජ౞(1,417㧦1,453 ජ౞)
2㧕ฃ⸤⎇ⓥߥߒ
3㧕౒ห⎇ⓥߥߒ
5㧚⊒᣿࡮․⸵಴㗿⁁ᴫߥߒ
6㧚ቇળᵴേ
1㧕ቇળᓎຬ
㋈ᧁᐽਯ㧦1㧕 ᣣᧄකቇᢎ⢒ቇળℂ੐(㨪⃻࿷)⮮ፒ๺ᒾ㧦1㧕 ᣣᧄකቇᢎ⢒ቇળ⹏⼏ຬ㧘ℂ੐(㨪⃻࿷)2㧕 ᣣᧄකቇᢎ⢒ቇળᢎ᧚㐿⊒࡮SP ዊᆔຬળᆔຬ㐳(㨪⃻࿷)3㧕 ක≮ࠦࡒࡘ࠾ࠤ࡯࡚ࠪࡦ⎇ⓥળળ㐳(㨪⃻࿷)4㧕 ․ቯ㕖༡೑ᵴേᴺੱᣣᧄኅᐸක≮ቇળℂ੐(㨪ᐔᚑ 20 ᐕ 6 ᦬)
5㧕 ᣣᧄ␠ળකቇળ⹏⼏ຬ(㨪⃻࿷)6㧕 ᣣᧄක≮⚻ᷣቇળᐙ੐(㨪⃻࿷)7㧕 RIAS ⎇ⓥળળ㐳(ᐔᚑ 18 ᐕ 4 ᦬㨪⃻࿷)ਤ⠀㓷ਯ㧦
1㧕 ᣣᧄකቇᢎ⢒ቇળ⹏⼏ຬ(㨪⃻࿷)㒙ㇱᕺሶ㧦1㧕 Association of Standardized Patient Educators, International committee member(ᐔᚑ 19 ᐕ 11᦬㨪⃻࿷)2㧕 RIAS ⎇ⓥળᆔຬ(ᐔᚑ 18 ᐕ 4 ᦬㨪⃻࿷)㧙㧙

2㧕ቇળ㐿௅㋈ᧁᐽਯ㧦1㧕 ╙ 27 ࿁කቇᢎ⢒࠮ࡒ࠽࡯ߣࡢ࡯࡚ࠢࠪ࠶ࡊ(ᐔᚑ 20 ᐕ 1 ᦬㧘ฬฎደ)2㧕 ╙ 28 ࿁කቇᢎ⢒࠮ࡒ࠽࡯ߣࡢ࡯࡚ࠢࠪ࠶ࡊ(ᐔᚑ 20 ᐕ 5 ᦬㧘ᄢ㒋)3㧕 ጘ㒂ᄢቇᮨᡆᖚ⠪ߩળ 10 ๟ᐕ⸥ᔨࠪࡦࡐࠫ࠙ࡓ(ᐔᚑ 20 ᐕ 6 ᦬㧘ጘ㒂)
4㧕 ╙ 29 ࿁කቇᢎ⢒࠮ࡒ࠽࡯ߣࡢ࡯࡚ࠢࠪ࠶ࡊ(ᐔᚑ 20 ᐕ 8 ᦬㧘ጘ㒂)
5㧕 ╙ 30 ࿁කቇᢎ⢒࠮ࡒ࠽࡯ߣࡢ࡯࡚ࠢࠪ࠶ࡊ(ᐔᚑ 20 ᐕ 10 ᦬㧘᧲੩)⮮ፒ๺ᒾ㧘㒙ㇱᕺሶ㧦
1㧕 ╙ 3 ࿁ RIAS ࡢ࡯࡚ࠢࠪ࠶ࡊ(ᐔᚑ 20 ᐕ 10 ᦬㧘11 ᦬㧘ฬฎደ)
3㧕ቇⴚ㔀⹹
㋈ᧁᐽਯ㧦1㧕 Medical Education: Editor(2008 ᐕ㨪⃻࿷)7㧚ቇળ᜗ᓙ⻠Ṷ㧘᜗ᓙࠪࡦࡐࠫࠬ࠻㧘ᐳ㐳
㋈ᧁᐽਯ㧦
1㧕 ╙ 111 ࿁ᣣᧄዊఽ⑼ቇળቇⴚ㓸ળ(ᐔᚑ 20 ᐕ 4 ᦬㧘᧲੩㧘ᄢቇ∛㒮ߩ┙႐߆ࠄ⷗ߚᢎ⢒࡮⎇ⓥߦ߅ߌࠆ∛⸻ㅪ៤㧚✚วࠪࡦࡐࠫ࠙ࡓ 5‫࡮≮⸻ޟ‬ᢎ⢒࡮⎇ⓥࠍ߰߹߃ߚ∛⸻ㅪ៤ߩ⃻⁁ߣᧂ᧪‫ޠ‬Ṷ⠪)2㧕 23rd Annual Meeting of Korean Society of Medical Education. (2008.05, Seoul, Plenary Lecture:
Medical Education in Japan: past, present and future; Performer)
3㧕 ᧲ᶏർ㒽࿾඙⥃ᐥ⎇ୃ∛㒮⺑᣿ળ(ᐔᚑ 20 ᐕ 5 ᦬㧘ฬฎደ㧘‫ߩ᧪ᧂޟ‬ᣣᧄࠍഃࠆዊఽ⑼ක‫ޠ‬Ṷ⠪)
4㧕 ᐔᚑ 20 ᐕᐲጘ㒂⋵⋴⼔ᢎ⢒ㅪ⛊ද⼏ળ✚ળ(ᐔᚑ 20 ᐕ 6 ᦬㧘ጘ㒂㧘․೎⻠Ṷ‫⼔⋴ޟ‬ᢎ⢒ߦ߅ߌࠆᮨ
ᡆᖚ⠪ዉ౉ߩᗧ⟵‫ޠ‬Ṷ⠪)
5㧕 ╙ 40 ࿁ᣣᧄකቇᢎ⢒ቇળᄢળ(ᐔᚑ 20 ᐕ 7 ᦬㧘᧲੩㧘Medical Education in Korea: The Historicalbackground and the influence of U.S. by Myung-Hyun Chung㧚ᐳ㐳)‫ޟ‬කቇᢎ⢒ߦ߅ߌࠆዊఽ⑼කߩᓎഀ‫ޠ‬
6㧕 ╙ 122 ࿁ᣣᧄዊఽ⑼ቇળጤᚻ࿾ᣇળ(ᐔᚑ 20 ᐕ 12 ᦬㧘⋓ጟ㧘
Ṷ⠪)
㒙ㇱᕺሶ㧦
1㧕 ᗲ⍮ක⑼ᄢቇ SP 㙃ᚑ࠮ࡒ࠽࡯(ᐔᚑ 20 ᐕ 8 ᦬㧘ฬฎደ㧘⻠Ṷ‫ޟ‬ᣣᧄߣ਎⇇ߩ SP ੐ᖱ‫ޠ‬Ṷ⠪)2㧕 Association for Medical Education in Europe(2008.08, Prague Czech Republic, Pre-conference:High stakes, low stakes, the proof is in the pudding preparation for quality SP programs;
Performer)
3㧕 International Conference on Communication in Healthcare 2008 by European Association forCommunication in Healthcare (2008.09, Oslo Norway, Symposium-Developing a global networkof national RIAS centres-: RIAS Japan; Symposist)4㧕 ᐔᚑ 18㧙20 ᐕᣣᧄቇⴚᝄ⥝ળ⑼ቇ⎇ⓥ⵬ഥ㊄੤ઃ⎇ⓥ‫ޟ‬ᣣᧄߩකቇㇱᢎ⢒ߦ߅ߌࠆ 6 ᐕ㑆⛔วဳⴕ
േ⑼ቇᢎ⢒ࡊࡠࠣ࡜ࡓߩ㐿⊒ߦ㑐ߔࠆ⎇ⓥ‫ࡓ࠙ࠫࡐࡦࠪޠ‬㧦ත೨කቇᢎ⢒ߦ߅ߌࠆⴕേ⑼ቇᢎ⢒ࠪࡦࡐࠫ࠙ࡓ in NAGOYA(ᐔᚑ 20 ᐕ 11 ᦬㧘ฬฎደ㧘⻠Ṷ‫ޟ‬࿾ၞߢߩࠦࡒࡘ࠾ࠤ࡯࡚ࠪࡦᢎ⢒߇ᖱേߦਈ߃ࠆᓇ㗀ߣኅᣖ࡜ࠗࡈࠨࠗࠢ࡞ߣ޿߁ⷞὐߩᔅⷐᕈ㧦࿦ఽ࡮ᅧᇚߣߩ⛮⛯⊛੤ᵹ߆ࠄ‫ޠ‬Ṷ⠪)
5㧕 ╙ 2 ࿁ၯᮨᡆᖚ⠪㙃ᚑ࠮ࡒ࠽࡯(ᐔᚑ 20 ᐕ 11 ᦬㧘ၯ₹㧘‫ߩࠢ࠶ࡃ࠼࡯ࠖࡈޟ‬ၮᧄ‫ޠ‬Ṷ⠪)
6㧕 ╙ 11 ࿁ᣣᧄࠦࡒࡘ࠾ࠤ࡯࡚ࠪࡦቇળਛㇱ྾࿖ᡰㇱᄢળ࡮ක≮ࠦࡒࡘ࠾ࠤ࡯࡚ࠪࡦᢎ⢒⎇ⓥ࠮ࡒ࠽࡯(ᐔᚑ 20 ᐕ 11 ᦬㧘ᐢፉ㧘‫ޟ‬਎⇇ߩ SP ᵴേ㧦SP ߩṶᛛ࡮ࡈࠖ࡯࠼ࡃ࠶ࠢ‫ޠ‬Ṷ⠪)7㧕 ╙ 15 ࿁ක≮ࠦࡒࡘ࠾ࠤ࡯࡚ࠪࡦ⎇ⓥળ(ᐔᚑ 20 ᐕ 11 ᦬㧘ฬฎደ㧘‫ޟ‬AMEE࡮EACH ቇળႎ๔‫ޠ‬Ṷ⠪)8㧕 ╙ 2 ࿁ක≮ࠦࡒࡘ࠾ࠤ࡯࡚ࠪࡦ࡮ࡈࠔࠪ࡝࠹࡯࠲࡯㙃ᚑ࠮ࡒ࠽࡯(ᐔᚑ 20 ᐕ 12 ᦬㧘ฬฎደ㧘‫ޟ‬਎⇇
ߩ SP ᵴേ‫ޠ‬Ṷ⠪)⧯ᨋ⧷᮸㧦
1㧕 ᐔᚑ 18㧙20 ᐕᣣᧄቇⴚᝄ⥝ળ⑼ቇ⎇ⓥ⵬ഥ㊄੤ઃ⎇ⓥ‫ޟ‬ᣣᧄߩකቇㇱᢎ⢒ߦ߅ߌࠆ 6 ᐕ㑆⛔วဳⴕ
േ⑼ቇᢎ⢒ࡊࡠࠣ࡜ࡓߩ㐿⊒ߦ㑐ߔࠆ⎇ⓥ‫ࡓ࠙ࠫࡐࡦࠪޠ‬㧦ත೨කቇᢎ⢒ߦ߅ߌࠆⴕേ⑼ቇᢎ⢒ࠪࡦࡐࠫ࠙ࡓ in NAGOYA(ᐔᚑ 20 ᐕ 11 ᦬㧘ฬฎደ㧘⻠Ṷ‫ޟ‬ᣣᧄߦ߅ߌࠆ੹ᓟߩ⛔วဳⴕേ⑼ቇᢎ⢒㧙㧙ࠍ⠨߃ࠆ‫ޠ‬Ṷ⠪)8㧚ቇⴚ⾨╬ߩฃ⾨⁁ᴫߥߒ9㧚␠ળᵴേ
㋈ᧁᐽਯ㧦1㧕 ෘ↢ഭ௛⋭╙ 102 ࿁කᏧ࿖ኅ⹜㛎⹜㛎ᆔຬ(㨪⃻࿷)⮮ፒ๺ᒾ㧦1㧕 ක≮♽ᄢቇ㑆౒↪⹜㛎ታᣉ⹏ଔᯏ᭴කቇ♽ OSCE ੐ᓟ⹏ଔ⸃ᨆዊᆔຬળᆔຬ㧘ቇ⠌࡮⹏ଔ㗄⋡╬ᡷ⸓ኾ㐷ㇱળᆔຬ㧘⺖㗴ᡷ⸓ኾ㐷ㇱળᆔຬ(㨪⃻࿷)2㧕 ᄢቇၮḰදળ‫ࠆ޽⦡․ޟ‬ᄢቇᢎ⢒ᡰេࡊࡠࠣ࡜ࡓ‫(࡯࡝ࠚࡈ࡟࡯ࡄ࡯ࡍޠ‬㨪⃻࿷)3㧕 ෘ↢ഭ௛⋭╙ 101 ࿁කᏧ࿖ኅ⹜㛎 ⹜㛎ᆔຬ(㨪⃻࿷)4㧕 ෘ↢ഭ௛⋭╙ 102 ࿁කᏧ࿖ኅ⹜㛎 ⹜㛎ᆔຬ(㨪⃻࿷)10㧚ႎ๔ᦠ
1㧕 ⮮ፒ๺ᒾ㧦⥃ᐥ୶ℂታ〣ߩߚ߼ߩࠦࡒࡘ࠾ࠤ࡯࡚ࠪࡦ㧦ᣣᧄකቇᢎ⢒ቇળ୶ℂ࡮ⴕേ⑼ቇዊᆔຬળ
╙ 3 ࿁⥃ᐥ⎇ୃᜰዉ⠪ߩߚ߼ߩ୶ℂᢎ⢒ࡢ࡯࡚ࠢࠪ࠶ࡊႎ๔ᦠ㧦55㧙58(2008 ᐕ 1 ᦬)
2㧕 ⮮ፒ๺ᒾ㧘਄↸੝Ꮧሶ㧦⮎ቇㇱ 6 ᐕ೙߳́ߎࠇ߆ࠄߩ⮎೷Ꮷߦ᳞߼ࠄࠇࠆࠦࡒࡘ࠾ࠤ࡯࡚ࠪࡦࠬࠠ
࡞㧦㒋␹࡮᷆〝ᄢ㔡ἴᓟߩ࿾ၞ␠ળߣߩ౒↢ࠍ߼ߑߒߚᄢቇߩᣂߒ޿ᓎഀߦ㑐ߔࠆታ〣⊛⎇ⓥႎ๔
ᦠ╙ 27 ภ㧦1㧙50(2008 ᐕ 1 ᦬)
3㧕 ਤ⠀㓷ਯ㧦╙ 28 ࿁කቇᢎ⢒࠮ࡒ࠽࡯ߣࡢ࡯࡚ࠢࠪ࠶ࡊ ࠕ࠽࠙ࡦࠬࡔࡦ࠻㧦කቇᢎ⢒ 38㧦86(2008ᐕ 3 ᦬)
4㧕 ਤ⠀㓷ਯ㧦╙ 29 ࿁කቇᢎ⢒࠮ࡒ࠽࡯ߣࡢ࡯࡚ࠢࠪ࠶ࡊ ࠾ࡘ࡯࠭㧦කቇᢎ⢒ 38㧦359(2008 ᐕ 10 ᦬)
5㧕 ਤ⠀㓷ਯ㧦╙ 30 ࿁කቇᢎ⢒࠮ࡒ࠽࡯ߣࡢ࡯࡚ࠢࠪ࠶ࡊ ࠕ࠽࠙ࡦࠬࡔࡦ࠻㧦කቇᢎ⢒ 39㧦346(2008ᐕ 10 ᦬)6㧕 ਤ⠀㓷ਯ㧦╙ 31 ࿁කቇᢎ⢒࠮ࡒ࠽࡯ߣࡢ࡯࡚ࠢࠪ࠶ࡊ ࠕ࠽࠙ࡦࠬࡔࡦ࠻㧦කቇᢎ⢒ 39㧦469(2008ᐕ 12 ᦬)7㧕 㒙ㇱᕺሶ㧘⮮ፒ๺ᒾ㧘ਤ⠀㓷ਯ㧘㋈ᧁᐽਯ㧘Phillip Evans㧦⁛⥄ᕈ⼾߆ߥ SP 㙃ᚑࡊࡠࠣ࡜ࡓ́ࠬ
ࠦ࠶࠻࡜ࡦ࠼ 5 ᄢቇⷞኤႎ๔́㧦කቇᢎ⢒ 39㧦199㧙204(2008 ᐕ)
8㧕 㒙ㇱᕺሶ㧘㋈ᧁን㓶㧘⮮ፒ๺ᒾ㧘઻ାᄥ㇢㧦ᮡḰᮨᡆᖚ⠪ߩ✵⠌⁁ᴫߣ OSCE ߦኻߔࠆᗧ⼂ ో࿖⺞ᩏ╙ 2 ႎ㧦කቇᢎ⢒ 39㧦259㧙266(2008 ᐕ)
11㧚ႎ㆏
1㧕 ⮮ፒ๺ᒾ㧦Ꮢ᳃߇ᮨᡆᖚ⠪ߣߒߡෳടߔࠆකቇᢎ⢒㧦Medical Tribune(2008 ᐕ 2 ᦬ 21 ᣣ)
2㧕 ⮮ፒ๺ᒾ㧦ᧂ᧪ߩකᏧ߇᧪ߥ޿㨪⎇ୃක࠯ࡠߩⴣ᠄㨪㧦NHK ࠽ࡆࠥ࡯࡚ࠪࡦ ࠬ࠲ࠫࠝ⸃⺑(2008ᐕ 6 ᦬ 6 ᣣ)
3㧕 㒙ㇱᕺሶ㧘⮮ፒ๺ᒾ㧦ᖚ⠪ࠍ↢߈ࠆ ᮨᡆᖚ⠪ ᖱႎ✬㧦ᦺᣣᣂ⡞(2008 ᐕ 10 ᦬ 5 ᣣ)
4㧕 ⮮ፒ๺ᒾ㧦ᖚ⠪ࠍ↢߈ࠆ ᮨᡆᖚ⠪ ᖱႎ✬㧦ᦺᣣᣂ⡞(2008 ᐕ 10 ᦬ 10 ᣣ)
12㧚⥄Ꮖ⹏ଔ
⹏ଔ
ᐔᚑ 20 ᐕ 4 ᦬ߦ㐿⻠ߒߡ㑆߽ߥ޿ߚ߼㧘߹ߛలಽߥ⹏ଔߪ಴᧪ߥ޿߇㧘એਅߩࠃ߁ߥ⎇ⓥࠍផㅴߔࠆ
⸘↹ߢ޽ࠆ‫ᧄޕ‬ᐕᐲ㧘ᄢቇ㒮↢㧔␠ળੱ㧕ࠍ 1 ฬฃߌ౉ࠇ㧘ᢎ⢒ࠍ㐿ᆎߒߚ‫ޕ‬1㧕ࠞ࡝ࠠࡘ࡜ࡓ㐿⊒ߣቇ↢⹏ଔᴺ
2㧕ࠦࡒࡘ࠾ࠤ࡯࡚ࠪࡦᢎ⢒ߣ Professionalism ᢎ⢒3㧕ࠃࠅലᨐ⊛ߥ⢻േ⊛໧㗴ၮ⋚ဳቇ⠌
4㧕ࠪࡒࡘ࡟࡯࡚ࠪࡦᢎ⢒࡮⥃ᐥࠬࠠ࡞ᢎ⢒ߣ E-learning ߩⲢว
5㧕࿾ၞၮ⋚ဳකቇᢎ⢒ߣ✚วකߩ⢒ᚑᣇᴺ
6㧕ࠃࠅലᨐ⊛ߥ⥃ᐥᢎ⢒ᴺ࡮ᜰዉᴺߩ㐿⊒7㧕ᣣᧄߦ߅ߌࠆකቇᢎ⢒ቇ⎇ⓥߩផㅴߣኾ㐷ኅ⢒ᚑ㧙㧙⃻⁁ߩ໧㗴ὐ෸߮ߘߩኻᔕ╷කቇᢎ⢒ቇߩ⎇ⓥߩᱧผߪᵻߊ㧘߹ߚ⎇ⓥᚻᴺ߽৻⥸⊛ߥකቇ↢‛ቇ㗔ၞߩ⎇ⓥߣᄢ߈ߊ⇣ߥࠆ߇㧘᰷☨ߢߪ 1 ߟߩ⎇ⓥಽ㊁ߣߒߡቯ⌕ߒߡ޿ࠆ‫ᧄޕ‬㇌ߦ߅޿ߡ߽කቇᢎ⢒ቇಽ㊁ߩሽ࿷ߦ㑐ߒߡ⹺⼂ࠍᐢ߼ࠆᔅⷐᕈ߇޽ࠆ‫⎇ߚ߹ޕ‬ⓥᚻᴺࠍ⏕┙ߒ᥉෸ߔࠆᓎഀ߽ᜂߞߡ޿ࠆߣ⠨߃ߡ޿ࠆ‫ߪߢ⁁⃻ޕ‬කቇᢎ⢒⎇ⓥಽ㊁ߦ㑐ᔃࠍ␜ߔකᏧ࡮ක≮㑐ଥ⠪ߪ߹ߛዋߥ޿߇㧘ẜ࿷⊛࠾࡯࠭ߪᄢ߈޿ߣᦼᓙߐࠇࠆߩߢ㧘ߘߩ⊒ជߦദ߼ߚ޿‫ޕ‬੹ᓟߩዷᦸ
ᧄಽ㊁߇ᄢቇ㒮ߩ৻ಽ㊁ߣߒߡ⏕┙ߔࠆߎߣ߇ᒰ㕙ߩ⋡ᮡߢ޽ࠅ㧘⌕ታߥ⎇ⓥᚑᨐߩ⊒ାߣੱ᧚⢒ᚑࠍㅢߒߡ㧘ᣣᧄߦ߅ߌࠆකቇᢎ⢒ቇߩ⏕┙ߦ⽸₂ߔࠆߎߣ߇ਛ㐳ᦼ⊛ߥ⋡ᮡߢ޽ࠆ‫ߦࠄߐޕ‬࿖㓙੤ᵹࠍㅢߓߡ㧘ᣣᧄߩකቇᢎ⢒ࠍ਎⇇ߦ⊒ାߒߡⴕ߈ߚ޿ߣ⠨߃ߡ޿ࠆ‫ޕ‬㧙㧙